These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
|
91-1962278
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
3003 Tasman Drive, Santa Clara, California
|
|
95054-1191
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
|
Page
|
|
|
|
Item 1.
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
Item 2.
|
||
|
|
|
Item 3.
|
||
|
|
|
Item 4.
|
||
|
|
|
|
|
|
Item 1.
|
||
|
|
|
Item 1A.
|
||
|
|
|
Item 2.
|
||
|
|
|
Item 3.
|
||
|
|
|
Item 4.
|
||
|
|
|
Item 5.
|
||
|
|
|
Item 6.
|
||
|
|
|
|
|
|
(Dollars in thousands, except par value and share data)
|
|
March 31,
2017 |
|
December 31,
2016 |
||||
Assets
|
|
|
|
|
||||
Cash and cash equivalents
|
|
$
|
3,795,679
|
|
|
$
|
2,545,750
|
|
Available-for-sale securities, at fair value (cost of $12,360,744 and $12,588,783, respectively)
|
|
12,384,007
|
|
|
12,620,411
|
|
||
Held-to-maturity securities, at cost (fair value of $8,567,817 and $8,376,138, respectively)
|
|
8,615,695
|
|
|
8,426,998
|
|
||
Non-marketable and other securities
|
|
635,550
|
|
|
622,552
|
|
||
Total investment securities
|
|
21,635,252
|
|
|
21,669,961
|
|
||
Loans, net of unearned income
|
|
20,427,451
|
|
|
19,899,944
|
|
||
Allowance for loan losses
|
|
(243,130
|
)
|
|
(225,366
|
)
|
||
Net loans
|
|
20,184,321
|
|
|
19,674,578
|
|
||
Premises and equipment, net of accumulated depreciation and amortization
|
|
122,304
|
|
|
120,683
|
|
||
Accrued interest receivable and other assets
|
|
675,783
|
|
|
672,688
|
|
||
Total assets
|
|
$
|
46,413,339
|
|
|
$
|
44,683,660
|
|
Liabilities and total equity
|
|
|
|
|
||||
Liabilities:
|
|
|
|
|
||||
Noninterest-bearing demand deposits
|
|
$
|
33,587,934
|
|
|
$
|
31,975,457
|
|
Interest-bearing deposits
|
|
7,491,766
|
|
|
7,004,411
|
|
||
Total deposits
|
|
41,079,700
|
|
|
38,979,868
|
|
||
Short-term borrowings
|
|
5,163
|
|
|
512,668
|
|
||
Other liabilities
|
|
629,555
|
|
|
618,383
|
|
||
Long-term debt
|
|
795,465
|
|
|
795,704
|
|
||
Total liabilities
|
|
42,509,883
|
|
|
40,906,623
|
|
||
Commitments and contingencies (Note 12 and Note 15)
|
|
|
|
|
|
|||
SVBFG stockholders’ equity:
|
|
|
|
|
||||
Preferred stock, $0.001 par value, 20,000,000 shares authorized; no shares issued and outstanding
|
|
—
|
|
|
—
|
|
||
Common stock, $0.001 par value, 150,000,000 shares authorized; 52,427,709 shares and 52,254,074 shares outstanding, respectively
|
|
52
|
|
|
52
|
|
||
Additional paid-in capital
|
|
1,268,507
|
|
|
1,242,741
|
|
||
Retained earnings
|
|
2,477,814
|
|
|
2,376,331
|
|
||
Accumulated other comprehensive income
|
|
17,958
|
|
|
23,430
|
|
||
Total SVBFG stockholders’ equity
|
|
3,764,331
|
|
|
3,642,554
|
|
||
Noncontrolling interests
|
|
139,125
|
|
|
134,483
|
|
||
Total equity
|
|
3,903,456
|
|
|
3,777,037
|
|
||
Total liabilities and total equity
|
|
$
|
46,413,339
|
|
|
$
|
44,683,660
|
|
|
|
Three months ended March 31,
|
||||||
(Dollars in thousands, except per share amounts)
|
|
2017
|
|
2016
|
||||
Interest income:
|
|
|
|
|
||||
Loans
|
|
$
|
227,341
|
|
|
$
|
197,942
|
|
Investment securities:
|
|
|
|
|
||||
Taxable
|
|
89,803
|
|
|
91,050
|
|
||
Non-taxable
|
|
646
|
|
|
596
|
|
||
Federal funds sold, securities purchased under agreements to resell and other short-term investment securities
|
|
3,136
|
|
|
2,070
|
|
||
Total interest income
|
|
320,926
|
|
|
291,658
|
|
||
Interest expense:
|
|
|
|
|
||||
Deposits
|
|
1,717
|
|
|
1,188
|
|
||
Borrowings
|
|
9,216
|
|
|
9,049
|
|
||
Total interest expense
|
|
10,933
|
|
|
10,237
|
|
||
Net interest income
|
|
309,993
|
|
|
281,421
|
|
||
Provision for credit losses (1)
|
|
30,734
|
|
|
33,475
|
|
||
Net interest income after provision for credit losses
|
|
279,259
|
|
|
247,946
|
|
||
Noninterest income:
|
|
|
|
|
||||
Gains (losses) on investment securities, net
|
|
15,970
|
|
|
(4,684
|
)
|
||
Gains on equity warrant assets, net (2)
|
|
6,690
|
|
|
6,606
|
|
||
Foreign exchange fees
|
|
26,247
|
|
|
26,966
|
|
||
Credit card fees
|
|
17,730
|
|
|
15,507
|
|
||
Deposit service charges
|
|
13,975
|
|
|
12,672
|
|
||
Client investment fees
|
|
9,026
|
|
|
7,995
|
|
||
Lending related fees
|
|
8,961
|
|
|
7,813
|
|
||
Letters of credit and standby letters of credit fees
|
|
6,639
|
|
|
5,589
|
|
||
Other (2)
|
|
12,421
|
|
|
7,670
|
|
||
Total noninterest income
|
|
117,659
|
|
|
86,134
|
|
||
Noninterest expense:
|
|
|
|
|
||||
Compensation and benefits
|
|
147,176
|
|
|
122,262
|
|
||
Professional services
|
|
25,419
|
|
|
19,000
|
|
||
Premises and equipment
|
|
15,858
|
|
|
14,984
|
|
||
Business development and travel
|
|
9,195
|
|
|
12,246
|
|
||
Net occupancy
|
|
11,651
|
|
|
10,035
|
|
||
FDIC and state assessments
|
|
8,682
|
|
|
6,927
|
|
||
Correspondent bank fees
|
|
3,445
|
|
|
3,652
|
|
||
Other
|
|
16,207
|
|
|
14,793
|
|
||
Total noninterest expense (1)
|
|
237,633
|
|
|
203,899
|
|
||
Income before income tax expense
|
|
159,285
|
|
|
130,181
|
|
||
Income tax expense (3)
|
|
51,405
|
|
|
53,584
|
|
||
Net income before noncontrolling interests
|
|
107,880
|
|
|
76,597
|
|
||
Net (income) loss attributable to noncontrolling interests
|
|
(6,397
|
)
|
|
2,577
|
|
||
Net income available to common stockholders (3)
|
|
$
|
101,483
|
|
|
$
|
79,174
|
|
Earnings per common share—basic (3)
|
|
$
|
1.94
|
|
|
$
|
1.53
|
|
Earnings per common share—diluted (3)
|
|
1.91
|
|
|
1.52
|
|
|
(1)
|
Our consolidated statements of income were modified from prior period's presentation to conform to the current period's presentation, which reflects our provision for loan losses and provision for unfunded credit commitments together as our “provision for credit losses”. In prior periods, our provision for unfunded credit commitments were reported as a component of noninterest expense.
|
(2)
|
Our consolidated statements of income were modified from prior period's presentation to conform to the current period's presentation, which reflects a new line item to separately disclose net gains on equity warrant assets. In prior periods, net gains on equity warrant assets were reported as a component of gains on derivative instruments, net. We removed the line item gains on derivative instruments, net and reclassified all other gains on derivative instruments, net to other noninterest income.
|
(3)
|
Included in income tax expense, net income available to common shareholders, earnings per common share-basic and earnings for common share-diluted, for the three months ended March 31, 2017, are tax benefits recognized associated with the adoption of Accounting Standards Update ("ASU") 2016-09, Improvements to Employee Share-Based Payment Accounting in the first quarter of 2017. This guidance was adopted on a prospective basis with no change to prior period amounts.
|
|
|
Three months ended March 31,
|
||||||
(Dollars in thousands)
|
|
2017
|
|
2016
|
||||
Net income before noncontrolling interests
|
|
$
|
107,880
|
|
|
$
|
76,597
|
|
Other comprehensive (loss) income, net of tax:
|
|
|
|
|
||||
Change in cumulative translation gains (losses):
|
|
|
|
|
||||
Foreign currency translation gains (losses)
|
|
957
|
|
|
(254
|
)
|
||
Related tax (expense) benefit
|
|
(390
|
)
|
|
104
|
|
||
Change in unrealized (losses) gains on available-for-sale securities:
|
|
|
|
|
||||
Unrealized holding (losses) gains
|
|
(7,757
|
)
|
|
170,831
|
|
||
Related tax benefit (expense)
|
|
3,136
|
|
|
(69,603
|
)
|
||
Reclassification adjustment for (gains) losses included in net income
|
|
(608
|
)
|
|
746
|
|
||
Related tax expense (benefit)
|
|
248
|
|
|
(304
|
)
|
||
Amortization of unrealized gains on securities transferred from available-for-sale to held-to-maturity
|
|
(1,771
|
)
|
|
(2,567
|
)
|
||
Related tax benefit
|
|
713
|
|
|
1,033
|
|
||
Other comprehensive (loss) income, net of tax
|
|
(5,472
|
)
|
|
99,986
|
|
||
Comprehensive income
|
|
102,408
|
|
|
176,583
|
|
||
Comprehensive (income) loss attributable to noncontrolling interests
|
|
(6,397
|
)
|
|
2,577
|
|
||
Comprehensive income attributable to SVBFG
|
|
$
|
96,011
|
|
|
$
|
179,160
|
|
|
|
Common Stock
|
|
Additional
Paid-in Capital |
|
Retained Earnings
|
|
Accumulated
Other Comprehensive Income |
|
Total SVBFG
Stockholders’ Equity |
|
Noncontrolling Interests
|
|
Total Equity
|
|||||||||||||||||
(Dollars in thousands)
|
|
Shares
|
|
Amount
|
|
|
|
|
|
|
|||||||||||||||||||||
Balance at December 31, 2015
|
|
51,610,226
|
|
|
$
|
52
|
|
|
$
|
1,189,032
|
|
|
$
|
1,993,646
|
|
|
$
|
15,404
|
|
|
$
|
3,198,134
|
|
|
$
|
135,097
|
|
|
$
|
3,333,231
|
|
Common stock issued under employee benefit plans, net of restricted stock cancellations
|
|
47,921
|
|
|
—
|
|
|
(250
|
)
|
|
—
|
|
|
—
|
|
|
(250
|
)
|
|
—
|
|
|
(250
|
)
|
|||||||
Common stock issued under ESOP
|
|
43,165
|
|
|
—
|
|
|
4,328
|
|
|
—
|
|
|
—
|
|
|
4,328
|
|
|
—
|
|
|
4,328
|
|
|||||||
Income tax effect from stock options exercised, vesting of restricted stock and other (1)
|
|
—
|
|
|
—
|
|
|
(8,483
|
)
|
|
—
|
|
|
—
|
|
|
(8,483
|
)
|
|
—
|
|
|
(8,483
|
)
|
|||||||
Net income (loss)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
79,174
|
|
|
—
|
|
|
79,174
|
|
|
(2,577
|
)
|
|
76,597
|
|
|||||||
Capital calls and distributions, net
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,524
|
)
|
|
(2,524
|
)
|
|||||||
Net change in unrealized gains and losses on AFS securities, net of tax
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
101,670
|
|
|
101,670
|
|
|
—
|
|
|
101,670
|
|
|||||||
Amortization of unrealized gains on securities transferred from AFS to HTM, net of tax
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,534
|
)
|
|
(1,534
|
)
|
|
—
|
|
|
(1,534
|
)
|
|||||||
Foreign currency translation adjustments, net of tax
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(150
|
)
|
|
(150
|
)
|
|
—
|
|
|
(150
|
)
|
|||||||
Share-based compensation, net
|
|
—
|
|
|
—
|
|
|
8,155
|
|
|
—
|
|
|
—
|
|
|
8,155
|
|
|
—
|
|
|
8,155
|
|
|||||||
Balance at March 31, 2016
|
|
51,701,312
|
|
|
$
|
52
|
|
|
$
|
1,192,782
|
|
|
$
|
2,072,820
|
|
|
$
|
115,390
|
|
|
$
|
3,381,044
|
|
|
$
|
129,996
|
|
|
$
|
3,511,040
|
|
Balance at December 31, 2016
|
|
52,254,074
|
|
|
$
|
52
|
|
|
$
|
1,242,741
|
|
|
$
|
2,376,331
|
|
|
$
|
23,430
|
|
|
$
|
3,642,554
|
|
|
$
|
134,483
|
|
|
$
|
3,777,037
|
|
Common stock issued under employee benefit plans, net of restricted stock cancellations
|
|
162,797
|
|
|
—
|
|
|
6,743
|
|
|
—
|
|
|
—
|
|
|
6,743
|
|
|
—
|
|
|
6,743
|
|
|||||||
Common stock issued under ESOP
|
|
10,838
|
|
|
—
|
|
|
2,094
|
|
|
—
|
|
|
—
|
|
|
2,094
|
|
|
—
|
|
|
2,094
|
|
|||||||
Income tax effect from stock options exercised, vesting of restricted stock and other (1)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
101,483
|
|
|
—
|
|
|
101,483
|
|
|
6,397
|
|
|
107,880
|
|
|||||||
Capital calls and distributions, net
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,755
|
)
|
|
(1,755
|
)
|
|||||||
Net change in unrealized gains and losses on AFS securities, net of tax
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(4,981
|
)
|
|
(4,981
|
)
|
|
—
|
|
|
(4,981
|
)
|
|||||||
Amortization of unrealized gains on securities transferred from AFS to HTM, net of tax
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,058
|
)
|
|
(1,058
|
)
|
|
—
|
|
|
(1,058
|
)
|
|||||||
Foreign currency translation adjustments, net of tax
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
567
|
|
|
567
|
|
|
—
|
|
|
567
|
|
|||||||
Share-based compensation, net
|
|
—
|
|
|
—
|
|
|
16,929
|
|
|
—
|
|
|
—
|
|
|
16,929
|
|
|
—
|
|
|
16,929
|
|
|||||||
Balance at March 31, 2017
|
|
52,427,709
|
|
|
$
|
52
|
|
|
$
|
1,268,507
|
|
|
$
|
2,477,814
|
|
|
$
|
17,958
|
|
|
$
|
3,764,331
|
|
|
$
|
139,125
|
|
|
$
|
3,903,456
|
|
|
(1)
|
During the first quarter of 2017 we adopted ASU 2016-09, Improvements to Employee Share-Based Payment Accounting. The amendments in this ASU require that all excess tax benefits and tax deficiencies associated with share-based compensation be recognized in income tax expense or benefit in the income statement. Previously, tax effects resulting from changes in the Company's share price subsequent to grant date of share-based compensation awards were recorded through additional paid-in-capital in stockholders' equity at the time of vesting and exercise. This guidance was adopted on a prospective basis with no change to prior period amounts. See
Note 1—"Basis of Presentation" of the "Notes to Interim Consolidated Financial Statements (unaudited)" under Part I, Item 1 of this report
for additional details.
|
|
|
Three months ended March 31,
|
||||||
(Dollars in thousands)
|
|
2017
|
|
2016
|
||||
Cash flows from operating activities:
|
|
|
|
|
||||
Net income before noncontrolling interests
|
|
$
|
107,880
|
|
|
$
|
76,597
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
|
||||
Provision for credit losses
|
|
30,734
|
|
|
33,475
|
|
||
Changes in fair values of equity warrant assets, net of proceeds from exercises
|
|
(1,545
|
)
|
|
(2,317
|
)
|
||
Changes in fair values of derivatives, net
|
|
3,887
|
|
|
3,159
|
|
||
(Gains) losses on investment securities, net
|
|
(15,970
|
)
|
|
4,684
|
|
||
Depreciation and amortization
|
|
12,391
|
|
|
11,536
|
|
||
Amortization of premiums and discounts on investment securities, net
|
|
400
|
|
|
4,931
|
|
||
Amortization of share-based compensation
|
|
9,203
|
|
|
6,877
|
|
||
Amortization of deferred loan fees
|
|
(23,650
|
)
|
|
(24,042
|
)
|
||
Deferred income tax benefit
|
|
(15,386
|
)
|
|
(5,982
|
)
|
||
Excess tax benefit from exercise of stock options and vesting of restricted shares (1)
|
|
(6,063
|
)
|
|
—
|
|
||
Changes in other assets and liabilities:
|
|
|
|
|
||||
Accrued interest receivable and payable, net
|
|
(6,750
|
)
|
|
(4,628
|
)
|
||
Accounts receivable and payable, net
|
|
(1,976
|
)
|
|
552
|
|
||
Income tax receivable and payable, net
|
|
65,524
|
|
|
28,711
|
|
||
Accrued compensation
|
|
(89,653
|
)
|
|
(101,241
|
)
|
||
Foreign exchange spot contracts, net
|
|
30,995
|
|
|
9,541
|
|
||
Other, net
|
|
(3,290
|
)
|
|
14,208
|
|
||
Net cash provided by operating activities
|
|
96,731
|
|
|
56,061
|
|
||
Cash flows from investing activities:
|
|
|
|
|
||||
Purchases of available-for-sale securities
|
|
(595,543
|
)
|
|
—
|
|
||
Proceeds from sales of available-for-sale securities
|
|
2,078
|
|
|
1,864,396
|
|
||
Proceeds from maturities and pay downs of available-for-sale securities
|
|
824,551
|
|
|
364,101
|
|
||
Purchases of held-to-maturity securities
|
|
(589,855
|
)
|
|
(98,199
|
)
|
||
Proceeds from maturities and pay downs of held-to-maturity securities
|
|
416,206
|
|
|
351,834
|
|
||
Purchases of non-marketable and other securities
|
|
(545
|
)
|
|
(12,412
|
)
|
||
Proceeds from sales and distributions of non-marketable and other securities
|
|
26,950
|
|
|
9,977
|
|
||
Net increase in loans
|
|
(519,454
|
)
|
|
(991,939
|
)
|
||
Purchases of premises and equipment
|
|
(10,599
|
)
|
|
(13,680
|
)
|
||
Net cash (used for) provided by investing activities
|
|
(446,211
|
)
|
|
1,474,078
|
|
||
Cash flows from financing activities:
|
|
|
|
|
||||
Net increase (decrease) in deposits
|
|
2,099,832
|
|
|
(383,055
|
)
|
||
Net decrease in short-term borrowings
|
|
(507,505
|
)
|
|
(774,900
|
)
|
||
(Distributions to noncontrolling interests), net of contributions from noncontrolling interests
|
|
(1,755
|
)
|
|
(2,524
|
)
|
||
Tax effect from stock exercises (1)
|
|
—
|
|
|
(8,483
|
)
|
||
Proceeds from issuance of common stock, ESPP, and ESOP
|
|
8,837
|
|
|
4,078
|
|
||
Net cash provided by (used for) financing activities
|
|
1,599,409
|
|
|
(1,164,884
|
)
|
||
Net increase in cash and cash equivalents
|
|
1,249,929
|
|
|
365,255
|
|
||
Cash and cash equivalents at beginning of period
|
|
2,545,750
|
|
|
1,503,257
|
|
||
Cash and cash equivalents at end of period
|
|
$
|
3,795,679
|
|
|
$
|
1,868,512
|
|
Supplemental disclosures:
|
|
|
|
|
||||
Cash paid during the period for:
|
|
|
|
|
||||
Interest
|
|
$
|
17,956
|
|
|
$
|
17,407
|
|
Income taxes
|
|
3,304
|
|
|
35,778
|
|
||
Noncash items during the period:
|
|
|
|
|
||||
Changes in unrealized gains and losses on available-for-sale securities, net of tax
|
|
$
|
(4,981
|
)
|
|
$
|
101,670
|
|
Distributions of stock from investments
|
|
357
|
|
|
34
|
|
|
(1)
|
During the first quarter of 2017 we adopted ASU 2016-09, Improvements to Employee Share-Based Payment Accounting. This guidance was adopted on a prospective basis with no change to prior period amounts. See
Note 1—"Basis of Presentation" of the "Notes to Interim Consolidated Financial Statements (unaudited)" under Part I, Item 1 of this report
for additional details.
|
1.
|
Basis of Presentation
|
2.
|
Stockholders’ Equity and EPS
|
|
|
|
|
Three months ended March 31,
|
||||||
(Dollars in thousands)
|
|
Income Statement Location
|
|
2017
|
|
2016
|
||||
Reclassification adjustment for (gains) losses included in net income
|
|
Gains (losses) on investment securities, net
|
|
$
|
(608
|
)
|
|
$
|
746
|
|
Related tax expense (benefit)
|
|
Income tax expense
|
|
248
|
|
|
(304
|
)
|
||
Total reclassification adjustment for (gains) losses included in net income, net of tax
|
|
|
|
$
|
(360
|
)
|
|
$
|
442
|
|
|
|
Three months ended March 31,
|
||||||
(Dollars and shares in thousands, except per share amounts)
|
|
2017
|
|
2016
|
||||
Numerator:
|
|
|
|
|
||||
Net income available to common stockholders
|
|
$
|
101,483
|
|
|
$
|
79,174
|
|
Denominator:
|
|
|
|
|
||||
Weighted average common shares outstanding-basic
|
|
52,344
|
|
|
51,646
|
|
||
Weighted average effect of dilutive securities:
|
|
|
|
|
||||
Stock options and ESPP
|
|
440
|
|
|
264
|
|
||
Restricted stock units
|
|
395
|
|
|
175
|
|
||
Denominator for diluted calculation
|
|
53,179
|
|
|
52,085
|
|
||
Earnings per common share:
|
|
|
|
|
||||
Basic
|
|
$
|
1.94
|
|
|
$
|
1.53
|
|
Diluted
|
|
$
|
1.91
|
|
|
$
|
1.52
|
|
|
|
Three months ended March 31,
|
||||
(Shares in thousands)
|
|
2017
|
|
2016
|
||
Stock options
|
|
—
|
|
|
351
|
|
Restricted stock units
|
|
21
|
|
|
14
|
|
Total
|
|
21
|
|
|
365
|
|
3.
|
Share-Based Compensation
|
|
|
Three months ended March 31,
|
||||||
(Dollars in thousands)
|
|
2017
|
|
2016
|
||||
Share-based compensation expense
|
|
$
|
9,203
|
|
|
$
|
6,877
|
|
Income tax benefit related to share-based compensation expense
|
|
(3,015
|
)
|
|
(2,117
|
)
|
(Dollars in thousands)
|
|
Unrecognized
Expense
|
|
Weighted Average
Expected
Recognition
Period - in Years
|
||
Stock options
|
|
$
|
8,005
|
|
|
2.27
|
Restricted stock units
|
|
42,706
|
|
|
2.50
|
|
Total unrecognized share-based compensation expense
|
|
$
|
50,711
|
|
|
|
|
|
Options
|
|
Weighted
Average
Exercise Price
|
|
Weighted Average Remaining Contractual Life - in Years
|
|
Aggregate
Intrinsic Value
of In-The-
Money
Options
|
|||||
Outstanding at December 31, 2016
|
|
1,010,557
|
|
|
$
|
87.24
|
|
|
|
|
|
||
Exercised
|
|
(140,698
|
)
|
|
65.76
|
|
|
|
|
|
|||
Forfeited
|
|
(1,605
|
)
|
|
93.18
|
|
|
|
|
|
|||
Outstanding at March 31, 2017
|
|
868,254
|
|
|
90.71
|
|
|
3.80
|
|
$
|
82,818,255
|
|
|
Vested and expected to vest at March 31, 2017
|
|
848,536
|
|
|
90.25
|
|
|
3.76
|
|
81,319,775
|
|
||
Exercisable at March 31, 2017
|
|
442,135
|
|
|
76.45
|
|
|
2.69
|
|
48,474,704
|
|
|
|
Shares
|
|
Weighted Average Grant Date Fair Value
|
|||
Nonvested at December 31, 2016
|
|
670,969
|
|
|
$
|
106.64
|
|
Granted
|
|
54,240
|
|
|
185.72
|
|
|
Vested
|
|
(36,414
|
)
|
|
105.65
|
|
|
Forfeited
|
|
(9,263
|
)
|
|
107.70
|
|
|
Nonvested at March 31, 2017
|
|
679,532
|
|
|
112.99
|
|
4.
|
Variable Interest Entities
|
(Dollars in thousands)
|
|
Consolidated VIEs
|
|
Unconsolidated VIEs
|
|
Maximum Exposure to Loss in Unconsolidated VIEs
|
||||||
March 31, 2017:
|
|
|
|
|
|
|
||||||
Assets:
|
|
|
|
|
|
|
||||||
Cash and cash equivalents
|
|
$
|
10,959
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Non-marketable and other securities (1)
|
|
196,708
|
|
|
326,169
|
|
|
326,169
|
|
|||
Accrued interest receivable and other assets
|
|
236
|
|
|
—
|
|
|
—
|
|
|||
Total assets
|
|
$
|
207,903
|
|
|
$
|
326,169
|
|
|
$
|
326,169
|
|
Liabilities:
|
|
|
|
|
|
|
||||||
Other liabilities (1)
|
|
387
|
|
|
81,650
|
|
|
—
|
|
|||
Total liabilities
|
|
$
|
387
|
|
|
$
|
81,650
|
|
|
$
|
—
|
|
December 31, 2016:
|
|
|
|
|
|
|
||||||
Assets:
|
|
|
|
|
|
|
||||||
Cash and cash equivalents
|
|
$
|
11,469
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Non-marketable and other securities (1)
|
|
196,140
|
|
|
314,810
|
|
|
314,810
|
|
|||
Accrued interest receivable and other assets
|
|
294
|
|
|
—
|
|
|
—
|
|
|||
Total assets
|
|
$
|
207,903
|
|
|
$
|
314,810
|
|
|
$
|
314,810
|
|
Liabilities:
|
|
|
|
|
|
|
||||||
Other liabilities (1)
|
|
517
|
|
|
58,095
|
|
|
—
|
|
|||
Total liabilities
|
|
$
|
517
|
|
|
$
|
58,095
|
|
|
$
|
—
|
|
|
(1)
|
Included in our unconsolidated non-marketable and other securities portfolio at
March 31, 2017
and
December 31, 2016
are investments in qualified affordable housing projects of
$132.8 million
and
$112.4 million
, respectively, and related unfunded commitments of
$81.7 million
and
$58.1 million
, respectively.
|
5.
|
Cash and Cash Equivalents
|
(Dollars in thousands)
|
|
March 31, 2017
|
|
December 31, 2016
|
||||
Cash and due from banks (1)
|
|
$
|
3,612,954
|
|
|
$
|
2,476,588
|
|
Securities purchased under agreements to resell (2)
|
|
178,037
|
|
|
64,028
|
|
||
Other short-term investment securities
|
|
4,688
|
|
|
5,134
|
|
||
Total cash and cash equivalents
|
|
$
|
3,795,679
|
|
|
$
|
2,545,750
|
|
|
(1)
|
At
March 31, 2017
and
December 31, 2016
,
$2.4 billion
and
$1.1 billion
, respectively, of our cash and due from banks was deposited at the Federal Reserve Bank and was earning interest at the Federal Funds target rate, and interest-earning deposits in other financial institutions were
$773 million
and
$721 million
, respectively.
|
(2)
|
At
March 31, 2017
and
December 31, 2016
, securities purchased und
er agreements to resell were collateralized by U.S. Treasury securities and U.S. agency securities with aggregate fair values of
$182 million
an
d
$66 million
, respectively. None of these securities were sold or repledged as of
March 31, 2017
and
December 31, 2016
.
|
6.
|
Investment Securities
|
|
|
March 31, 2017
|
||||||||||||||
(Dollars in thousands)
|
|
Amortized
Cost
|
|
Unrealized
Gains
|
|
Unrealized
Losses
|
|
Carrying
Value
|
||||||||
Available-for-sale securities, at fair value:
|
|
|
|
|
|
|
|
|
||||||||
U.S. Treasury securities
|
|
$
|
8,182,666
|
|
|
$
|
24,878
|
|
|
$
|
(1,454
|
)
|
|
$
|
8,206,090
|
|
U.S. agency debentures
|
|
2,066,507
|
|
|
12,763
|
|
|
(1,457
|
)
|
|
2,077,813
|
|
||||
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
||||||||
Agency-issued collateralized mortgage obligations—fixed rate
|
|
1,661,505
|
|
|
2,707
|
|
|
(13,883
|
)
|
|
1,650,329
|
|
||||
Agency-issued collateralized mortgage obligations—variable rate
|
|
445,575
|
|
|
668
|
|
|
(662
|
)
|
|
445,581
|
|
||||
Equity securities
|
|
4,491
|
|
|
430
|
|
|
(727
|
)
|
|
4,194
|
|
||||
Total available-for-sale securities
|
|
$
|
12,360,744
|
|
|
$
|
41,446
|
|
|
$
|
(18,183
|
)
|
|
$
|
12,384,007
|
|
|
|
December 31, 2016
|
||||||||||||||
(Dollars in thousands)
|
|
Amortized
Cost
|
|
Unrealized
Gains
|
|
Unrealized
Losses
|
|
Carrying
Value
|
||||||||
Available-for-sale securities, at fair value:
|
|
|
|
|
|
|
|
|
||||||||
U.S. Treasury securities
|
|
$
|
8,880,358
|
|
|
$
|
30,323
|
|
|
$
|
(1,190
|
)
|
|
$
|
8,909,491
|
|
U.S. agency debentures
|
|
2,065,535
|
|
|
14,443
|
|
|
(1,603
|
)
|
|
2,078,375
|
|
||||
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
||||||||
Agency-issued collateralized mortgage obligations—fixed rate
|
|
1,163,017
|
|
|
3,046
|
|
|
(13,398
|
)
|
|
1,152,665
|
|
||||
Agency-issued collateralized mortgage obligations—variable rate
|
|
474,238
|
|
|
685
|
|
|
(640
|
)
|
|
474,283
|
|
||||
Equity securities
|
|
5,635
|
|
|
748
|
|
|
(786
|
)
|
|
5,597
|
|
||||
Total available-for-sale securities
|
|
$
|
12,588,783
|
|
|
$
|
49,245
|
|
|
$
|
(17,617
|
)
|
|
$
|
12,620,411
|
|
|
|
March 31, 2017
|
||||||||||||||||||||||
|
|
Less than 12 months
|
|
12 months or longer
|
|
Total
|
||||||||||||||||||
(Dollars in thousands)
|
|
Fair Value of
Investments
|
|
Unrealized
Losses
|
|
Fair Value of
Investments
|
|
Unrealized
Losses
|
|
Fair Value of
Investments
|
|
Unrealized
Losses
|
||||||||||||
Available-for-sale securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
U.S. Treasury securities
|
|
$
|
1,377,573
|
|
|
$
|
(1,454
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,377,573
|
|
|
$
|
(1,454
|
)
|
U.S. agency debentures
|
|
513,209
|
|
|
(1,457
|
)
|
|
—
|
|
|
—
|
|
|
513,209
|
|
|
(1,457
|
)
|
||||||
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Agency-issued collateralized mortgage obligations—fixed rate
|
|
843,542
|
|
|
(7,607
|
)
|
|
214,507
|
|
|
(6,276
|
)
|
|
1,058,049
|
|
|
(13,883
|
)
|
||||||
Agency-issued collateralized mortgage obligations—variable rate
|
|
179,675
|
|
|
(454
|
)
|
|
48,464
|
|
|
(208
|
)
|
|
228,139
|
|
|
(662
|
)
|
||||||
Equity securities
|
|
2,042
|
|
|
(727
|
)
|
|
—
|
|
|
—
|
|
|
2,042
|
|
|
(727
|
)
|
||||||
Total temporarily impaired securities: (1)
|
|
$
|
2,916,041
|
|
|
$
|
(11,699
|
)
|
|
$
|
262,971
|
|
|
$
|
(6,484
|
)
|
|
$
|
3,179,012
|
|
|
$
|
(18,183
|
)
|
|
(1)
|
As of
March 31, 2017
, we identified a total of
189
investments that were in unrealized loss positions, of which
36
investments totaling
$263.0 million
with unrealized losses of
$6.5 million
have been in an impaired position for a period of time greater than 12 months. As of
March 31, 2017
, we do not intend to sell any impaired fixed income investment securities prior to recovery of our adjusted cost basis, and it is more likely than not that we will not be required to sell any of our securities prior to recovery of our adjusted cost basis. Based on our analysis as of
March 31, 2017
, we deem all impairments to be temporary, and therefore changes in value for our temporarily impaired securities as of the same date are included in other comprehensive income. Market valuations and impairment analyses on assets in the available-for-sale securities portfolio are reviewed and monitored on a quarterly basis.
|
|
|
December 31, 2016
|
||||||||||||||||||||||
|
|
Less than 12 months
|
|
12 months or longer
|
|
Total
|
||||||||||||||||||
(Dollars in thousands)
|
|
Fair Value of
Investments
|
|
Unrealized
Losses
|
|
Fair Value of
Investments
|
|
Unrealized
Losses
|
|
Fair Value of
Investments
|
|
Unrealized
Losses
|
||||||||||||
Available-for-sale securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
U.S. Treasury securities
|
|
$
|
879,255
|
|
|
$
|
(1,190
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
879,255
|
|
|
$
|
(1,190
|
)
|
U.S. agency debentures
|
|
513,198
|
|
|
(1,603
|
)
|
|
—
|
|
|
—
|
|
|
513,198
|
|
|
(1,603
|
)
|
||||||
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Agency-issued collateralized mortgage obligations—fixed rate
|
|
635,566
|
|
|
(6,704
|
)
|
|
227,480
|
|
|
(6,694
|
)
|
|
863,046
|
|
|
(13,398
|
)
|
||||||
Agency-issued collateralized mortgage obligations—variable rate
|
|
258,325
|
|
|
(613
|
)
|
|
6,068
|
|
|
(27
|
)
|
|
264,393
|
|
|
(640
|
)
|
||||||
Equity securities
|
|
3,693
|
|
|
(786
|
)
|
|
—
|
|
|
—
|
|
|
3,693
|
|
|
(786
|
)
|
||||||
Total temporarily impaired securities (1):
|
|
$
|
2,290,037
|
|
|
$
|
(10,896
|
)
|
|
$
|
233,548
|
|
|
$
|
(6,721
|
)
|
|
$
|
2,523,585
|
|
|
$
|
(17,617
|
)
|
|
(1)
|
As of
December 31, 2016
, we identified a total of
174
investments that were in unrealized loss positions, of which
20
investments totaling
$233.5 million
with unrealized losses of
$6.7 million
have been in an impaired position for a period of time greater than 12 months.
|
|
|
March 31, 2017
|
||||||||||||||||||
(Dollars in thousands)
|
|
Total
|
|
One Year
or Less |
|
After One
Year to Five Years |
|
After Five
Years to Ten Years |
|
After
Ten Years |
||||||||||
U.S. Treasury securities
|
|
$
|
8,206,090
|
|
|
$
|
2,321,436
|
|
|
$
|
5,884,654
|
|
|
$
|
—
|
|
|
$
|
—
|
|
U.S. agency debentures
|
|
2,077,813
|
|
|
500,035
|
|
|
1,577,778
|
|
|
—
|
|
|
—
|
|
|||||
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Agency-issued collateralized mortgage obligations - fixed rate
|
|
1,650,329
|
|
|
—
|
|
|
—
|
|
|
622,312
|
|
|
1,028,017
|
|
|||||
Agency-issued collateralized mortgage obligations - variable rate
|
|
445,581
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
445,581
|
|
|||||
Total
|
|
$
|
12,379,813
|
|
|
$
|
2,821,471
|
|
|
$
|
7,462,432
|
|
|
$
|
622,312
|
|
|
$
|
1,473,598
|
|
|
|
March 31, 2017
|
||||||||||||||
(Dollars in thousands)
|
|
Amortized
Cost
|
|
Unrealized
Gains
|
|
Unrealized
Losses
|
|
Fair Value
|
||||||||
Held-to-maturity securities, at cost:
|
|
|
|
|
|
|
|
|
||||||||
U.S. agency debentures (1)
|
|
$
|
641,421
|
|
|
$
|
7,106
|
|
|
$
|
(1,948
|
)
|
|
$
|
646,579
|
|
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
||||||||
Agency-issued mortgage-backed securities
|
|
3,020,929
|
|
|
5,498
|
|
|
(16,694
|
)
|
|
3,009,733
|
|
||||
Agency-issued collateralized mortgage obligations—fixed rate
|
|
3,223,055
|
|
|
638
|
|
|
(30,595
|
)
|
|
3,193,098
|
|
||||
Agency-issued collateralized mortgage obligations—variable rate
|
|
299,257
|
|
|
217
|
|
|
(477
|
)
|
|
298,997
|
|
||||
Agency-issued commercial mortgage-backed securities
|
|
1,292,744
|
|
|
1,242
|
|
|
(11,558
|
)
|
|
1,282,428
|
|
||||
Municipal bonds and notes
|
|
138,289
|
|
|
295
|
|
|
(1,602
|
)
|
|
136,982
|
|
||||
Total held-to-maturity securities
|
|
$
|
8,615,695
|
|
|
$
|
14,996
|
|
|
$
|
(62,874
|
)
|
|
$
|
8,567,817
|
|
|
(1)
|
Consists of pools of Small Business Investment Company debentures issued and guaranteed by the U.S. Small Business Administration, an independent agency of the United States.
|
|
|
December 31, 2016
|
||||||||||||||
(Dollars in thousands)
|
|
Amortized
Cost |
|
Unrealized
Gains |
|
Unrealized
Losses |
|
Fair Value
|
||||||||
Held-to-maturity securities, at cost:
|
|
|
|
|
|
|
|
|
||||||||
U.S. agency debentures (1)
|
|
$
|
622,445
|
|
|
$
|
7,840
|
|
|
$
|
(1,198
|
)
|
|
$
|
629,087
|
|
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
||||||||
Agency-issued mortgage-backed securities
|
|
2,896,179
|
|
|
6,919
|
|
|
(24,526
|
)
|
|
2,878,572
|
|
||||
Agency-issued collateralized mortgage obligations—fixed rate
|
|
3,362,598
|
|
|
788
|
|
|
(31,274
|
)
|
|
3,332,112
|
|
||||
Agency-issued collateralized mortgage obligations—variable rate
|
|
312,665
|
|
|
176
|
|
|
(1,339
|
)
|
|
311,502
|
|
||||
Agency-issued commercial mortgage-backed securities
|
|
1,151,363
|
|
|
1,237
|
|
|
(7,638
|
)
|
|
1,144,962
|
|
||||
Municipal bonds and notes
|
|
81,748
|
|
|
8
|
|
|
(1,853
|
)
|
|
79,903
|
|
||||
Total held-to-maturity securities
|
|
$
|
8,426,998
|
|
|
$
|
16,968
|
|
|
$
|
(67,828
|
)
|
|
$
|
8,376,138
|
|
|
(1)
|
Consists of pools of Small Business Investment Company debentures issued and guaranteed by the U.S. Small Business Administration, an independent agency of the United States.
|
|
|
March 31, 2017
|
||||||||||||||||||||||
|
|
Less than 12 months
|
|
12 months or longer
|
|
Total
|
||||||||||||||||||
(Dollars in thousands)
|
|
Fair Value of
Investments
|
|
Unrealized
Losses
|
|
Fair Value of
Investments
|
|
Unrealized
Losses
|
|
Fair Value of
Investments
|
|
Unrealized
Losses
|
||||||||||||
Held-to-maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
U.S. agency debentures
|
|
$
|
117,916
|
|
|
$
|
(1,948
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
117,916
|
|
|
$
|
(1,948
|
)
|
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Agency-issued mortgage-backed securities
|
|
2,152,438
|
|
|
(15,863
|
)
|
|
21,350
|
|
|
(831
|
)
|
|
2,173,788
|
|
|
(16,694
|
)
|
||||||
Agency-issued collateralized mortgage obligations—fixed rate
|
|
2,749,432
|
|
|
(25,442
|
)
|
|
213,674
|
|
|
(5,153
|
)
|
|
2,963,106
|
|
|
(30,595
|
)
|
||||||
Agency-issued collateralized mortgage obligations—variable rate
|
|
89,927
|
|
|
(469
|
)
|
|
3,234
|
|
|
(8
|
)
|
|
93,161
|
|
|
(477
|
)
|
||||||
Agency-issued commercial mortgage-backed securities
|
|
1,106,777
|
|
|
(11,453
|
)
|
|
14,225
|
|
|
(105
|
)
|
|
1,121,002
|
|
|
(11,558
|
)
|
||||||
Municipal bonds and notes
|
|
38,086
|
|
|
(613
|
)
|
|
33,644
|
|
|
(989
|
)
|
|
71,730
|
|
|
(1,602
|
)
|
||||||
Total temporarily impaired securities (1):
|
|
$
|
6,254,576
|
|
|
$
|
(55,788
|
)
|
|
$
|
286,127
|
|
|
$
|
(7,086
|
)
|
|
$
|
6,540,703
|
|
|
$
|
(62,874
|
)
|
|
(1)
|
As of
March 31, 2017
, we identified a total of
478
investments that were in unrealized loss positions, of which
96
investments totaling
$286.1 million
with unrealized losses of
$7.1 million
have been in an impaired position for a period of time greater than 12 months. As of
March 31, 2017
, we do not intend to sell any impaired fixed income investment securities prior to recovery of our adjusted cost basis, and it is more likely than not that we will not be required to sell any of our securities prior to recovery of our adjusted cost basis, which is consistent with our classification of these securities. Based on our analysis as of
March 31, 2017
, we deem all impairments to be temporary. Market valuations and impairment analyses on assets in the held-to-maturity securities portfolio are reviewed and monitored on a quarterly basis.
|
|
|
December 31, 2016
|
||||||||||||||||||||||
|
|
Less than 12 months
|
|
12 months or longer
|
|
Total
|
||||||||||||||||||
(Dollars in thousands)
|
|
Fair Value of
Investments |
|
Unrealized
Losses |
|
Fair Value of
Investments |
|
Unrealized
Losses |
|
Fair Value of
Investments |
|
Unrealized
Losses |
||||||||||||
Held-to-maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
U.S. agency debentures
|
|
$
|
118,721
|
|
|
$
|
(1,198
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
118,721
|
|
|
$
|
(1,198
|
)
|
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Agency-issued mortgage-backed securities
|
|
1,801,861
|
|
|
(23,558
|
)
|
|
21,917
|
|
|
(968
|
)
|
|
1,823,778
|
|
|
(24,526
|
)
|
||||||
Agency-issued collateralized mortgage obligations—fixed rate
|
|
2,729,889
|
|
|
(25,723
|
)
|
|
228,220
|
|
|
(5,551
|
)
|
|
2,958,109
|
|
|
(31,274
|
)
|
||||||
Agency-issued collateralized mortgage obligations—variable rate
|
|
251,012
|
|
|
(1,339
|
)
|
|
—
|
|
|
—
|
|
|
251,012
|
|
|
(1,339
|
)
|
||||||
Agency-issued commercial mortgage-backed securities
|
|
999,440
|
|
|
(7,494
|
)
|
|
14,934
|
|
|
(144
|
)
|
|
1,014,374
|
|
|
(7,638
|
)
|
||||||
Municipal bonds and notes
|
|
42,267
|
|
|
(877
|
)
|
|
30,586
|
|
|
(976
|
)
|
|
72,853
|
|
|
(1,853
|
)
|
||||||
Total temporarily impaired securities (1):
|
|
$
|
5,943,190
|
|
|
$
|
(60,189
|
)
|
|
$
|
295,657
|
|
|
$
|
(7,639
|
)
|
|
$
|
6,238,847
|
|
|
$
|
(67,828
|
)
|
|
(1)
|
As of
December 31, 2016
, we identified a total of
462
investments that were in unrealized loss positions, of which
85
investments totaling
$295.7 million
with unrealized losses of
$7.6 million
have been in an impaired position for a period of time greater than 12 months.
|
|
|
March 31, 2017
|
||||||||||||||||||||||||||||||||||||||
|
|
Total
|
|
One Year
or Less
|
|
After One Year to
Five Years
|
|
After Five Years to
Ten Years
|
|
After
Ten Years
|
||||||||||||||||||||||||||||||
(Dollars in thousands)
|
|
Amortized Cost
|
|
Fair Value
|
|
Amortized Cost
|
|
Fair Value
|
|
Amortized Cost
|
|
Fair Value
|
|
Amortized Cost
|
|
Fair Value
|
|
Amortized Cost
|
|
Fair Value
|
||||||||||||||||||||
U.S. agency debentures
|
|
$
|
641,421
|
|
|
$
|
646,579
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
75,459
|
|
|
$
|
76,306
|
|
|
$
|
565,962
|
|
|
$
|
570,273
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
Agency-issued mortgage-backed securities
|
|
3,020,929
|
|
|
3,009,733
|
|
|
—
|
|
|
—
|
|
|
317,056
|
|
|
315,424
|
|
|
77,461
|
|
|
76,978
|
|
|
2,626,412
|
|
|
2,617,331
|
|
||||||||||
Agency-issued collateralized mortgage obligations - fixed rate
|
|
3,223,055
|
|
|
3,193,098
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
160,700
|
|
|
158,587
|
|
|
3,062,355
|
|
|
3,034,511
|
|
||||||||||
Agency-issued collateralized mortgage obligations - variable rate
|
|
299,257
|
|
|
298,997
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
299,257
|
|
|
298,997
|
|
||||||||||
Agency-issued commercial mortgage-backed securities
|
|
1,292,744
|
|
|
1,282,428
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,292,744
|
|
|
1,282,428
|
|
||||||||||
Municipal bonds and notes
|
|
138,289
|
|
|
136,982
|
|
|
6,168
|
|
|
6,159
|
|
|
55,716
|
|
|
55,259
|
|
|
59,517
|
|
|
58,913
|
|
|
16,888
|
|
|
16,651
|
|
||||||||||
Total
|
|
$
|
8,615,695
|
|
|
$
|
8,567,817
|
|
|
$
|
6,168
|
|
|
$
|
6,159
|
|
|
$
|
448,231
|
|
|
$
|
446,989
|
|
|
$
|
863,640
|
|
|
$
|
864,751
|
|
|
$
|
7,297,656
|
|
|
$
|
7,249,918
|
|
(Dollars in thousands)
|
|
March 31, 2017
|
|
December 31, 2016
|
||||
Non-marketable and other securities:
|
|
|
|
|
||||
Non-marketable securities (fair value accounting):
|
|
|
|
|
||||
Venture capital and private equity fund investments (1)
|
|
$
|
139,715
|
|
|
$
|
141,649
|
|
Other venture capital investments (2)
|
|
2,040
|
|
|
2,040
|
|
||
Other securities (fair value accounting) (3)
|
|
646
|
|
|
753
|
|
||
Non-marketable securities (equity method accounting) (4):
|
|
|
|
|
||||
Venture capital and private equity fund investments
|
|
85,529
|
|
|
82,823
|
|
||
Debt funds
|
|
16,509
|
|
|
17,020
|
|
||
Other investments
|
|
112,665
|
|
|
123,514
|
|
||
Non-marketable securities (cost method accounting):
|
|
|
|
|
||||
Venture capital and private equity fund investments (5)
|
|
117,243
|
|
|
114,606
|
|
||
Other investments
|
|
28,437
|
|
|
27,700
|
|
||
Investments in qualified affordable housing projects, net (6)
|
|
132,766
|
|
|
112,447
|
|
||
Total non-marketable and other securities
|
|
$
|
635,550
|
|
|
$
|
622,552
|
|
|
(1)
|
The following table shows the amounts of venture capital and private equity fund investments held by the following consolidated funds and our ownership percentage of each fund at
March 31, 2017
and
December 31, 2016
(fair value accounting):
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||||||||
(Dollars in thousands)
|
|
Amount
|
|
Ownership %
|
|
Amount
|
|
Ownership %
|
||||||
Strategic Investors Fund, LP
|
|
$
|
18,048
|
|
|
12.6
|
%
|
|
$
|
18,459
|
|
|
12.6
|
%
|
Capital Preferred Return Fund, LP
|
|
59,225
|
|
|
20.0
|
|
|
57,627
|
|
|
20.0
|
|
||
Growth Partners, LP
|
|
62,442
|
|
|
33.0
|
|
|
59,718
|
|
|
33.0
|
|
||
Other private equity fund (i)
|
|
—
|
|
|
—
|
|
|
5,845
|
|
|
58.2
|
|
||
Total venture capital and private equity fund investments
|
|
$
|
139,715
|
|
|
|
|
$
|
141,649
|
|
|
|
|
(i)
|
At
December 31, 2016
, we had a direct ownership interest of
41.5 percent
in the other private equity fund and an indirect ownership interest of
12.6 percent
through our ownership interest of Growth Partners, LP and an indirect ownership interest of
4.1 percent
through our ownership interest of Capital Preferred Return Fund, LP. On January 3, 2017, the other private equity fund was closed resulting in an immaterial impact on the Company's financial statements for the three months ended
March 31, 2017
.
|
(2)
|
The following table shows the amounts of other venture capital investments held by the following consolidated funds and our ownership percentage at
March 31, 2017
and
December 31, 2016
(fair value accounting):
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||||||||
(Dollars in thousands)
|
|
Amount
|
|
Ownership %
|
|
Amount
|
|
Ownership %
|
||||||
CP I, LP
|
|
$
|
2,040
|
|
|
10.7
|
%
|
|
$
|
2,040
|
|
|
10.7
|
%
|
Total other venture capital investments
|
|
$
|
2,040
|
|
|
|
|
$
|
2,040
|
|
|
|
(3)
|
Investments classified as other securities (fair value accounting) represent direct equity investments in public companies held by our consolidated funds.
|
(4)
|
The following table shows the carrying value and our ownership percentage of each investment at
March 31, 2017
and
December 31, 2016
(equity method accounting):
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||||||||
(Dollars in thousands)
|
|
Amount
|
|
Ownership %
|
|
Amount
|
|
Ownership %
|
||||||
Venture capital and private equity fund investments:
|
|
|
|
|
|
|
|
|
||||||
Strategic Investors Fund II, LP
|
|
$
|
7,540
|
|
|
8.6
|
%
|
|
$
|
7,720
|
|
|
8.6
|
%
|
Strategic Investors Fund III, LP
|
|
20,188
|
|
|
5.9
|
|
|
20,449
|
|
|
5.9
|
|
||
Strategic Investors Fund IV, LP
|
|
26,342
|
|
|
5.0
|
|
|
24,530
|
|
|
5.0
|
|
||
Strategic Investors Fund V funds
|
|
12,521
|
|
|
Various
|
|
|
12,029
|
|
|
Various
|
|
||
CP II, LP (i)
|
|
7,568
|
|
|
5.1
|
|
|
7,798
|
|
|
5.1
|
|
||
Other venture capital and private equity fund investments
|
|
11,370
|
|
|
Various
|
|
|
10,297
|
|
|
Various
|
|
||
Total venture capital and private equity fund investments
|
|
$
|
85,529
|
|
|
|
|
$
|
82,823
|
|
|
|
||
Debt funds:
|
|
|
|
|
|
|
|
|
||||||
Gold Hill Capital 2008, LP (ii)
|
|
$
|
12,888
|
|
|
15.5
|
%
|
|
$
|
13,557
|
|
|
15.5
|
%
|
Other debt funds
|
|
3,621
|
|
|
Various
|
|
|
3,463
|
|
|
Various
|
|
||
Total debt funds
|
|
$
|
16,509
|
|
|
|
|
$
|
17,020
|
|
|
|
||
Other investments:
|
|
|
|
|
|
|
|
|
||||||
SPD Silicon Valley Bank Co., Ltd.
|
|
$
|
75,316
|
|
|
50.0
|
%
|
|
$
|
75,296
|
|
|
50.0
|
%
|
Other investments
|
|
37,349
|
|
|
Various
|
|
|
48,218
|
|
|
Various
|
|
||
Total other investments
|
|
$
|
112,665
|
|
|
|
|
$
|
123,514
|
|
|
|
|
(i)
|
Our ownership includes direct ownership of
1.3 percent
and indirect ownership interest of
3.8 percent
through our investments in Strategic Investors Fund II, LP.
|
(ii)
|
At March 31, 2017, we had a direct ownership interest of
11.5 percent
in the fund and an indirect interest in the fund through our investment in Gold Hill Capital 2008, LLC of
4.0 percent
.
|
(5)
|
Represents investments in
249
and
252
funds (primarily venture capital funds) at
March 31, 2017
and
December 31, 2016
, respectively, where our ownership interest is typically less than
5%
of the voting interests of each such fund and in which we do not have the ability to exercise significant influence over the partnerships operating activities and financial policies. The carrying value, and estimated fair value, of these venture capital and private equity fund investments (cost method accounting) was
$117.2 million
and
$223.7 million
, respectively, as of
March 31, 2017
. The carrying value, and estimated fair value, of these venture capital and private equity fund investments (cost method accounting) was
$114.6 million
and
$221.7 million
, respectively, as of
December 31, 2016
.
|
(6)
|
The following table presents the balances of our investments in qualified affordable housing projects and related unfunded commitments included as a component of “other liabilities” on our consolidated balance sheets at
March 31, 2017
and
December 31, 2016
:
|
(Dollars in thousands)
|
|
March 31,
2017
|
|
December 31, 2016
|
||||
Investments in qualified affordable housing projects, net
|
|
$
|
132,766
|
|
|
$
|
112,447
|
|
Other liabilities
|
|
81,650
|
|
|
58,095
|
|
|
|
Three months ended March 31,
|
||||||
(Dollars in thousands)
|
|
2017
|
|
2016
|
||||
Tax credits and other tax benefits recognized
|
|
$
|
4,692
|
|
|
$
|
4,207
|
|
Amortization expense included in provision for income taxes (i)
|
|
3,236
|
|
|
3,612
|
|
|
(i)
|
All investments are amortized using the proportional amortization method and amortization expense is included in the provision for income taxes.
|
|
|
Three months ended March 31,
|
||||||
(Dollars in thousands)
|
|
2017
|
|
2016
|
||||
Gross gains on investment securities:
|
|
|
|
|
||||
Available-for-sale securities, at fair value (1)
|
|
$
|
675
|
|
|
$
|
1,753
|
|
Non-marketable securities (fair value accounting):
|
|
|
|
|
||||
Venture capital and private equity fund investments
|
|
7,082
|
|
|
2,823
|
|
||
Other venture capital investments
|
|
—
|
|
|
8
|
|
||
Other securities (fair value accounting)
|
|
156
|
|
|
63
|
|
||
Non-marketable securities (equity method accounting):
|
|
|
|
|
||||
Venture capital and private equity fund investments
|
|
3,917
|
|
|
1,653
|
|
||
Debt funds
|
|
238
|
|
|
900
|
|
||
Other investments
|
|
742
|
|
|
851
|
|
||
Non-marketable securities (cost method accounting):
|
|
|
|
|
||||
Venture capital and private equity fund investments
|
|
3,159
|
|
|
2,338
|
|
||
Other investments
|
|
3,569
|
|
|
—
|
|
||
Total gross gains on investment securities
|
|
19,538
|
|
|
10,389
|
|
||
Gross losses on investment securities:
|
|
|
|
|
||||
Available-for-sale securities, at fair value (1)
|
|
(67
|
)
|
|
(2,499
|
)
|
||
Non-marketable securities (fair value accounting):
|
|
|
|
|
||||
Venture capital and private equity fund investments
|
|
(619
|
)
|
|
(7,893
|
)
|
||
Other venture capital investments
|
|
—
|
|
|
(38
|
)
|
||
Other securities (fair value accounting)
|
|
(238
|
)
|
|
(157
|
)
|
||
Non-marketable securities (equity method accounting):
|
|
|
|
|
||||
Venture capital and private equity fund investments
|
|
(183
|
)
|
|
(3,555
|
)
|
||
Debt funds
|
|
(669
|
)
|
|
(45
|
)
|
||
Other investments
|
|
(1,484
|
)
|
|
(644
|
)
|
||
Non-marketable securities (cost method accounting):
|
|
|
|
|
||||
Venture capital and private equity fund investments (2)
|
|
(112
|
)
|
|
(171
|
)
|
||
Other investments
|
|
(196
|
)
|
|
(71
|
)
|
||
Total gross losses on investment securities
|
|
(3,568
|
)
|
|
(15,073
|
)
|
||
Gains (losses) on investment securities, net
|
|
$
|
15,970
|
|
|
$
|
(4,684
|
)
|
|
(1)
|
Includes realized gains (losses) on sales of available-for-sale equity securities that are recognized in the income statement. Unrealized gains (losses) on available-for-sale fixed income and equity securities are recognized in other comprehensive income. The cost basis of available-for-sale securities sold is determined on a specific identification basis.
|
(2)
|
For the
three months ended
March 31, 2017
and
2016
, includes OTTI losses of
$0.1 million
from the declines in value for
5
of the
249
investments and
$0.2 million
from the declines in value for
10
of the
267
investments, respectively. We concluded that any declines in value for the remaining investments were temporary, and as such, no OTTI was required to be recognized.
|
7.
|
Loans, Allowance for Loan Losses and Allowance for Unfunded Credit Commitments
|
(Dollars in thousands)
|
|
March 31, 2017
|
|
December 31, 2016
|
||||
Commercial loans:
|
|
|
|
|
||||
Software/internet
|
|
$
|
5,458,203
|
|
|
$
|
5,627,031
|
|
Hardware
|
|
1,097,835
|
|
|
1,180,398
|
|
||
Private equity/venture capital
|
|
8,426,831
|
|
|
7,691,148
|
|
||
Life science/healthcare
|
|
1,735,987
|
|
|
1,853,004
|
|
||
Premium wine
|
|
203,736
|
|
|
200,156
|
|
||
Other
|
|
473,918
|
|
|
393,551
|
|
||
Total commercial loans
|
|
17,396,510
|
|
|
16,945,288
|
|
||
Real estate secured loans:
|
|
|
|
|
||||
Premium wine (1)
|
|
672,831
|
|
|
678,166
|
|
||
Consumer loans (2)
|
|
2,012,977
|
|
|
1,926,968
|
|
||
Other
|
|
43,281
|
|
|
43,487
|
|
||
Total real estate secured loans
|
|
2,729,089
|
|
|
2,648,621
|
|
||
Construction loans
|
|
70,755
|
|
|
64,671
|
|
||
Consumer loans
|
|
231,097
|
|
|
241,364
|
|
||
Total loans, net of unearned income (3)
|
|
$
|
20,427,451
|
|
|
$
|
19,899,944
|
|
|
(1)
|
Included in our premium wine portfolio are gross construction loans of
$103 million
and
$110 million
at
March 31, 2017
and
December 31, 2016
, respectively.
|
(2)
|
Consumer loans secured by real estate at
March 31, 2017
and
December 31, 2016
were comprised of the following:
|
(Dollars in thousands)
|
|
March 31, 2017
|
|
December 31, 2016
|
||||
Loans for personal residence
|
|
$
|
1,735,925
|
|
|
$
|
1,655,349
|
|
Loans to eligible employees
|
|
207,420
|
|
|
199,291
|
|
||
Home equity lines of credit
|
|
69,632
|
|
|
72,328
|
|
||
Consumer loans secured by real estate
|
|
$
|
2,012,977
|
|
|
$
|
1,926,968
|
|
(3)
|
Included within our total loan portfolio are credit card loans of
$242 million
and
$224 million
at
March 31, 2017
and
December 31, 2016
, respectively.
|
(Dollars in thousands)
|
|
March 31, 2017
|
|
December 31, 2016
|
||||
Commercial loans:
|
|
|
|
|
||||
Software/internet
|
|
$
|
5,458,203
|
|
|
$
|
5,627,031
|
|
Hardware
|
|
1,097,835
|
|
|
1,180,398
|
|
||
Private equity/venture capital
|
|
8,426,831
|
|
|
7,691,148
|
|
||
Life science/healthcare
|
|
1,735,987
|
|
|
1,853,004
|
|
||
Premium wine
|
|
876,567
|
|
|
878,322
|
|
||
Other
|
|
587,954
|
|
|
501,709
|
|
||
Total commercial loans
|
|
18,183,377
|
|
|
17,731,612
|
|
||
Consumer loans:
|
|
|
|
|
||||
Real estate secured loans
|
|
2,012,977
|
|
|
1,926,968
|
|
||
Other consumer loans
|
|
231,097
|
|
|
241,364
|
|
||
Total consumer loans
|
|
2,244,074
|
|
|
2,168,332
|
|
||
Total loans, net of unearned income
|
|
$
|
20,427,451
|
|
|
$
|
19,899,944
|
|
(Dollars in thousands)
|
|
30 - 59
Days Past
Due
|
|
60 - 89
Days Past
Due
|
|
Greater
Than 90
Days Past
Due
|
|
Total Past
Due
|
|
Current
|
|
Loans Past Due
90 Days or
More Still
Accruing
Interest
|
||||||||||||
March 31, 2017:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Software/internet
|
|
$
|
26,927
|
|
|
$
|
3,331
|
|
|
$
|
38
|
|
|
$
|
30,296
|
|
|
$
|
5,350,664
|
|
|
$
|
38
|
|
Hardware
|
|
7,406
|
|
|
4
|
|
|
20
|
|
|
7,430
|
|
|
1,071,772
|
|
|
20
|
|
||||||
Private equity/venture capital
|
|
33,878
|
|
|
3,235
|
|
|
—
|
|
|
37,113
|
|
|
8,399,895
|
|
|
—
|
|
||||||
Life science/healthcare
|
|
708
|
|
|
20
|
|
|
2
|
|
|
730
|
|
|
1,743,014
|
|
|
2
|
|
||||||
Premium wine
|
|
3,037
|
|
|
1,201
|
|
|
—
|
|
|
4,238
|
|
|
869,106
|
|
|
—
|
|
||||||
Other
|
|
1,684
|
|
|
300
|
|
|
—
|
|
|
1,984
|
|
|
591,996
|
|
|
—
|
|
||||||
Total commercial loans
|
|
73,640
|
|
|
8,091
|
|
|
60
|
|
|
81,791
|
|
|
18,026,447
|
|
|
60
|
|
||||||
Consumer loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Real estate secured loans
|
|
3,115
|
|
|
—
|
|
|
—
|
|
|
3,115
|
|
|
2,005,869
|
|
|
—
|
|
||||||
Other consumer loans
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
228,813
|
|
|
—
|
|
||||||
Total consumer loans
|
|
3,115
|
|
|
—
|
|
|
—
|
|
|
3,115
|
|
|
2,234,682
|
|
|
—
|
|
||||||
Total gross loans excluding impaired loans
|
|
76,755
|
|
|
8,091
|
|
|
60
|
|
|
84,906
|
|
|
20,261,129
|
|
|
60
|
|
||||||
Impaired loans
|
|
4,888
|
|
|
2,207
|
|
|
38,353
|
|
|
45,448
|
|
|
157,168
|
|
|
—
|
|
||||||
Total gross loans
|
|
$
|
81,643
|
|
|
$
|
10,298
|
|
|
$
|
38,413
|
|
|
$
|
130,354
|
|
|
$
|
20,418,297
|
|
|
$
|
60
|
|
December 31, 2016:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Software/internet
|
|
$
|
37,087
|
|
|
$
|
1,162
|
|
|
$
|
6
|
|
|
$
|
38,255
|
|
|
$
|
5,507,575
|
|
|
$
|
6
|
|
Hardware
|
|
5,591
|
|
|
36
|
|
|
27
|
|
|
5,654
|
|
|
1,118,065
|
|
|
27
|
|
||||||
Private equity/venture capital
|
|
689
|
|
|
—
|
|
|
—
|
|
|
689
|
|
|
7,747,222
|
|
|
—
|
|
||||||
Life science/healthcare
|
|
283
|
|
|
551
|
|
|
—
|
|
|
834
|
|
|
1,827,490
|
|
|
—
|
|
||||||
Premium wine
|
|
1,003
|
|
|
4
|
|
|
—
|
|
|
1,007
|
|
|
876,185
|
|
|
—
|
|
||||||
Other
|
|
34
|
|
|
300
|
|
|
—
|
|
|
334
|
|
|
504,021
|
|
|
—
|
|
||||||
Total commercial loans
|
|
44,687
|
|
|
2,053
|
|
|
33
|
|
|
46,773
|
|
|
17,580,558
|
|
|
33
|
|
||||||
Consumer loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Real estate secured loans
|
|
850
|
|
|
—
|
|
|
—
|
|
|
850
|
|
|
1,923,266
|
|
|
—
|
|
||||||
Other consumer loans
|
|
1,402
|
|
|
—
|
|
|
—
|
|
|
1,402
|
|
|
237,353
|
|
|
—
|
|
||||||
Total consumer loans
|
|
2,252
|
|
|
—
|
|
|
—
|
|
|
2,252
|
|
|
2,160,619
|
|
|
—
|
|
||||||
Total gross loans excluding impaired loans
|
|
46,939
|
|
|
2,053
|
|
|
33
|
|
|
49,025
|
|
|
19,741,177
|
|
|
33
|
|
||||||
Impaired loans
|
|
34,636
|
|
|
3,451
|
|
|
11,180
|
|
|
49,267
|
|
|
185,193
|
|
|
—
|
|
||||||
Total gross loans
|
|
$
|
81,575
|
|
|
$
|
5,504
|
|
|
$
|
11,213
|
|
|
$
|
98,292
|
|
|
$
|
19,926,370
|
|
|
$
|
33
|
|
(Dollars in thousands)
|
|
Impaired loans for
which there is a
related allowance
for loan losses
|
|
Impaired loans for
which there is no
related allowance
for loan losses
|
|
Total carrying value of impaired loans
|
|
Total unpaid
principal of impaired loans
|
||||||||
March 31, 2017:
|
|
|
|
|
|
|
|
|
||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
||||||||
Software/internet
|
|
$
|
123,305
|
|
|
$
|
1,531
|
|
|
$
|
124,836
|
|
|
$
|
132,588
|
|
Hardware
|
|
27,531
|
|
|
2,002
|
|
|
29,533
|
|
|
34,307
|
|
||||
Private equity/venture capital
|
|
346
|
|
|
—
|
|
|
346
|
|
|
346
|
|
||||
Life science/healthcare
|
|
38,552
|
|
|
741
|
|
|
39,293
|
|
|
42,478
|
|
||||
Premium wine
|
|
3,321
|
|
|
—
|
|
|
3,321
|
|
|
3,321
|
|
||||
Other
|
|
1,659
|
|
|
—
|
|
|
1,659
|
|
|
1,953
|
|
||||
Total commercial loans
|
|
194,714
|
|
|
4,274
|
|
|
198,988
|
|
|
214,993
|
|
||||
Consumer loans:
|
|
|
|
|
|
|
|
|
||||||||
Real estate secured loans
|
|
1,480
|
|
|
—
|
|
|
1,480
|
|
|
2,768
|
|
||||
Other consumer loans
|
|
2,148
|
|
|
—
|
|
|
2,148
|
|
|
2,148
|
|
||||
Total consumer loans
|
|
3,628
|
|
|
—
|
|
|
3,628
|
|
|
4,916
|
|
||||
Total
|
|
$
|
198,342
|
|
|
$
|
4,274
|
|
|
$
|
202,616
|
|
|
$
|
219,909
|
|
December 31, 2016:
|
|
|
|
|
|
|
|
|
||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
||||||||
Software/internet
|
|
$
|
121,658
|
|
|
$
|
1,090
|
|
|
$
|
122,748
|
|
|
$
|
129,648
|
|
Hardware
|
|
65,395
|
|
|
—
|
|
|
65,395
|
|
|
70,683
|
|
||||
Private equity/venture capital
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Life science/healthcare
|
|
38,361
|
|
|
—
|
|
|
38,361
|
|
|
41,130
|
|
||||
Premium wine
|
|
3,187
|
|
|
—
|
|
|
3,187
|
|
|
3,187
|
|
||||
Other
|
|
867
|
|
|
—
|
|
|
867
|
|
|
867
|
|
||||
Total commercial loans
|
|
229,468
|
|
|
1,090
|
|
|
230,558
|
|
|
245,515
|
|
||||
Consumer loans:
|
|
|
|
|
|
|
|
|
||||||||
Real estate secured loans
|
|
1,504
|
|
|
—
|
|
|
1,504
|
|
|
2,779
|
|
||||
Other consumer loans
|
|
2,398
|
|
|
—
|
|
|
2,398
|
|
|
2,398
|
|
||||
Total consumer loans
|
|
3,902
|
|
|
—
|
|
|
3,902
|
|
|
5,177
|
|
||||
Total
|
|
$
|
233,370
|
|
|
$
|
1,090
|
|
|
$
|
234,460
|
|
|
$
|
250,692
|
|
Three months ended March 31,
|
|
Average impaired loans
|
|
Interest income on impaired loans
|
||||||||||||
(Dollars in thousands)
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
||||||||
Software/internet
|
|
$
|
109,916
|
|
|
$
|
89,367
|
|
|
$
|
422
|
|
|
$
|
421
|
|
Hardware
|
|
34,110
|
|
|
24,426
|
|
|
572
|
|
|
397
|
|
||||
Private equity/venture capital
|
|
358
|
|
|
—
|
|
|
2
|
|
|
—
|
|
||||
Life science/healthcare
|
|
38,942
|
|
|
39,690
|
|
|
150
|
|
|
133
|
|
||||
Premium wine
|
|
3,213
|
|
|
2,171
|
|
|
38
|
|
|
17
|
|
||||
Other
|
|
1,061
|
|
|
3,853
|
|
|
4
|
|
|
7
|
|
||||
Total commercial loans
|
|
187,600
|
|
|
159,507
|
|
|
1,188
|
|
|
975
|
|
||||
Consumer loans:
|
|
|
|
|
|
|
|
|
||||||||
Real estate secured loans
|
|
1,488
|
|
|
135
|
|
|
—
|
|
|
—
|
|
||||
Other consumer loans
|
|
2,148
|
|
|
34
|
|
|
8
|
|
|
—
|
|
||||
Total consumer loans
|
|
3,636
|
|
|
169
|
|
|
8
|
|
|
—
|
|
||||
Total average impaired loans
|
|
$
|
191,236
|
|
|
$
|
159,676
|
|
|
$
|
1,196
|
|
|
$
|
975
|
|
Three months ended March 31, 2017 (Dollars in thousands)
|
|
Beginning Balance December 31, 2016
|
|
Charge-offs
|
|
Recoveries
|
|
Provision for
(Reduction of) Loan Losses
|
|
Foreign Currency Translation Adjustments
|
|
Ending Balance March 31, 2017
|
||||||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Software/internet
|
|
$
|
97,388
|
|
|
$
|
(7,980
|
)
|
|
$
|
1,171
|
|
|
$
|
18,719
|
|
|
$
|
204
|
|
|
$
|
109,502
|
|
Hardware
|
|
31,166
|
|
|
(4,024
|
)
|
|
267
|
|
|
(4,080
|
)
|
|
(45
|
)
|
|
23,284
|
|
||||||
Private equity/venture capital
|
|
50,299
|
|
|
—
|
|
|
—
|
|
|
6,706
|
|
|
73
|
|
|
57,078
|
|
||||||
Life science/healthcare
|
|
25,446
|
|
|
(1,732
|
)
|
|
36
|
|
|
7,708
|
|
|
84
|
|
|
31,542
|
|
||||||
Premium wine
|
|
4,115
|
|
|
—
|
|
|
—
|
|
|
226
|
|
|
2
|
|
|
4,343
|
|
||||||
Other
|
|
4,768
|
|
|
(294
|
)
|
|
297
|
|
|
(390
|
)
|
|
(4
|
)
|
|
4,377
|
|
||||||
Total commercial loans
|
|
213,182
|
|
|
(14,030
|
)
|
|
1,771
|
|
|
28,889
|
|
|
314
|
|
|
230,126
|
|
||||||
Total consumer loans
|
|
12,184
|
|
|
—
|
|
|
21
|
|
|
790
|
|
|
9
|
|
|
13,004
|
|
||||||
Total allowance for loan losses
|
|
$
|
225,366
|
|
|
$
|
(14,030
|
)
|
|
$
|
1,792
|
|
|
$
|
29,679
|
|
|
$
|
323
|
|
|
$
|
243,130
|
|
Three months ended March 31, 2016 (Dollars in thousands)
|
|
Beginning Balance December 31, 2015
|
|
Charge-offs
|
|
Recoveries
|
|
Provision for
(Reduction of) Loan Losses
|
|
Foreign Currency Translation Adjustments (1)
|
|
Ending Balance March 31, 2016
|
||||||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Software/internet
|
|
$
|
103,045
|
|
|
$
|
(22,161
|
)
|
|
$
|
3,960
|
|
|
$
|
21,632
|
|
|
$
|
422
|
|
|
$
|
106,898
|
|
Hardware
|
|
23,085
|
|
|
(1,486
|
)
|
|
239
|
|
|
1,959
|
|
|
39
|
|
|
23,836
|
|
||||||
Private equity/venture capital
|
|
35,282
|
|
|
—
|
|
|
—
|
|
|
8,243
|
|
|
161
|
|
|
43,686
|
|
||||||
Life science/healthcare
|
|
36,576
|
|
|
(2,395
|
)
|
|
491
|
|
|
(4,303
|
)
|
|
(84
|
)
|
|
30,285
|
|
||||||
Premium wine
|
|
5,205
|
|
|
—
|
|
|
—
|
|
|
39
|
|
|
—
|
|
|
5,244
|
|
||||||
Other
|
|
4,252
|
|
|
(30
|
)
|
|
74
|
|
|
5,145
|
|
|
106
|
|
|
9,547
|
|
||||||
Total commercial loans
|
|
207,445
|
|
|
(26,072
|
)
|
|
4,764
|
|
|
32,715
|
|
|
644
|
|
|
219,496
|
|
||||||
Total consumer loans
|
|
10,168
|
|
|
(102
|
)
|
|
49
|
|
|
626
|
|
|
12
|
|
|
10,753
|
|
||||||
Total allowance for loan losses
|
|
$
|
217,613
|
|
|
$
|
(26,174
|
)
|
|
$
|
4,813
|
|
|
$
|
33,341
|
|
|
$
|
656
|
|
|
$
|
230,249
|
|
|
(1)
|
Reflects foreign currency translation adjustments within the allowance for loan losses. Prior period amounts were previously reported with loan recoveries and have been revised to conform to current period presentation.
|
|
|
Three months ended March 31,
|
||||||
(Dollars in thousands)
|
|
2017
|
|
2016
|
||||
Beginning balance
|
|
$
|
45,265
|
|
|
$
|
34,415
|
|
Provision for unfunded credit commitments
|
|
1,055
|
|
|
134
|
|
||
Foreign currency translation adjustments
|
|
15
|
|
|
(8
|
)
|
||
Ending balance (1)
|
|
$
|
46,335
|
|
|
$
|
34,541
|
|
|
(1)
|
See
Note 12—"Off-Balance Sheet Arrangements, Guarantees and Other Commitments" of the "Notes to Interim Consolidated Financial Statements (unaudited)" under Part I, Item 1 of this report
for additional disclosures related to our commitments to extend credit.
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||||||||||||||||||||||||||
|
|
Individually Evaluated for
Impairment
|
|
Collectively Evaluated for
Impairment
|
|
Individually Evaluated for
Impairment
|
|
Collectively Evaluated for
Impairment
|
||||||||||||||||||||||||
(Dollars in thousands)
|
|
Allowance for loan losses
|
|
Recorded investment in loans
|
|
Allowance for loan losses
|
|
Recorded investment in loans
|
|
Allowance for loan losses
|
|
Recorded investment in loans
|
|
Allowance for loan losses
|
|
Recorded investment in loans
|
||||||||||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Software/internet
|
|
$
|
38,563
|
|
|
$
|
124,836
|
|
|
$
|
70,939
|
|
|
$
|
5,333,367
|
|
|
$
|
28,245
|
|
|
$
|
122,748
|
|
|
$
|
69,143
|
|
|
$
|
5,504,283
|
|
Hardware
|
|
2,674
|
|
|
29,533
|
|
|
20,610
|
|
|
1,068,302
|
|
|
9,995
|
|
|
65,395
|
|
|
21,171
|
|
|
1,115,003
|
|
||||||||
Private equity/venture capital
|
|
35
|
|
|
346
|
|
|
57,043
|
|
|
8,426,485
|
|
|
—
|
|
|
—
|
|
|
50,299
|
|
|
7,691,148
|
|
||||||||
Life science/healthcare
|
|
13,580
|
|
|
39,293
|
|
|
17,962
|
|
|
1,696,694
|
|
|
8,709
|
|
|
38,361
|
|
|
16,737
|
|
|
1,814,643
|
|
||||||||
Premium wine
|
|
513
|
|
|
3,321
|
|
|
3,830
|
|
|
873,246
|
|
|
520
|
|
|
3,187
|
|
|
3,595
|
|
|
875,135
|
|
||||||||
Other
|
|
342
|
|
|
1,659
|
|
|
4,035
|
|
|
586,295
|
|
|
233
|
|
|
867
|
|
|
4,535
|
|
|
500,842
|
|
||||||||
Total commercial loans
|
|
55,707
|
|
|
198,988
|
|
|
174,419
|
|
|
17,984,389
|
|
|
47,702
|
|
|
230,558
|
|
|
165,480
|
|
|
17,501,054
|
|
||||||||
Total consumer loans
|
|
1,074
|
|
|
3,628
|
|
|
11,930
|
|
|
2,240,446
|
|
|
1,123
|
|
|
3,902
|
|
|
11,061
|
|
|
2,164,430
|
|
||||||||
Total
|
|
$
|
56,781
|
|
|
$
|
202,616
|
|
|
$
|
186,349
|
|
|
$
|
20,224,835
|
|
|
$
|
48,825
|
|
|
$
|
234,460
|
|
|
$
|
176,541
|
|
|
$
|
19,665,484
|
|
(Dollars in thousands)
|
|
Pass
|
|
Performing
(Criticized)
|
|
Performing Impaired (Criticized)
|
|
Nonperforming Impaired (Nonaccrual)
|
|
Total
|
||||||||||
March 31, 2017:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Software/internet
|
|
$
|
4,858,104
|
|
|
$
|
522,856
|
|
|
$
|
25,165
|
|
|
$
|
99,671
|
|
|
$
|
5,505,796
|
|
Hardware
|
|
938,269
|
|
|
140,933
|
|
|
27,464
|
|
|
2,069
|
|
|
1,108,735
|
|
|||||
Private equity/venture capital
|
|
8,436,841
|
|
|
167
|
|
|
346
|
|
|
—
|
|
|
8,437,354
|
|
|||||
Life science/healthcare
|
|
1,588,709
|
|
|
155,035
|
|
|
7,153
|
|
|
32,140
|
|
|
1,783,037
|
|
|||||
Premium wine
|
|
854,409
|
|
|
18,935
|
|
|
2,831
|
|
|
490
|
|
|
876,665
|
|
|||||
Other
|
|
573,527
|
|
|
20,453
|
|
|
357
|
|
|
1,302
|
|
|
595,639
|
|
|||||
Total commercial loans
|
|
17,249,859
|
|
|
858,379
|
|
|
63,316
|
|
|
135,672
|
|
|
18,307,226
|
|
|||||
Consumer loans:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Real estate secured loans
|
|
1,997,248
|
|
|
11,736
|
|
|
—
|
|
|
1,480
|
|
|
2,010,464
|
|
|||||
Other consumer loans
|
|
228,162
|
|
|
651
|
|
|
536
|
|
|
1,612
|
|
|
230,961
|
|
|||||
Total consumer loans
|
|
2,225,410
|
|
|
12,387
|
|
|
536
|
|
|
3,092
|
|
|
2,241,425
|
|
|||||
Total gross loans
|
|
$
|
19,475,269
|
|
|
$
|
870,766
|
|
|
$
|
63,852
|
|
|
$
|
138,764
|
|
|
$
|
20,548,651
|
|
December 31, 2016:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Software/internet
|
|
$
|
4,924,923
|
|
|
$
|
620,907
|
|
|
$
|
46,143
|
|
|
$
|
76,605
|
|
|
$
|
5,668,578
|
|
Hardware
|
|
985,889
|
|
|
137,830
|
|
|
58,814
|
|
|
6,581
|
|
|
1,189,114
|
|
|||||
Private equity/venture capital
|
|
7,747,317
|
|
|
594
|
|
|
—
|
|
|
—
|
|
|
7,747,911
|
|
|||||
Life science/healthcare
|
|
1,707,499
|
|
|
120,825
|
|
|
6,578
|
|
|
31,783
|
|
|
1,866,685
|
|
|||||
Premium wine
|
|
865,354
|
|
|
11,838
|
|
|
2,696
|
|
|
491
|
|
|
880,379
|
|
|||||
Other
|
|
480,845
|
|
|
23,510
|
|
|
464
|
|
|
403
|
|
|
505,222
|
|
|||||
Total commercial loans
|
|
16,711,827
|
|
|
915,504
|
|
|
114,695
|
|
|
115,863
|
|
|
17,857,889
|
|
|||||
Consumer loans:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Real estate secured loans
|
|
1,914,512
|
|
|
9,604
|
|
|
—
|
|
|
1,504
|
|
|
1,925,620
|
|
|||||
Other consumer loans
|
|
238,256
|
|
|
499
|
|
|
786
|
|
|
1,612
|
|
|
241,153
|
|
|||||
Total consumer loans
|
|
2,152,768
|
|
|
10,103
|
|
|
786
|
|
|
3,116
|
|
|
2,166,773
|
|
|||||
Total gross loans
|
|
$
|
18,864,595
|
|
|
$
|
925,607
|
|
|
$
|
115,481
|
|
|
$
|
118,979
|
|
|
$
|
20,024,662
|
|
(Dollars in thousands)
|
|
March 31, 2017
|
|
December 31, 2016
|
||||
Loans modified in TDRs:
|
|
|
|
|
||||
Commercial loans:
|
|
|
|
|
||||
Software/internet
|
|
$
|
59,419
|
|
|
$
|
52,646
|
|
Hardware
|
|
10,687
|
|
|
14,870
|
|
||
Life science/healthcare
|
|
21,561
|
|
|
24,176
|
|
||
Premium wine
|
|
3,177
|
|
|
3,194
|
|
||
Other
|
|
33
|
|
|
387
|
|
||
Total commercial loans
|
|
94,877
|
|
|
95,273
|
|
||
Consumer loans:
|
|
|
|
|
||||
Other consumer loans
|
|
536
|
|
|
786
|
|
||
Total consumer loans
|
|
536
|
|
|
786
|
|
||
Total
|
|
$
|
95,413
|
|
|
$
|
96,059
|
|
|
|
Three months ended March 31,
|
||||||
(Dollars in thousands)
|
|
2017
|
|
2016
|
||||
Loans modified in TDRs during the period:
|
|
|
|
|
||||
Commercial loans:
|
|
|
|
|
||||
Software/internet
|
|
$
|
6,309
|
|
|
$
|
10,854
|
|
Other
|
|
—
|
|
|
505
|
|
||
Total commercial loans
|
|
6,309
|
|
|
11,359
|
|
||
Total consumer loans
|
|
—
|
|
|
—
|
|
||
Total loans modified in TDRs during the period (1)
|
|
$
|
6,309
|
|
|
$
|
11,359
|
|
|
(1)
|
There were
$6.2 million
of partial charge-offs during the
three months ended
March 31, 2017
and
$3.8 million
of partial charge-offs during the
three months ended
March 31, 2016
.
|
|
|
Three months ended March 31,
|
||
(Dollars in thousands)
|
|
2017
|
||
TDRs modified within the previous 12 months that defaulted during the period:
|
|
|
||
Commercial loans:
|
|
|
||
Hardware
|
|
$
|
3,105
|
|
Total commercial loans
|
|
3,105
|
|
|
Consumer loans:
|
|
|
||
Other consumer loans
|
|
536
|
|
|
Total consumer loans
|
|
536
|
|
|
Total TDRs modified within the previous 12 months that defaulted in the period
|
|
$
|
3,641
|
|
8.
|
Short-Term Borrowings and Long-Term Debt
|
|
|
|
|
|
|
Carrying Value
|
||||||||
(Dollars in thousands)
|
|
Maturity
|
|
Principal value at March 31, 2017
|
|
March 31,
2017 |
|
December 31,
2016 |
||||||
Short-term borrowings:
|
|
|
|
|
|
|
|
|
||||||
Short-term FHLB advances
|
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
500,000
|
|
Other short-term borrowings
|
|
(1)
|
|
5,163
|
|
|
5,163
|
|
|
12,668
|
|
|||
Total short-term borrowings
|
|
|
|
|
|
$
|
5,163
|
|
|
$
|
512,668
|
|
||
Long-term debt:
|
|
|
|
|
|
|
|
|
||||||
3.50% Senior Notes
|
|
January 29, 2025
|
|
$
|
350,000
|
|
|
$
|
347,059
|
|
|
$
|
346,979
|
|
5.375% Senior Notes
|
|
September 15, 2020
|
|
350,000
|
|
|
347,733
|
|
|
347,586
|
|
|||
6.05% Subordinated Notes (2)
|
|
June 1, 2017
|
|
45,964
|
|
|
46,223
|
|
|
46,646
|
|
|||
7.0% Junior Subordinated Debentures
|
|
October 15, 2033
|
|
50,000
|
|
|
54,450
|
|
|
54,493
|
|
|||
Total long-term debt
|
|
|
|
|
|
$
|
795,465
|
|
|
$
|
795,704
|
|
|
(1)
|
Represents cash collateral received from certain counterparties in relation to market value exposures of derivative contracts in our favor, which includes an interest rate swap agreement related to our 6.05% Subordinated Notes.
|
(2)
|
At
March 31, 2017
and
December 31, 2016
, included in the carrying value of our 6.05% Subordinated Notes were
$0.3 million
and
$0.8 million
, respectively, related to hedge accounting associated with the notes.
|
9.
|
Derivative Financial Instruments
|
|
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||||||||||||||||||||||||||
(Dollars in thousands)
|
|
Balance Sheet
Location
|
|
Notional or
Contractual
Amount
|
|
Fair Value
|
|
Collateral
(1)
|
|
Net
Exposure
(2)
|
|
Notional or
Contractual
Amount
|
|
Fair Value
|
|
Collateral
(1)
|
|
Net
Exposure
(2)
|
||||||||||||||||
Derivatives designated as hedging instruments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Interest rate risks:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Interest rate swaps
|
|
Other assets
|
|
$
|
45,964
|
|
|
$
|
318
|
|
|
$
|
—
|
|
|
$
|
318
|
|
|
$
|
45,964
|
|
|
$
|
810
|
|
|
$
|
89
|
|
|
$
|
721
|
|
Derivatives not designated as hedging instruments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Currency exchange risks:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Foreign exchange forwards
|
|
Other assets
|
|
93,012
|
|
|
759
|
|
|
—
|
|
|
759
|
|
|
219,950
|
|
|
3,057
|
|
|
—
|
|
|
3,057
|
|
||||||||
Foreign exchange forwards
|
|
Other liabilities
|
|
114,317
|
|
|
(950
|
)
|
|
—
|
|
|
(950
|
)
|
|
54,338
|
|
|
(968
|
)
|
|
—
|
|
|
(968
|
)
|
||||||||
Net exposure
|
|
|
|
|
|
(191
|
)
|
|
—
|
|
|
(191
|
)
|
|
|
|
2,089
|
|
|
—
|
|
|
2,089
|
|
||||||||||
Other derivative instruments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Equity warrant assets
|
|
Other assets
|
|
211,327
|
|
|
124,233
|
|
|
—
|
|
|
124,233
|
|
|
211,434
|
|
|
131,123
|
|
|
—
|
|
|
131,123
|
|
||||||||
Other derivatives:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Client foreign exchange forwards
|
|
Other assets
|
|
1,747,019
|
|
|
50,291
|
|
|
5,163
|
|
|
45,128
|
|
|
1,251,308
|
|
|
54,587
|
|
|
12,579
|
|
|
42,008
|
|
||||||||
Client foreign exchange forwards
|
|
Other liabilities
|
|
1,588,628
|
|
|
(40,346
|
)
|
|
—
|
|
|
(40,346
|
)
|
|
1,068,991
|
|
|
(43,317
|
)
|
|
—
|
|
|
(43,317
|
)
|
||||||||
Client foreign currency options
|
|
Other assets
|
|
813,579
|
|
|
3,861
|
|
|
—
|
|
|
3,861
|
|
|
775,000
|
|
|
10,383
|
|
|
—
|
|
|
10,383
|
|
||||||||
Client foreign currency options
|
|
Other liabilities
|
|
813,579
|
|
|
(3,861
|
)
|
|
—
|
|
|
(3,861
|
)
|
|
775,000
|
|
|
(10,383
|
)
|
|
—
|
|
|
(10,383
|
)
|
||||||||
Client interest rate derivatives
|
|
Other assets
|
|
669,139
|
|
|
10,702
|
|
|
—
|
|
|
10,702
|
|
|
583,511
|
|
|
10,110
|
|
|
—
|
|
|
10,110
|
|
||||||||
Client interest rate derivatives
|
|
Other liabilities
|
|
712,965
|
|
|
(10,592
|
)
|
|
—
|
|
|
(10,592
|
)
|
|
627,639
|
|
|
(9,770
|
)
|
|
—
|
|
|
(9,770
|
)
|
||||||||
Net exposure
|
|
|
|
|
|
10,055
|
|
|
5,163
|
|
|
4,892
|
|
|
|
|
11,610
|
|
|
12,579
|
|
|
(969
|
)
|
||||||||||
Net
|
|
|
|
|
|
$
|
134,415
|
|
|
$
|
5,163
|
|
|
$
|
129,252
|
|
|
|
|
$
|
145,632
|
|
|
$
|
12,668
|
|
|
$
|
132,964
|
|
|
(1)
|
Cash collateral received from our counterparties in relation to market value exposures of derivative contracts in our favor is recorded as a component of “short-term borrowings” on our consolidated balance sheets.
|
(2)
|
Net exposure for contracts in a gain position reflects the replacement cost in the event of nonperformance by all such counterparties. The credit ratings of our institutional counterparties as of
March 31, 2017
remain at investment grade or higher and there were no material changes in their credit ratings during the
three months ended
March 31, 2017
.
|
|
|
|
|
Three months ended March 31,
|
||||||
(Dollars in thousands)
|
|
Statement of income location
|
|
2017
|
|
2016
|
||||
Derivatives designated as hedging instruments:
|
|
|
|
|
|
|
||||
Interest rate risks:
|
|
|
|
|
|
|
||||
Net cash benefit associated with interest rate swaps
|
|
Interest expense—borrowings
|
|
$
|
554
|
|
|
$
|
609
|
|
Changes in fair value of interest rate swaps
|
|
Other noninterest income
|
|
(1
|
)
|
|
(17
|
)
|
||
Net gains associated with interest rate risk derivatives
|
|
|
|
$
|
553
|
|
|
$
|
592
|
|
Derivatives not designated as hedging instruments:
|
|
|
|
|
|
|
||||
Currency exchange risks:
|
|
|
|
|
|
|
||||
Gains on revaluations of internal foreign currency instruments, net
|
|
Other noninterest income
|
|
$
|
4,108
|
|
|
$
|
2,491
|
|
Losses on internal foreign exchange forward contracts, net
|
|
Other noninterest income
|
|
(3,245
|
)
|
|
(2,208
|
)
|
||
Net gains associated with internal currency risk
|
|
|
|
$
|
863
|
|
|
$
|
283
|
|
Other derivative instruments:
|
|
|
|
|
|
|
||||
Gains on revaluations of client foreign currency instruments, net
|
|
Other noninterest income
|
|
$
|
2,754
|
|
|
$
|
3,653
|
|
Losses on client foreign exchange forward contracts, net
|
|
Other noninterest income
|
|
(2,289
|
)
|
|
(5,654
|
)
|
||
Net gains (losses) associated with client currency risk
|
|
|
|
$
|
465
|
|
|
$
|
(2,001
|
)
|
Net gains on equity warrant assets
|
|
Gains on equity warrant assets, net
|
|
$
|
6,690
|
|
|
$
|
6,607
|
|
Net losses on other derivatives
|
|
Other noninterest income
|
|
$
|
(276
|
)
|
|
$
|
(421
|
)
|
|
|
Gross Amounts of Recognized Assets
|
|
Gross Amounts offset in the Statement of Financial Position
|
|
Net Amounts of Assets Presented in the Statement of Financial Position
|
|
Gross Amounts Not Offset in the Statement of Financial Position But Subject to Master Netting Arrangements
|
|
Net Amount
|
||||||||||||||
(Dollars in thousands)
|
|
|
|
|
Financial Instruments
|
|
Cash Collateral Received
|
|
||||||||||||||||
March 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Derivative Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Interest rate swaps
|
|
$
|
318
|
|
|
$
|
—
|
|
|
$
|
318
|
|
|
$
|
(318
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
Foreign exchange forwards
|
|
51,050
|
|
|
—
|
|
|
51,050
|
|
|
(22,222
|
)
|
|
(5,163
|
)
|
|
23,665
|
|
||||||
Foreign currency options
|
|
3,861
|
|
|
—
|
|
|
3,861
|
|
|
(563
|
)
|
|
—
|
|
|
3,298
|
|
||||||
Client interest rate derivatives
|
|
10,702
|
|
|
—
|
|
|
10,702
|
|
|
(10,686
|
)
|
|
—
|
|
|
16
|
|
||||||
Total derivative assets:
|
|
65,931
|
|
|
—
|
|
|
65,931
|
|
|
(33,789
|
)
|
|
(5,163
|
)
|
|
26,979
|
|
||||||
Reverse repurchase, securities borrowing, and similar arrangements
|
|
178,037
|
|
|
—
|
|
|
178,037
|
|
|
(178,037
|
)
|
|
—
|
|
|
—
|
|
||||||
Total
|
|
$
|
243,968
|
|
|
$
|
—
|
|
|
$
|
243,968
|
|
|
$
|
(211,826
|
)
|
|
$
|
(5,163
|
)
|
|
$
|
26,979
|
|
December 31, 2016
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Derivative Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Interest rate swaps
|
|
$
|
810
|
|
|
$
|
—
|
|
|
$
|
810
|
|
|
$
|
(721
|
)
|
|
$
|
(89
|
)
|
|
$
|
—
|
|
Foreign exchange forwards
|
|
57,644
|
|
|
—
|
|
|
57,644
|
|
|
(22,738
|
)
|
|
(12,579
|
)
|
|
22,327
|
|
||||||
Foreign currency options
|
|
10,383
|
|
|
—
|
|
|
10,383
|
|
|
(8,806
|
)
|
|
—
|
|
|
1,577
|
|
||||||
Client interest rate derivatives
|
|
10,110
|
|
|
—
|
|
|
10,110
|
|
|
(10,091
|
)
|
|
—
|
|
|
19
|
|
||||||
Total derivative assets:
|
|
78,947
|
|
|
—
|
|
|
78,947
|
|
|
(42,356
|
)
|
|
(12,668
|
)
|
|
23,923
|
|
||||||
Reverse repurchase, securities borrowing, and similar arrangements
|
|
64,028
|
|
|
—
|
|
|
64,028
|
|
|
(64,028
|
)
|
|
—
|
|
|
—
|
|
||||||
Total
|
|
$
|
142,975
|
|
|
$
|
—
|
|
|
$
|
142,975
|
|
|
$
|
(106,384
|
)
|
|
$
|
(12,668
|
)
|
|
$
|
23,923
|
|
|
|
Gross Amounts of Recognized Liabilities
|
|
Gross Amounts offset in the Statement of Financial Position
|
|
Net Amounts of Liabilities Presented in the Statement of Financial Position
|
|
Gross Amounts Not Offset in the Statement of Financial Position But Subject to Master Netting Arrangements
|
|
Net Amount
|
||||||||||||||
(Dollars in thousands)
|
|
|
|
|
Financial Instruments
|
|
Cash Collateral Pledged
|
|
||||||||||||||||
March 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Derivative Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Foreign exchange forwards
|
|
$
|
41,296
|
|
|
$
|
—
|
|
|
$
|
41,296
|
|
|
$
|
(22,246
|
)
|
|
$
|
—
|
|
|
$
|
19,050
|
|
Foreign currency options
|
|
3,861
|
|
|
—
|
|
|
3,861
|
|
|
(3,298
|
)
|
|
—
|
|
|
563
|
|
||||||
Client interest rate derivatives
|
|
10,592
|
|
|
—
|
|
|
10,592
|
|
|
(10,592
|
)
|
|
—
|
|
|
—
|
|
||||||
Total derivative liabilities:
|
|
55,749
|
|
|
—
|
|
|
55,749
|
|
|
(36,136
|
)
|
|
—
|
|
|
19,613
|
|
||||||
Repurchase, securities lending, and similar arrangements
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Total
|
|
$
|
55,749
|
|
|
$
|
—
|
|
|
$
|
55,749
|
|
|
$
|
(36,136
|
)
|
|
$
|
—
|
|
|
$
|
19,613
|
|
December 31, 2016
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Derivative Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Foreign exchange forwards
|
|
$
|
44,285
|
|
|
$
|
—
|
|
|
$
|
44,285
|
|
|
$
|
(17,964
|
)
|
|
$
|
—
|
|
|
$
|
26,321
|
|
Foreign currency options
|
|
10,383
|
|
|
—
|
|
|
10,383
|
|
|
(1,585
|
)
|
|
—
|
|
|
8,798
|
|
||||||
Client interest rate derivatives
|
|
9,770
|
|
|
—
|
|
|
9,770
|
|
|
(9,770
|
)
|
|
—
|
|
|
—
|
|
||||||
Total derivative liabilities:
|
|
64,438
|
|
|
—
|
|
|
64,438
|
|
|
(29,319
|
)
|
|
—
|
|
|
35,119
|
|
||||||
Repurchase, securities lending, and similar arrangements
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Total
|
|
$
|
64,438
|
|
|
$
|
—
|
|
|
$
|
64,438
|
|
|
$
|
(29,319
|
)
|
|
$
|
—
|
|
|
$
|
35,119
|
|
10.
|
Other Noninterest Income and Other Noninterest Expense
|
|
|
Three months ended March 31,
|
||||||
(Dollars in thousands)
|
|
2017
|
|
2016
|
||||
Fund management fees
|
|
$
|
5,169
|
|
|
$
|
4,620
|
|
Service-based fee income
|
|
1,895
|
|
|
2,092
|
|
||
Gains on revaluation of client foreign currency instruments, net (1)
|
|
2,754
|
|
|
3,653
|
|
||
Losses on client foreign exchange forward contracts, net (1)
|
|
(2,289
|
)
|
|
(5,654
|
)
|
||
Gains on revaluation of internal foreign currency instruments, net (2)
|
|
4,108
|
|
|
2,491
|
|
||
Losses on internal foreign exchange forward contracts, net (2)
|
|
(3,245
|
)
|
|
(2,208
|
)
|
||
Other (3)
|
|
4,029
|
|
|
2,676
|
|
||
Total other noninterest income
|
|
$
|
12,421
|
|
|
$
|
7,670
|
|
|
(1)
|
Represents the net revaluation of client foreign currency denominated financial instruments. We enter into client foreign exchange forward contracts to economically reduce our foreign exchange exposure related to client foreign currency denominated financial instruments.
|
(2)
|
Represents the net revaluation of foreign currency denominated financial instruments issued and held by us, primarily loans, deposits and cash. We enter into internal foreign exchange forward contracts to economically reduce our foreign exchange exposure related to these foreign currency denominated financial instruments issued and held by us.
|
(3)
|
Includes dividends on FHLB/FRB stock, correspondent bank rebate income, incentive fees related to carried interest and other fee income.
|
|
|
Three months ended March 31,
|
||||||
(Dollars in thousands)
|
|
2017
|
|
2016
|
||||
Lending and other client related processing costs
|
|
$
|
5,539
|
|
|
$
|
4,295
|
|
Telephone
|
|
2,703
|
|
|
2,233
|
|
||
Data processing services
|
|
2,582
|
|
|
1,829
|
|
||
Dues and publications
|
|
795
|
|
|
802
|
|
||
Postage and supplies
|
|
749
|
|
|
790
|
|
||
Other
|
|
3,839
|
|
|
4,844
|
|
||
Total other noninterest expense
|
|
$
|
16,207
|
|
|
$
|
14,793
|
|
11.
|
Segment Reporting
|
•
|
Global Commercial Bank
is comprised of results from the following:
|
◦
|
Our
Commercial Bank
products and services are provided by the Bank and its subsidiaries to commercial clients in the technology, life science/healthcare and private equity/venture capital industries. The Bank provides solutions to the financial needs of commercial clients, through credit, global treasury management, foreign exchange, global trade finance, and other services. It serves clients within the United States, as well as non-U.S. clients in key international innovation markets. In addition, the Bank and its subsidiaries offer a variety of investment services and solutions to its clients that enable them to effectively manage their assets.
|
◦
|
Our
Private Equity Division
provides banking products and services primarily to our private equity and venture capital clients.
|
◦
|
Our
Wine
practice provides banking products and services to our premium wine industry clients, including vineyard development loans.
|
◦
|
SVB Analytics
provides equity valuation services to companies and private equity/venture capital firms.
|
◦
|
Debt Fund Investments
is comprised of our investments in certain debt funds in which we are a strategic investor.
|
•
|
SVB Private Bank
is the private banking division of the Bank, which provides a range of personal financial solutions for consumers. Our clients are primarily private equity/venture capital professionals and executive leaders of the innovation companies they support. We offer a customized suite of private banking services, including mortgages,
|
•
|
SVB Capital
is the funds management business of SVBFG, which focuses primarily on venture capital investments. SVB Capital manages funds (primarily venture capital funds) on behalf of third party limited partners and, on a more limited basis, SVB Financial Group. The SVB Capital family of funds is comprised of direct venture funds that invest in companies and funds of funds that invest in other venture capital funds. SVB Capital generates income for the Company primarily from investment returns (including carried interest allocations) and management fees.
|
(Dollars in thousands)
|
|
Global
Commercial
Bank (1)
|
|
SVB Private
Bank
|
|
SVB Capital (1)
|
|
Other Items (2)
|
|
Total
|
||||||||||
Three months ended March 31, 2017
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net interest income
|
|
$
|
275,684
|
|
|
$
|
13,610
|
|
|
$
|
—
|
|
|
$
|
20,699
|
|
|
$
|
309,993
|
|
Provision for credit losses
|
|
(28,889
|
)
|
|
(790
|
)
|
|
—
|
|
|
(1,055
|
)
|
|
(30,734
|
)
|
|||||
Noninterest income
|
|
79,519
|
|
|
718
|
|
|
16,775
|
|
|
20,647
|
|
|
117,659
|
|
|||||
Noninterest expense (3)
|
|
(172,374
|
)
|
|
(3,919
|
)
|
|
(3,472
|
)
|
|
(57,868
|
)
|
|
(237,633
|
)
|
|||||
Income (loss) before income tax expense (4)
|
|
$
|
153,940
|
|
|
$
|
9,619
|
|
|
$
|
13,303
|
|
|
$
|
(17,577
|
)
|
|
$
|
159,285
|
|
Total average loans, net of unearned income
|
|
$
|
17,647,055
|
|
|
$
|
2,245,317
|
|
|
$
|
—
|
|
|
$
|
176,942
|
|
|
$
|
20,069,314
|
|
Total average assets (5)
|
|
42,888,336
|
|
|
2,259,018
|
|
|
372,876
|
|
|
(219,196
|
)
|
|
45,301,034
|
|
|||||
Total average deposits
|
|
38,296,563
|
|
|
1,336,849
|
|
|
—
|
|
|
325,123
|
|
|
39,958,535
|
|
|||||
Three months ended March 31, 2016
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net interest income
|
|
$
|
256,178
|
|
|
$
|
13,672
|
|
|
$
|
—
|
|
|
$
|
11,571
|
|
|
$
|
281,421
|
|
Provision for credit losses
|
|
(32,703
|
)
|
|
(638
|
)
|
|
—
|
|
|
(134
|
)
|
|
(33,475
|
)
|
|||||
Noninterest income
|
|
74,759
|
|
|
627
|
|
|
2,453
|
|
|
8,295
|
|
|
86,134
|
|
|||||
Noninterest expense (3)
|
|
(154,787
|
)
|
|
(3,405
|
)
|
|
(3,913
|
)
|
|
(41,794
|
)
|
|
(203,899
|
)
|
|||||
Income before income tax expense (4)
|
|
$
|
143,447
|
|
|
$
|
10,256
|
|
|
$
|
(1,460
|
)
|
|
$
|
(22,062
|
)
|
|
$
|
130,181
|
|
Total average loans, net of unearned income
|
|
$
|
14,919,735
|
|
|
$
|
1,871,820
|
|
|
$
|
—
|
|
|
$
|
220,880
|
|
|
$
|
17,012,435
|
|
Total average assets (5)
|
|
41,533,434
|
|
|
1,893,413
|
|
|
349,011
|
|
|
414,332
|
|
|
44,190,190
|
|
|||||
Total average deposits
|
|
37,837,645
|
|
|
1,130,736
|
|
|
—
|
|
|
299,748
|
|
|
39,268,129
|
|
|
(1)
|
Global Commercial Bank’s and SVB Capital’s components of net interest income, noninterest income, noninterest expense and total average assets are shown net of noncontrolling interests for all periods presented. Noncontrolling interest is included within "Other Items".
|
(2)
|
The "Other Items" column reflects the adjustments necessary to reconcile the results of the operating segments to the consolidated financial statements prepared in conformity with GAAP. Net interest income consists primarily of interest earned from our fixed income investment portfolio, net of FTP. Noninterest income consists primarily of gains on equity warrant assets and gains on the sale of fixed income securities. Noninterest expense consists primarily of expenses associated with corporate support functions such as finance, human resources, marketing, legal and other expenses.
|
(3)
|
The Global Commercial Bank segment includes direct depreciation and amortization of
$6.1 million
and
$5.7 million
for the three months ended
March 31, 2017
and
2016
, respectively.
|
(4)
|
The internal reporting model used by management to assess segment performance does not calculate income tax expense by segment. Our effective tax rate is a reasonable approximation of the segment rates.
|
(5)
|
Total average assets equal the greater of total average assets or the sum of total average liabilities and total average stockholders’ equity for each segment to reconcile the results to the consolidated financial statements prepared in conformity with GAAP.
|
12.
|
Off-Balance Sheet Arrangements, Guarantees and Other Commitments
|
(Dollars in thousands)
|
|
March 31, 2017
|
|
December 31, 2016
|
||||
Loan commitments available for funding: (1)
|
|
|
|
|
||||
Fixed interest rate commitments
|
|
$
|
1,452,107
|
|
|
$
|
1,475,179
|
|
Variable interest rate commitments
|
|
12,950,544
|
|
|
13,572,161
|
|
||
Total loan commitments available for funding
|
|
14,402,651
|
|
|
15,047,340
|
|
||
Commercial and standby letters of credit (2)
|
|
1,679,680
|
|
|
1,695,856
|
|
||
Total unfunded credit commitments
|
|
$
|
16,082,331
|
|
|
$
|
16,743,196
|
|
Commitments unavailable for funding (3)
|
|
$
|
1,952,726
|
|
|
$
|
1,719,524
|
|
Maximum lending limits for accounts receivable factoring arrangements (4)
|
|
686,553
|
|
|
725,395
|
|
||
Allowance for unfunded credit commitments (5)
|
|
46,335
|
|
|
45,265
|
|
|
(1)
|
Represents commitments which are available for funding, due to clients meeting all collateral, compliance and financial covenants required under loan commitment agreements.
|
(2)
|
See below for additional information on our commercial and standby letters of credit.
|
(3)
|
Represents commitments which are currently unavailable for funding, due to clients failing to meet all collateral, compliance and financial covenants under loan commitment agreements.
|
(4)
|
We extend credit under accounts receivable factoring arrangements when our clients’ sales invoices are deemed creditworthy under existing underwriting practices.
|
(5)
|
Our allowance for unfunded credit commitments includes an allowance for both our unfunded loan commitments and our letters of credit.
|
(Dollars in thousands)
|
|
Expires In One
Year or Less
|
|
Expires After
One Year
|
|
Total Amount
Outstanding
|
|
Maximum Amount
of Future Payments
|
||||||||
Financial standby letters of credit
|
|
$
|
1,519,329
|
|
|
$
|
45,306
|
|
|
$
|
1,564,635
|
|
|
$
|
1,564,635
|
|
Performance standby letters of credit
|
|
89,155
|
|
|
7,890
|
|
|
97,045
|
|
|
97,045
|
|
||||
Commercial letters of credit
|
|
18,000
|
|
|
—
|
|
|
18,000
|
|
|
18,000
|
|
||||
Total
|
|
$
|
1,626,484
|
|
|
$
|
53,196
|
|
|
$
|
1,679,680
|
|
|
$
|
1,679,680
|
|
Our Ownership in Venture Capital and Private Equity Funds
(Dollars in thousands)
|
|
SVBFG Capital Commitments
|
|
SVBFG Unfunded
Commitments
|
|
SVBFG Ownership
of each Fund (3)
|
|||||
CP I, LP
|
|
$
|
6,000
|
|
|
$
|
270
|
|
|
10.7
|
%
|
CP II, LP (1)
|
|
1,200
|
|
|
162
|
|
|
5.1
|
|
||
Shanghai Yangpu Venture Capital Fund (LP)
|
|
842
|
|
|
—
|
|
|
6.8
|
|
||
Strategic Investors Fund, LP
|
|
15,300
|
|
|
688
|
|
|
12.6
|
|
||
Strategic Investors Fund II, LP
|
|
15,000
|
|
|
1,050
|
|
|
8.6
|
|
||
Strategic Investors Fund III, LP
|
|
15,000
|
|
|
1,275
|
|
|
5.9
|
|
||
Strategic Investors Fund IV, LP
|
|
12,239
|
|
|
2,325
|
|
|
5.0
|
|
||
Strategic Investors Fund V funds
|
|
515
|
|
|
141
|
|
|
Various
|
|
||
Capital Preferred Return Fund, LP
|
|
12,688
|
|
|
—
|
|
|
20.0
|
|
||
Growth Partners, LP
|
|
24,670
|
|
|
1,340
|
|
|
33.0
|
|
||
Debt funds (equity method accounting)
|
|
58,493
|
|
|
—
|
|
|
Various
|
|
||
Other fund investments (2)
|
|
306,269
|
|
|
10,441
|
|
|
Various
|
|
||
Total
|
|
$
|
468,216
|
|
|
$
|
17,692
|
|
|
|
|
(1)
|
Our ownership includes direct ownership of
1.3
percent and indirect ownership interest of
3.8
percent through our investment in Strategic Investors Fund II, LP.
|
(2)
|
Represents commitments to
255
funds (primarily venture capital funds) where our ownership interest is generally less than
5 percent
of the voting interests of each such fund.
|
(3)
|
We are subject to the Volcker Rule, which restricts or limits us from sponsoring or having ownership interests in “covered” funds including venture capital and private equity funds. See “Business - Supervision and Regulation” under Item 1 of Part I of our 2016 Form 10-K.
|
Limited Partnership
(Dollars in thousands)
|
|
Unfunded Commitments
|
||
Strategic Investors Fund, LP
|
|
$
|
1,338
|
|
Capital Preferred Return Fund, LP
|
|
1,723
|
|
|
Growth Partners, LP
|
|
1,524
|
|
|
Total
|
|
$
|
4,585
|
|
13.
|
Income Taxes
|
14.
|
Fair Value of Financial Instruments
|
(Dollars in thousands)
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Balance at
March 31, 2017
|
||||||||
Assets
|
|
|
|
|
|
|
|
|
||||||||
Available-for-sale securities:
|
|
|
|
|
|
|
|
|
||||||||
U.S. Treasury securities
|
|
$
|
8,206,090
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
8,206,090
|
|
U.S. agency debentures
|
|
—
|
|
|
2,077,813
|
|
|
—
|
|
|
2,077,813
|
|
||||
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
||||||||
Agency-issued collateralized mortgage obligations - fixed rate
|
|
—
|
|
|
1,650,329
|
|
|
—
|
|
|
1,650,329
|
|
||||
Agency-issued collateralized mortgage obligations - variable rate
|
|
—
|
|
|
445,581
|
|
|
—
|
|
|
445,581
|
|
||||
Equity securities
|
|
744
|
|
|
3,450
|
|
|
—
|
|
|
4,194
|
|
||||
Total available-for-sale securities
|
|
8,206,834
|
|
|
4,177,173
|
|
|
—
|
|
|
12,384,007
|
|
||||
Non-marketable and other securities (fair value accounting):
|
|
|
|
|
|
|
|
|
||||||||
Non-marketable securities:
|
|
|
|
|
|
|
|
|
||||||||
Venture capital and private equity fund investments measured at net asset value
|
|
—
|
|
|
—
|
|
|
—
|
|
|
139,715
|
|
||||
Other venture capital investments (1)
|
|
—
|
|
|
—
|
|
|
2,040
|
|
|
2,040
|
|
||||
Other securities (1)
|
|
646
|
|
|
—
|
|
|
—
|
|
|
646
|
|
||||
Total non-marketable and other securities (fair value accounting)
|
|
646
|
|
|
—
|
|
|
2,040
|
|
|
142,401
|
|
||||
Other assets:
|
|
|
|
|
|
|
|
|
||||||||
Interest rate swaps
|
|
—
|
|
|
318
|
|
|
—
|
|
|
318
|
|
||||
Foreign exchange forward and option contracts
|
|
—
|
|
|
54,911
|
|
|
—
|
|
|
54,911
|
|
||||
Equity warrant assets
|
|
—
|
|
|
2,034
|
|
|
122,199
|
|
|
124,233
|
|
||||
Client interest rate derivatives
|
|
—
|
|
|
10,702
|
|
|
—
|
|
|
10,702
|
|
||||
Total assets
|
|
$
|
8,207,480
|
|
|
$
|
4,245,138
|
|
|
$
|
124,239
|
|
|
$
|
12,716,572
|
|
Liabilities
|
|
|
|
|
|
|
|
|
||||||||
Foreign exchange forward and option contracts
|
|
$
|
—
|
|
|
$
|
45,157
|
|
|
$
|
—
|
|
|
$
|
45,157
|
|
Client interest rate derivatives
|
|
—
|
|
|
10,592
|
|
|
—
|
|
|
10,592
|
|
||||
Total liabilities
|
|
$
|
—
|
|
|
$
|
55,749
|
|
|
$
|
—
|
|
|
$
|
55,749
|
|
|
(1)
|
Included in Level 1 and Level 3 assets are
$0.5 million
and
$1.8 million
, respectively, attributable to noncontrolling interests calculated based on the ownership percentages of the noncontrolling interests.
|
(Dollars in thousands)
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Balance at December 31, 2016
|
||||||||
Assets
|
|
|
|
|
|
|
|
|
||||||||
Available-for-sale securities:
|
|
|
|
|
|
|
|
|
||||||||
U.S. Treasury securities
|
|
$
|
8,909,491
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
8,909,491
|
|
U.S. agency debentures
|
|
—
|
|
|
2,078,375
|
|
|
—
|
|
|
2,078,375
|
|
||||
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
||||||||
Agency-issued collateralized mortgage obligations - fixed rate
|
|
—
|
|
|
1,152,665
|
|
|
—
|
|
|
1,152,665
|
|
||||
Agency-issued collateralized mortgage obligations - variable rate
|
|
—
|
|
|
474,283
|
|
|
—
|
|
|
474,283
|
|
||||
Equity securities
|
|
175
|
|
|
5,422
|
|
|
—
|
|
|
5,597
|
|
||||
Total available-for-sale securities
|
|
8,909,666
|
|
|
3,710,745
|
|
|
—
|
|
|
12,620,411
|
|
||||
Non-marketable and other securities (fair value accounting):
|
|
|
|
|
|
|
|
|
||||||||
Non-marketable securities:
|
|
|
|
|
|
|
|
|
||||||||
Venture capital and private equity fund investments measured at net asset value
|
|
—
|
|
|
—
|
|
|
—
|
|
|
141,649
|
|
||||
Other venture capital investments (1)
|
|
—
|
|
|
—
|
|
|
2,040
|
|
|
2,040
|
|
||||
Other securities (1)
|
|
753
|
|
|
—
|
|
|
—
|
|
|
753
|
|
||||
Total non-marketable and other securities (fair value accounting)
|
|
753
|
|
|
—
|
|
|
2,040
|
|
|
144,442
|
|
||||
Other assets:
|
|
|
|
|
|
|
|
|
||||||||
Interest rate swaps
|
|
—
|
|
|
810
|
|
|
—
|
|
|
810
|
|
||||
Foreign exchange forward and option contracts
|
|
—
|
|
|
68,027
|
|
|
—
|
|
|
68,027
|
|
||||
Equity warrant assets
|
|
—
|
|
|
2,310
|
|
|
128,813
|
|
|
131,123
|
|
||||
Client interest rate derivatives
|
|
—
|
|
|
10,110
|
|
|
—
|
|
|
10,110
|
|
||||
Total assets
|
|
$
|
8,910,419
|
|
|
$
|
3,792,002
|
|
|
$
|
130,853
|
|
|
$
|
12,974,923
|
|
Liabilities
|
|
|
|
|
|
|
|
|
||||||||
Foreign exchange forward and option contracts
|
|
$
|
—
|
|
|
$
|
54,668
|
|
|
$
|
—
|
|
|
$
|
54,668
|
|
Client interest rate derivatives
|
|
—
|
|
|
9,770
|
|
|
—
|
|
|
9,770
|
|
||||
Total liabilities
|
|
$
|
—
|
|
|
$
|
64,438
|
|
|
$
|
—
|
|
|
$
|
64,438
|
|
|
(1)
|
Included in Level 1 and Level 3 assets are
$0.6 million
and
$1.8 million
, respectively, attributable to noncontrolling interests calculated based on the ownership percentages of the noncontrolling interests.
|
(Dollars in thousands)
|
|
Beginning
Balance
|
|
Total Realized and Unrealized Gains (Losses) Included in Income
|
|
Sales
|
|
Issuances
|
|
Distributions and Other Settlements
|
|
Transfers Out of Level 3
|
|
Ending
Balance
|
||||||||||||||
Three months ended March 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Non-marketable and other securities (fair value accounting):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Other venture capital investments (1)
|
|
$
|
2,040
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
2,040
|
|
Other assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Equity warrant assets (2)
|
|
128,813
|
|
|
6,609
|
|
|
(17,086
|
)
|
|
4,030
|
|
|
—
|
|
|
(167
|
)
|
|
122,199
|
|
|||||||
Total assets
|
|
$
|
130,853
|
|
|
$
|
6,609
|
|
|
$
|
(17,086
|
)
|
|
$
|
4,030
|
|
|
$
|
—
|
|
|
$
|
(167
|
)
|
|
$
|
124,239
|
|
Three months ended March 31, 2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Non-marketable and other securities (fair value accounting):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Other venture capital investments (1)
|
|
$
|
2,040
|
|
|
$
|
(30
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
30
|
|
|
$
|
—
|
|
|
$
|
2,040
|
|
Other assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Equity warrant assets (2)
|
|
135,168
|
|
|
7,179
|
|
|
(15,416
|
)
|
|
2,374
|
|
|
—
|
|
|
(323
|
)
|
|
128,982
|
|
|||||||
Total assets
|
|
$
|
137,208
|
|
|
$
|
7,149
|
|
|
$
|
(15,416
|
)
|
|
$
|
2,374
|
|
|
$
|
30
|
|
|
$
|
(323
|
)
|
|
$
|
131,022
|
|
|
(1)
|
Realized and unrealized gains (losses) are recorded in the line item “Gains on investment securities, net”, a component of noninterest income.
|
(2)
|
Realized and unrealized gains (losses) are recorded in the line item “Gains on equity warrant assets, net”, a component of noninterest income.
|
|
|
Three months ended March 31,
|
||||||
(Dollars in thousands)
|
|
2017
|
|
2016
|
||||
Non-marketable and other securities (fair value accounting):
|
|
|
|
|
||||
Other venture capital investments (1)
|
|
$
|
—
|
|
|
$
|
—
|
|
Other assets:
|
|
|
|
|
||||
Equity warrant assets (2)
|
|
(347
|
)
|
|
1,465
|
|
||
Total unrealized (losses) gains, net
|
|
$
|
(347
|
)
|
|
$
|
1,465
|
|
Unrealized (losses) gains attributable to noncontrolling interests
|
|
$
|
—
|
|
|
$
|
—
|
|
|
(1)
|
Unrealized gains (losses) are recorded in the line item “Gains
on investment securities, net
”, a component of noninterest income.
|
(2)
|
Unrealized gains (losses) are recorded in the line item “Gains
on equity warrant assets, net
”, a component of noninterest income.
|
(Dollars in thousands)
|
|
Fair value
|
|
Valuation Technique
|
|
Significant Unobservable Inputs
|
|
Weighted
Average
|
|||
March 31, 2017:
|
|
|
|
|
|
|
|
|
|||
Other venture capital investments (fair value accounting)
|
|
$
|
2,040
|
|
|
Private company equity pricing
|
|
(1)
|
|
(1
|
)
|
Equity warrant assets (public portfolio)
|
|
1,223
|
|
|
Modified Black-Scholes option pricing model
|
|
Volatility
|
|
40.7
|
%
|
|
|
|
|
|
Risk-Free interest rate
|
|
1.8
|
%
|
||||
|
|
|
|
Sales restrictions discount (2)
|
|
15.1
|
%
|
||||
Equity warrant assets (private portfolio)
|
|
120,976
|
|
|
Modified Black-Scholes option pricing model
|
|
Volatility
|
|
37.1
|
%
|
|
|
|
|
|
Risk-Free interest rate
|
|
1.3
|
%
|
||||
|
|
|
|
Marketability discount (3)
|
|
16.8
|
%
|
||||
|
|
|
|
Remaining life assumption (4)
|
|
45.0
|
%
|
||||
December 31, 2016:
|
|
|
|
|
|
|
|
|
|||
Other venture capital investments (fair value accounting)
|
|
$
|
2,040
|
|
|
Private company equity pricing
|
|
(1)
|
|
(1
|
)
|
Equity warrant assets (public portfolio)
|
|
764
|
|
|
Modified Black-Scholes option pricing model
|
|
Volatility
|
|
46.6
|
%
|
|
|
|
|
|
Risk-Free interest rate
|
|
2.1
|
%
|
||||
|
|
|
|
Sales restrictions discount (2)
|
|
17.7
|
%
|
||||
Equity warrant assets (private portfolio)
|
|
128,049
|
|
|
Modified Black-Scholes option pricing model
|
|
Volatility
|
|
36.9
|
%
|
|
|
|
|
|
Risk-Free interest rate
|
|
1.3
|
%
|
||||
|
|
|
|
Marketability discount (3)
|
|
17.1
|
%
|
||||
|
|
|
|
Remaining life assumption (4)
|
|
45.0
|
%
|
|
(1)
|
In determining the fair value of our other venture capital investment portfolio, we evaluate a variety of factors related to each underlying private portfolio company including, but not limited to, actual and forecasted results, cash position, recent or planned transactions and market comparable companies. Additionally, we have ongoing communication with the portfolio companies and venture capital fund managers, to determine whether there is a material change in fair value. We use company provided valuation reports, if available, to support our valuation assumptions. These factors are specific to each portfolio company and a weighted average or range of values of the unobservable inputs is not meaningful.
|
(2)
|
We adjust quoted market prices of public companies, which are subject to certain sales restrictions. Sales restriction discounts generally range from
10 percent
to
20 percent
depending on the duration of the sales restrictions, which typically range from
three
to
six
months.
|
(3)
|
Our marketability discount is applied to all private company warrants to account for a general lack of liquidity due to the private nature of the associated underlying company. The quantitative measure used is based upon various option-pricing models. On a quarterly basis, a sensitivity analysis is performed on our marketability discount.
|
(4)
|
We adjust the contractual remaining term of private company warrants based on our estimate of the actual remaining life, which we determine by utilizing historical data on cancellations and exercises. At
March 31, 2017
, the weighted average contractual remaining term was
5.9
years, compared to our estimated remaining life of
2.6
years. On a quarterly basis, a sensitivity analysis is performed on our remaining life assumption.
|
|
|
|
|
Estimated Fair Value
|
||||||||||||||||
(Dollars in thousands)
|
|
Carrying Amount
|
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||||||
March 31, 2017:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Financial assets:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash and cash equivalents
|
|
$
|
3,795,679
|
|
|
$
|
3,795,679
|
|
|
$
|
3,795,679
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Held-to-maturity securities
|
|
8,615,695
|
|
|
8,567,817
|
|
|
—
|
|
|
8,567,817
|
|
|
—
|
|
|||||
Non-marketable securities (cost and equity method accounting) not measured at net asset value
|
|
121,108
|
|
|
125,650
|
|
|
—
|
|
|
—
|
|
|
125,650
|
|
|||||
Non-marketable securities (cost and equity method accounting) measured at net asset value
|
|
239,275
|
|
|
346,890
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Net commercial loans
|
|
17,953,251
|
|
|
18,165,969
|
|
|
—
|
|
|
—
|
|
|
18,165,969
|
|
|||||
Net consumer loans
|
|
2,231,070
|
|
|
2,267,387
|
|
|
—
|
|
|
—
|
|
|
2,267,387
|
|
|||||
FHLB and Federal Reserve Bank stock
|
|
57,592
|
|
|
57,592
|
|
|
—
|
|
|
—
|
|
|
57,592
|
|
|||||
Accrued interest receivable
|
|
110,949
|
|
|
110,949
|
|
|
—
|
|
|
110,949
|
|
|
—
|
|
|||||
Financial liabilities:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Other short-term borrowings
|
|
5,163
|
|
|
5,163
|
|
|
5,163
|
|
|
—
|
|
|
—
|
|
|||||
Non-maturity deposits (1)
|
|
41,038,552
|
|
|
41,038,552
|
|
|
41,038,552
|
|
|
—
|
|
|
—
|
|
|||||
Time deposits
|
|
41,148
|
|
|
40,982
|
|
|
—
|
|
|
40,982
|
|
|
—
|
|
|||||
3.50% Senior Notes
|
|
347,059
|
|
|
340,582
|
|
|
—
|
|
|
340,582
|
|
|
—
|
|
|||||
5.375% Senior Notes
|
|
347,733
|
|
|
379,236
|
|
|
—
|
|
|
379,236
|
|
|
—
|
|
|||||
6.05% Subordinated Notes (2)
|
|
46,223
|
|
|
46,587
|
|
|
—
|
|
|
46,587
|
|
|
—
|
|
|||||
7.0% Junior Subordinated Debentures
|
|
54,450
|
|
|
54,021
|
|
|
—
|
|
|
54,021
|
|
|
—
|
|
|||||
Accrued interest payable
|
|
4,990
|
|
|
4,990
|
|
|
—
|
|
|
4,990
|
|
|
—
|
|
|||||
Off-balance sheet financial assets:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Commitments to extend credit
|
|
—
|
|
|
21,127
|
|
|
—
|
|
|
—
|
|
|
21,127
|
|
|||||
December 31, 2016:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Financial assets:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash and cash equivalents
|
|
$
|
2,545,750
|
|
|
$
|
2,545,750
|
|
|
$
|
2,545,750
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Held-to-maturity securities
|
|
8,426,998
|
|
|
8,376,138
|
|
|
—
|
|
|
8,376,138
|
|
|
—
|
|
|||||
Non-marketable securities (cost and equity method accounting) not measured at net asset value
|
|
120,037
|
|
|
127,343
|
|
|
—
|
|
|
—
|
|
|
127,343
|
|
|||||
Non-marketable securities (cost and equity method accounting) measured at net asset value
|
|
245,626
|
|
|
353,870
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Net commercial loans
|
|
17,518,430
|
|
|
17,811,356
|
|
|
—
|
|
|
—
|
|
|
17,811,356
|
|
|||||
Net consumer loans
|
|
2,156,148
|
|
|
2,199,501
|
|
|
—
|
|
|
—
|
|
|
2,199,501
|
|
|||||
FHLB and Federal Reserve Bank stock
|
|
57,592
|
|
|
57,592
|
|
|
—
|
|
|
—
|
|
|
57,592
|
|
|||||
Accrued interest receivable
|
|
111,222
|
|
|
111,222
|
|
|
—
|
|
|
111,222
|
|
|
—
|
|
|||||
Financial liabilities:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Short-term FHLB advances
|
|
500,000
|
|
|
500,000
|
|
|
500,000
|
|
|
—
|
|
|
—
|
|
|||||
Other short-term borrowings
|
|
12,668
|
|
|
12,668
|
|
|
12,668
|
|
|
—
|
|
|
—
|
|
|||||
Non-maturity deposits (1)
|
|
38,923,750
|
|
|
38,923,750
|
|
|
38,923,750
|
|
|
—
|
|
|
—
|
|
|||||
Time deposits
|
|
56,118
|
|
|
55,949
|
|
|
—
|
|
|
55,949
|
|
|
—
|
|
|||||
3.50% Senior Notes
|
|
346,979
|
|
|
337,600
|
|
|
—
|
|
|
337,600
|
|
|
—
|
|
|||||
5.375% Senior Notes
|
|
347,586
|
|
|
378,777
|
|
|
—
|
|
|
378,777
|
|
|
—
|
|
|||||
6.05% Subordinated Notes (2)
|
|
46,646
|
|
|
47,489
|
|
|
—
|
|
|
47,489
|
|
|
—
|
|
|||||
7.0% Junior Subordinated Debentures
|
|
54,493
|
|
|
53,140
|
|
|
—
|
|
|
53,140
|
|
|
—
|
|
|||||
Accrued interest payable
|
|
12,013
|
|
|
12,013
|
|
|
—
|
|
|
12,013
|
|
|
—
|
|
|||||
Off-balance sheet financial assets:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Commitments to extend credit
|
|
—
|
|
|
22,074
|
|
|
—
|
|
|
—
|
|
|
22,074
|
|
|
(1)
|
Includes noninterest-bearing demand deposits, interest-bearing checking accounts, money market accounts and interest-bearing sweep deposits.
|
(2)
|
At
March 31, 2017
and
December 31, 2016
, included in the carrying value and estimated fair value of our 6.05% Subordinated Notes was an interest rate swap valued at
$0.3 million
and
$0.8 million
, respectively, related to hedge accounting associated with the notes.
|
(Dollars in thousands)
|
|
Carrying Amount
|
|
Fair Value
|
|
Unfunded Commitments
|
||||||
Non-marketable securities (fair value accounting):
|
|
|
|
|
|
|
||||||
Venture capital and private equity fund investments (1)
|
|
$
|
139,715
|
|
|
$
|
139,715
|
|
|
$
|
4,585
|
|
Non-marketable securities (equity method accounting):
|
|
|
|
|
|
|
||||||
Venture capital and private equity fund investments (2)
|
|
85,529
|
|
|
85,529
|
|
|
4,953
|
|
|||
Debt funds (2)
|
|
16,509
|
|
|
17,676
|
|
|
—
|
|
|||
Other investments (2)
|
|
19,994
|
|
|
19,994
|
|
|
715
|
|
|||
Non-marketable securities (cost method accounting):
|
|
|
|
|
|
|
||||||
Venture capital and private equity fund investments (2)
|
|
117,243
|
|
|
223,691
|
|
|
9,633
|
|
|||
Total
|
|
$
|
378,990
|
|
|
$
|
486,605
|
|
|
$
|
19,886
|
|
|
(1)
|
Venture capital and private equity fund investments within non-marketable securities (fair value accounting) include investments made by our managed funds of funds and one of our direct venture funds. These investments represent investments in venture capital and private equity funds that invest primarily in U.S. and global technology and life science/healthcare companies. Included in the fair value and unfunded commitments of fund investments under fair value accounting are
$103.9 million
and
$3.5 million
, respectively, attributable to noncontrolling interests. It is estimated that we will receive distributions from the fund investments over the next
10
to
13
years, depending on the age of the funds and any potential extensions of terms of the funds.
|
(2)
|
Venture capital and private equity fund investments, debt funds, and other fund investments within non-marketable securities (equity and cost method accounting) include funds that invest in or lend money to primarily U.S. and global technology and life science/healthcare companies. It is estimated that we will receive distributions from the funds over the next
10
to
13
years, depending on the age of the funds and any potential extensions of the terms of the funds.
|
15.
|
Legal Matters
|
16.
|
Related Parties
|
•
|
Financial projections, including with respect to our net interest income, noninterest income, earnings per share, noninterest expenses (including professional services, compliance, compensation and other costs), cash flows, balance sheet positions, capital expenditures, liquidity and capitalization or other financial items;
|
•
|
Descriptions of our strategic initiatives, plans or objectives for future operations, including pending sales or acquisitions;
|
•
|
Forecasts of private equity/venture capital funding and investment levels;
|
•
|
Forecasts of future interest rates, economic performance, and income from investments;
|
•
|
Forecasts of expected levels of provisions for loan losses, nonperforming loans, loan growth and client funds; and
|
•
|
Descriptions of assumptions underlying or relating to any of the foregoing.
|
•
|
Market and economic conditions, including the interest rate environment, and the associated impact on us;
|
•
|
The credit profile and credit quality of our loan portfolio and volatility of our levels of nonperforming assets and charge-offs;
|
•
|
The adequacy of our allowance for loan losses and the need to make provisions for loan losses for any period;
|
•
|
The borrowing needs of our clients;
|
•
|
The sufficiency of our capital and liquidity positions;
|
•
|
The levels of loans, deposits and client investment fund balances;
|
•
|
The performance of our portfolio investments; the general condition of the public and private equity and mergers and acquisitions markets and their impact on our investments, including equity warrant assets, venture capital and private equity funds and direct equity investments;
|
•
|
Our overall investment plans and strategies; the realization, timing, valuation and performance of our equity or other investments;
|
•
|
The levels of public offerings, mergers and acquisitions and venture capital investment activity of our clients that may impact the borrowing needs of our clients;
|
•
|
The occurrence of fraudulent activity, including breaches of our information security or cyber security-related incidents;
|
•
|
Business disruptions and interruptions due to natural disasters and other external events;
|
•
|
The impact on our reputation and business from our interactions with business partners, counterparties, service providers and other third parties;
|
•
|
Expansion of our business internationally, and the impact of international market and economic events on us;
|
•
|
The impact of governmental policy, legal requirements and regulations, including the Dodd-Frank Act, the Volcker Rule and Federal Reserve and other regulatory requirements;
|
•
|
The impact of lawsuits and claims, as well as, legal or regulatory proceedings;
|
•
|
Changes in accounting standards and tax laws;
|
•
|
The levels of equity capital available to our client or portfolio companies;
|
•
|
The effectiveness of our risk management framework and quantitative models;
|
•
|
The sale of impaired assets;
|
•
|
Our ability to maintain or increase our market share, including through successfully implementing our business strategy and undertaking new business initiatives; and
|
•
|
Other factors as discussed in “Risk Factors” under Part I, Item 1A in our
2016
Form 10-K.
|
BALANCE SHEET
|
|
EARNINGS
|
Assets.
$45.3 billion in average total assets (up 2.5%). $46.4 billion in period-end total assets (up 6.5%).
Loans.
$20.1 billion in average total loan balances, net of unearned income (up 18.0%). $20.4 billion in period-end total loan balances, net of unearned income (up 15.2%).
Deposits.
$40.0 billion in average total deposit balances (up 1.8%). $41.1 billion in period-end total deposit balances (up 6.0%).
Off-Balance Sheet Client Investment Funds.
$46.1 billion in total average client investment fund balances (up 8.6%). $46.4 billion in total period-end client investment fund balances (up 9.8%).
|
|
EPS
.
Earnings per diluted share of $1.91 (up 25.7%).
Net Income
.
Consolidated net income available to common stockholders of $101.5 million (up 28.2%).
- Net interest income of $310.0 million (up 10.2%).
- Net interest margin of 2.88% (up 21 bps).
- Noninterest income of $117.7 million (up 36.6%), with non-GAAP core fee income
+
of $82.6 million (up 7.9%).
- Noninterest expense of $237.6 million (up 16.5%)
ROE
.
Return on average equity (annualized) (“
ROE
”) performance of 11.03%.
|
|
|
|
CAPITAL
|
|
CREDIT QUALITY
|
Capital
.
Continued strong capital levels, with all capital ratios considered "well-capitalized" under banking regulations. SVBFG and SVB capital ratios, respectively, were:
- CET 1 risk-based capital ratio of 13.05% and 12.75%.
- Tier 1 risk-based capital ratio of 13.44% and 12.75%.
- Total risk-based capital ratio of 14.45% and 13.80%.
- Tier 1 leverage ratio of 8.51% and 7.81%.
|
|
Credit Quality
.
Continued disciplined underwriting.
- Allowance for loan losses of 1.18% as a percentage of period-end total gross loans.
- Provision for loan losses of 0.59% as a percentage of period-end total gross loans (annualized).
- Net loan charge-offs of 0.25% as a percentage of average total gross loans (annualized).
|
|
|
Three months ended March 31,
|
||||||||||
(Dollars in thousands, except per share data, employees and ratios)
|
|
2017
|
|
2016
|
|
% Change
|
||||||
|
|
|
|
|
|
|
|
|||||
Diluted earnings per common share
|
|
$
|
1.91
|
|
|
$
|
1.52
|
|
|
25.7
|
|
%
|
Net income available to common stockholders
|
|
101,483
|
|
|
79,174
|
|
|
28.2
|
|
|
||
Net interest income
|
|
309,993
|
|
|
281,421
|
|
|
10.2
|
|
|
||
Net interest margin
|
|
2.88
|
%
|
|
2.67
|
%
|
|
21
|
|
bps
|
||
Provision for credit losses
|
|
$
|
30,734
|
|
|
$
|
33,475
|
|
|
(8.2
|
)
|
%
|
Noninterest income
|
|
117,659
|
|
|
86,134
|
|
|
36.6
|
|
|
||
Noninterest expense
|
|
237,633
|
|
|
203,899
|
|
|
16.5
|
|
|
||
Non-GAAP core fee income (1)
|
|
82,578
|
|
|
76,542
|
|
|
7.9
|
|
|
||
Non-GAAP noninterest income, net of noncontrolling interests (1)
|
|
111,100
|
|
|
88,805
|
|
|
25.1
|
|
|
||
Non-GAAP noninterest expense, net of noncontrolling interests (2)
|
|
237,464
|
|
|
203,990
|
|
|
16.4
|
|
|
||
Balance Sheet:
|
|
|
|
|
|
|
|
|||||
Average available-for-sale securities
|
|
$
|
12,550,264
|
|
|
$
|
14,692,632
|
|
|
(14.6
|
)
|
%
|
Average held-to-maturity securities
|
|
8,600,176
|
|
|
8,658,684
|
|
|
(0.7
|
)
|
|
||
Average loans, net of unearned income
|
|
20,069,314
|
|
|
17,012,435
|
|
|
18.0
|
|
|
||
Average noninterest-bearing demand deposits
|
|
32,709,423
|
|
|
31,219,504
|
|
|
4.8
|
|
|
||
Average interest-bearing deposits
|
|
7,249,112
|
|
|
8,048,625
|
|
|
(9.9
|
)
|
|
||
Average total deposits
|
|
39,958,535
|
|
|
39,268,129
|
|
|
1.8
|
|
|
||
Earnings Ratios:
|
|
|
|
|
|
|
|
|||||
Return on average assets (annualized) (3)
|
|
0.91
|
%
|
|
0.72
|
%
|
|
26.4
|
|
%
|
||
Return on average SVBFG stockholders’ equity (annualized) (4)
|
|
11.03
|
|
|
9.59
|
|
|
15.0
|
|
|
||
Asset Quality Ratios:
|
|
|
|
|
|
|
|
|||||
Allowance for loan losses as a % of total period-end gross loans
|
|
1.18
|
%
|
|
1.29
|
%
|
|
(11
|
)
|
bps
|
||
Allowance for loan losses for performing loans as a % of total gross performing loans
|
|
0.94
|
|
|
1.01
|
|
|
(7
|
)
|
|
||
Gross loan charge-offs as a % of average total gross loans (annualized)
|
|
0.28
|
|
|
0.61
|
|
|
(33
|
)
|
|
||
Net loan charge-offs as a % of average total gross loans (annualized)
|
|
0.25
|
|
|
0.50
|
|
|
(25
|
)
|
|
||
Capital Ratios:
|
|
|
|
|
|
|
|
|||||
CET 1 risk-based capital ratio
|
|
13.05
|
%
|
|
12.38
|
%
|
|
67
|
|
bps
|
||
Tier 1 risk-based capital ratio
|
|
13.44
|
|
|
12.86
|
|
|
58
|
|
|
||
Total risk-based capital ratio
|
|
14.45
|
|
|
13.90
|
|
|
55
|
|
|
||
Tier 1 leverage ratio
|
|
8.51
|
|
|
7.69
|
|
|
82
|
|
|
||
Tangible common equity to tangible assets (5)
|
|
8.11
|
|
|
7.76
|
|
|
35
|
|
|
||
Tangible common equity to risk-weighted assets (5)
|
|
13.12
|
|
|
12.82
|
|
|
30
|
|
|
||
Bank CET 1 risk-based capital ratio
|
|
12.75
|
|
|
12.57
|
|
|
18
|
|
|
||
Bank tier 1 risk-based capital ratio
|
|
12.75
|
|
|
12.57
|
|
|
18
|
|
|
||
Bank total risk-based capital ratio
|
|
13.80
|
|
|
13.66
|
|
|
14
|
|
|
||
Bank tier 1 leverage ratio
|
|
7.81
|
|
|
7.19
|
|
|
62
|
|
|
||
Bank tangible common equity to tangible assets (5)
|
|
7.66
|
|
|
7.55
|
|
|
11
|
|
|
||
Bank tangible common equity to risk-weighted assets (5)
|
|
12.82
|
|
|
13.03
|
|
|
(21
|
)
|
|
||
Other Ratios:
|
|
|
|
|
|
|
|
|||||
GAAP operating efficiency ratio (6)
|
|
55.57
|
%
|
|
55.47
|
%
|
|
0.2
|
|
%
|
||
Non-GAAP operating efficiency ratio (2)
|
|
56.35
|
|
|
55.05
|
|
|
2.4
|
|
|
||
Book value per common share (7)
|
|
$
|
71.80
|
|
|
$
|
65.40
|
|
|
9.8
|
|
|
Other Statistics:
|
|
|
|
|
|
|
|
|||||
Average full-time equivalent employees
|
|
2,345
|
|
|
2,160
|
|
|
8.6
|
|
%
|
||
Period-end full-time equivalent employees
|
|
2,347
|
|
|
2,170
|
|
|
8.2
|
|
|
|
(1)
|
See “Results of Operations–Noninterest Income” for a description and reconciliation of non-GAAP core fee income and noninterest income.
|
(2)
|
See “Results of Operations–Noninterest Expense” for a description and reconciliation of non-GAAP noninterest expense and non-GAAP operating efficiency ratio.
|
(3)
|
Ratio represents annualized consolidated net income available to common stockholders divided by quarterly average assets.
|
(4)
|
Ratio represents annualized consolidated net income available to common stockholders divided by quarterly average SVBFG stockholders’ equity.
|
(5)
|
See “Capital Resources–Capital Ratios” for a reconciliation of non-GAAP tangible common equity to tangible assets and tangible common equity to risk-weighted assets.
|
(6)
|
The operating efficiency ratio is calculated by dividing total noninterest expense by total taxable-equivalent net interest income plus noninterest income.
|
(7)
|
Book value per common share is calculated by dividing total SVBFG stockholders’ equity by total outstanding common shares at period-end.
|
|
|
2017 Compared to 2016
|
||||||||||
|
|
Three months ended March 31, increase (decrease) due to change in
|
||||||||||
(Dollars in thousands)
|
|
Volume
|
|
Rate
|
|
Total
|
||||||
Interest income:
|
|
|
|
|
|
|
||||||
Federal Reserve deposits, federal funds sold, securities purchased under agreements to resell, trade receivables purchased and other short-term investment securities
|
|
$
|
458
|
|
|
$
|
608
|
|
|
$
|
1,066
|
|
Fixed income investment portfolio (taxable)
|
|
(8,693
|
)
|
|
7,446
|
|
|
(1,247
|
)
|
|||
Fixed income investment portfolio (non-taxable)
|
|
388
|
|
|
(312
|
)
|
|
76
|
|
|||
Loans, net of unearned income
|
|
33,196
|
|
|
(3,797
|
)
|
|
29,399
|
|
|||
Increase in interest income, net
|
|
25,349
|
|
|
3,945
|
|
|
29,294
|
|
|||
Interest expense:
|
|
|
|
|
|
|
||||||
Interest bearing checking and savings accounts
|
|
16
|
|
|
(2
|
)
|
|
14
|
|
|||
Money market deposits
|
|
(159
|
)
|
|
711
|
|
|
552
|
|
|||
Money market deposits in foreign offices
|
|
2
|
|
|
(1
|
)
|
|
1
|
|
|||
Time deposits
|
|
(4
|
)
|
|
(2
|
)
|
|
(6
|
)
|
|||
Sweep deposits in foreign offices
|
|
(32
|
)
|
|
—
|
|
|
(32
|
)
|
|||
Total (decrease) increase in deposits expense
|
|
(177
|
)
|
|
706
|
|
|
529
|
|
|||
Short-term borrowings
|
|
39
|
|
|
39
|
|
|
78
|
|
|||
3.50% Senior Notes
|
|
2
|
|
|
—
|
|
|
2
|
|
|||
5.375% Senior Notes
|
|
6
|
|
|
3
|
|
|
9
|
|
|||
Junior Subordinated Debentures
|
|
(4
|
)
|
|
5
|
|
|
1
|
|
|||
6.05% Subordinated Notes
|
|
(10
|
)
|
|
87
|
|
|
77
|
|
|||
Total increase in borrowings expense
|
|
33
|
|
|
134
|
|
|
167
|
|
|||
(Decrease) increase in interest expense, net
|
|
(144
|
)
|
|
840
|
|
|
696
|
|
|||
Increase in net interest income
|
|
$
|
25,493
|
|
|
$
|
3,105
|
|
|
$
|
28,598
|
|
•
|
Interest income
for the
three months ended
March 31, 2017
increased by $29.3 million due primarily to:
|
◦
|
A $29.4 million increase in interest income on loans to
$227.3 million
for the
three months ended
March 31, 2017
, compared to
$197.9 million
for the comparable
2016
period. The increase was reflective of an increase in average loan balances of
$3.1 billion
, partially offset by a decrease in both gross loan yields and loan fee yields. Gross loan yields, excluding loan interest recoveries and loan fees, decreased to 4.03 percent from 4.06 percent, reflective of a shift in the mix of our overall loan portfolio from the first quarter of 2016, as well as continued competition which has put downward pressure on the loan yields for newly originated loans and renewals of existing loans, primarily in the Private Equity Division, SVB Accelerator practice and Sponsored Finance group. The decreases in the shift in the mix of our portfolio and margin compression from competition were partially offset by the 25 basis point increase in the target federal funds rate by the Federal Reserve in both December 2016 and March 2017. The shift in the mix of loans primarily reflects growth in private equity/venture capital and SVB Private Bank loans, which tend to be higher credit quality, lower yielding loans. Loan fee yields decreased five basis points to 55 basis points, from 60 basis points in the comparable 2016 period. This decrease was a result of lower amortizing fee income as a percentage of our overall loan portfolio, primarily reflective of the growth of our private equity/venture capital and SVB Private Bank loans which tend to have lower fees.
|
◦
|
A $1.1 million increase in interest income from our Federal Reserve deposits to $3.1 million, compared to $2.1 million in 2016. The increase is reflective of the increase in the target federal funds rate by the Federal Reserve in December 2016 as well as higher average interest-earning cash balances in the first quarter of 2017 as compared to the first quarter of 2016.
|
◦
|
A $1.2 million decrease in interest income on fixed income investment securities to
$90.8 million
for the
three months ended
March 31, 2017
, compared to
$92.0 million
for the comparable
2016
period. The decrease was reflective primarily of a decrease in average fixed income investment securities of $2.2 billion from the first quarter of 2016, as a result of our $2.9 billion of sales of investment securities during the first and second quarters of 2016 to fund loans and repay short-term borrowings. The decrease was partially offset by lower premium amortization expense and higher yields on our fixed income investment portfolio both reflective of higher market interest rates in the latter half of 2016 and during the first quarter of 2017.
|
•
|
Our net interest margin increased by 21 basis points to 2.88 percent for the
three months ended
March 31, 2017
, compared to
2.67
percent for the comparable
2016
period. The higher margin during the first quarter of 2017 was reflective primarily of a shift in the mix of our average interest-earning assets towards our loan portfolio as well as from the impact of the changes in the federal funds target rate from December 2015 through March 2017. The shift was reflective of the utilization of fixed income investment securities to fund loan growth in 2016 as a result of the tempered growth in average deposits. Average loans represented 46 percent of interest earning assets for the first quarter of 2017 compared to 40 percent for the comparable
2016
period.
|
|
|
Three months ended March 31,
|
||||||||||||||||||||
|
|
2017
|
|
2016
|
||||||||||||||||||
(Dollars in thousands)
|
|
Average
Balance
|
|
Interest
Income/
Expense
|
|
Yield/
Rate
|
|
Average
Balance
|
|
Interest
Income/
Expense
|
|
Yield/
Rate
|
||||||||||
Interest-earning assets
:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Federal Reserve deposits, federal funds sold, securities purchased under agreements to resell and other short-term investment securities (1)
|
|
$
|
2,502,930
|
|
|
$
|
3,136
|
|
|
0.51
|
%
|
|
$
|
2,130,958
|
|
|
$
|
2,070
|
|
|
0.39
|
%
|
Investment securities: (2)
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Available-for-sale securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Taxable
|
|
12,550,264
|
|
|
45,707
|
|
|
1.48
|
|
|
14,692,632
|
|
|
50,083
|
|
|
1.37
|
|
||||
Held-to-maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Taxable
|
|
8,495,674
|
|
|
44,096
|
|
|
2.10
|
|
|
8,595,081
|
|
|
40,967
|
|
|
1.92
|
|
||||
Non-taxable (3)
|
|
104,502
|
|
|
994
|
|
|
3.86
|
|
|
63,603
|
|
|
918
|
|
|
5.81
|
|
||||
Total loans, net of unearned income (4) (5)
|
|
20,069,314
|
|
|
227,341
|
|
|
4.59
|
|
|
17,012,435
|
|
|
197,942
|
|
|
4.68
|
|
||||
Total interest-earning assets
|
|
43,722,684
|
|
|
321,274
|
|
|
2.98
|
|
|
42,494,709
|
|
|
291,980
|
|
|
2.76
|
|
||||
Cash and due from banks
|
|
354,684
|
|
|
|
|
|
|
402,433
|
|
|
|
|
|
||||||||
Allowance for loan losses
|
|
(234,274
|
)
|
|
|
|
|
|
(225,344
|
)
|
|
|
|
|
||||||||
Other assets (6)
|
|
1,457,940
|
|
|
|
|
|
|
1,518,392
|
|
|
|
|
|
||||||||
Total assets
|
|
$
|
45,301,034
|
|
|
|
|
|
|
$
|
44,190,190
|
|
|
|
|
|
||||||
Funding sources
:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Interest-bearing liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Interest bearing checking and savings accounts
|
|
$
|
394,928
|
|
|
$
|
75
|
|
|
0.08
|
%
|
|
$
|
313,460
|
|
|
$
|
61
|
|
|
0.08
|
%
|
Money market deposits
|
|
5,525,682
|
|
|
1,498
|
|
|
0.11
|
|
|
6,097,575
|
|
|
946
|
|
|
0.06
|
|
||||
Money market deposits in foreign offices
|
|
151,474
|
|
|
16
|
|
|
0.04
|
|
|
132,171
|
|
|
15
|
|
|
0.05
|
|
||||
Time deposits
|
|
53,811
|
|
|
17
|
|
|
0.13
|
|
|
67,466
|
|
|
23
|
|
|
0.14
|
|
||||
Sweep deposits in foreign offices
|
|
1,123,217
|
|
|
111
|
|
|
0.04
|
|
|
1,437,953
|
|
|
143
|
|
|
0.04
|
|
||||
Total interest-bearing deposits
|
|
7,249,112
|
|
|
1,717
|
|
|
0.10
|
|
|
8,048,625
|
|
|
1,188
|
|
|
0.06
|
|
||||
Short-term borrowings
|
|
67,471
|
|
|
120
|
|
|
0.72
|
|
|
44,752
|
|
|
42
|
|
|
0.38
|
|
||||
3.50% Senior Notes
|
|
347,008
|
|
|
3,142
|
|
|
3.67
|
|
|
346,693
|
|
|
3,140
|
|
|
3.64
|
|
||||
5.375% Senior Notes
|
|
347,636
|
|
|
4,851
|
|
|
5.66
|
|
|
347,063
|
|
|
4,842
|
|
|
5.61
|
|
||||
Junior Subordinated Debentures
|
|
54,478
|
|
|
832
|
|
|
6.19
|
|
|
54,654
|
|
|
831
|
|
|
6.12
|
|
||||
6.05% Subordinated Notes
|
|
46,498
|
|
|
271
|
|
|
2.36
|
|
|
48,295
|
|
|
194
|
|
|
1.62
|
|
||||
Total interest-bearing liabilities
|
|
8,112,203
|
|
|
10,933
|
|
|
0.55
|
|
|
8,890,082
|
|
|
10,237
|
|
|
0.46
|
|
||||
Portion of noninterest-bearing funding sources
|
|
35,610,481
|
|
|
|
|
|
|
33,604,627
|
|
|
|
|
|
||||||||
Total funding sources
|
|
43,722,684
|
|
|
10,933
|
|
|
0.10
|
|
|
42,494,709
|
|
|
10,237
|
|
|
0.09
|
|
||||
Noninterest-bearing funding sources
:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Demand deposits
|
|
32,709,423
|
|
|
|
|
|
|
31,219,504
|
|
|
|
|
|
||||||||
Other liabilities
|
|
612,800
|
|
|
|
|
|
|
624,796
|
|
|
|
|
|
||||||||
SVBFG stockholders’ equity
|
|
3,732,134
|
|
|
|
|
|
|
3,322,362
|
|
|
|
|
|
||||||||
Noncontrolling interests
|
|
134,474
|
|
|
|
|
|
|
133,446
|
|
|
|
|
|
||||||||
Portion used to fund interest-earning assets
|
|
(35,610,481
|
)
|
|
|
|
|
|
(33,604,627
|
)
|
|
|
|
|
||||||||
Total liabilities, noncontrolling interest, and SVBFG stockholders’ equity
|
|
$
|
45,301,034
|
|
|
|
|
|
|
$
|
44,190,190
|
|
|
|
|
|
||||||
Net interest income and margin
|
|
|
|
$
|
310,341
|
|
|
2.88
|
%
|
|
|
|
$
|
281,743
|
|
|
2.67
|
%
|
||||
Total deposits
|
|
$
|
39,958,535
|
|
|
|
|
|
|
$
|
39,268,129
|
|
|
|
|
|
||||||
Reconciliation to reported net interest income
:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Adjustments for taxable equivalent basis
|
|
|
|
(348
|
)
|
|
|
|
|
|
(322
|
)
|
|
|
||||||||
Net interest income, as reported
|
|
|
|
$
|
309,993
|
|
|
|
|
|
|
$
|
281,421
|
|
|
|
|
(1)
|
Includes average interest-earning deposits in other financial institutions of
$799 million
and
$566 million
for the
three months ended
March 31, 2017
and
2016
, respectively. For the
three months ended
March 31, 2017
and
2016
, balances also include
$1.6 billion
and
$1.5 billion
, respectively, deposited at the FRB, earning interest at the Federal Funds target rate.
|
(2)
|
Yields on interest-earning investment securities do not give effect to changes in fair value that are reflected in other comprehensive income.
|
(3)
|
Interest income on non-taxable investment securities are presented on a fully taxable-equivalent basis using the federal statutory income tax rate of 35.0 percent for all periods presented.
|
(4)
|
Nonaccrual loans are reflected in the average balances of loans.
|
(5)
|
Interest income includes loan fees of
$27 million
and
$25 million
for the
three months ended
March 31, 2017
and
2016
, respectively.
|
(6)
|
Average investment securities of
$658 million
and
$781 million
for the
three months ended
March 31, 2017
and
2016
, respectively, were classified as other assets as they were noninterest-earning assets. These investments consisted primarily of non-marketable and other securities.
|
|
|
Three months ended March 31,
|
||||||
(Dollars in thousands, except ratios)
|
|
2017
|
|
2016
|
||||
Allowance for loan losses, beginning balance
|
|
$
|
225,366
|
|
|
$
|
217,613
|
|
Provision for loan losses (1)
|
|
29,679
|
|
|
33,341
|
|
||
Gross loan charge-offs
|
|
(14,030
|
)
|
|
(26,174
|
)
|
||
Loan recoveries
|
|
1,792
|
|
|
4,813
|
|
||
Foreign currency translation adjustments (2)
|
|
323
|
|
|
656
|
|
||
Allowance for loan losses, ending balance
|
|
$
|
243,130
|
|
|
$
|
230,249
|
|
|
|
|
|
|
||||
Allowance for unfunded credit commitments, beginning balance
|
|
$
|
45,265
|
|
|
$
|
34,415
|
|
Provision for unfunded credit commitments
(1)
|
|
1,055
|
|
|
134
|
|
||
Foreign currency translation adjustments
|
|
15
|
|
|
(8
|
)
|
||
Allowance for unfunded credit commitments, ending balance (3)
|
|
$
|
46,335
|
|
|
$
|
34,541
|
|
Ratios and other information:
|
|
|
|
|
||||
Provision for loan losses as a percentage of period-end total gross loans (annualized)
|
|
0.59
|
%
|
|
0.75
|
%
|
||
Gross loan charge-offs as a percentage of average total gross loans (annualized)
|
|
0.28
|
|
|
0.61
|
|
||
Net loan charge-offs as a percentage of average total gross loans (annualized)
|
|
0.25
|
|
|
0.50
|
|
||
Allowance for loan losses as a percentage of period-end total gross loans
|
|
1.18
|
|
|
1.29
|
|
||
Provision for credit losses (1)
|
|
$
|
30,734
|
|
|
$
|
33,475
|
|
Period-end total gross loans
|
|
20,548,651
|
|
|
17,846,081
|
|
||
Average total gross loans
|
|
20,189,562
|
|
|
17,123,718
|
|
|
(1)
|
Our consolidated statements of income were modified from prior periods’ presentation to conform to the current period presentation, which reflect our provision for loan losses and provision for unfunded credit commitments together as our “provision for credit losses”.
|
(2)
|
Reflects foreign currency translation adjustments within the allowance for loan losses. Prior period amount was previously reported with loan recoveries and has been revised to conform to the current period presentation.
|
(3)
|
The “allowance for unfunded credit commitments” is included as a component of “other liabilities.”
|
|
|
Three months ended March 31,
|
|||||||||
(Dollars in thousands)
|
|
2017
|
|
2016
|
|
% Change
|
|||||
GAAP noninterest income
|
|
$
|
117,659
|
|
|
$
|
86,134
|
|
|
36.6
|
%
|
Less: income (loss) attributable to noncontrolling interests, including carried interest allocation
|
|
6,559
|
|
|
(2,671
|
)
|
|
NM
|
|
||
Non-GAAP noninterest income, net of noncontrolling interests
|
|
$
|
111,100
|
|
|
$
|
88,805
|
|
|
25.1
|
|
|
|
|
Three months ended March 31,
|
|||||||||
(Dollars in thousands)
|
|
2017
|
|
2016
|
|
% Change
|
|||||
GAAP noninterest income
|
|
$
|
117,659
|
|
|
$
|
86,134
|
|
|
36.6
|
%
|
Less: gains (losses) on investment securities, net
|
|
15,970
|
|
|
(4,684
|
)
|
|
NM
|
|
||
Less: gains on equity warrant assets, net
|
|
6,690
|
|
|
6,606
|
|
|
1.3
|
|
||
Less: other noninterest income
|
|
12,421
|
|
|
7,670
|
|
|
61.9
|
|
||
Non-GAAP core fee income (1)
|
|
$
|
82,578
|
|
|
$
|
76,542
|
|
|
7.9
|
|
|
(1)
|
Non-GAAP core fee income represents noninterest income, but excludes certain line items where performance is typically subject to market or other conditions beyond our control and includes foreign exchange fees, credit card fees, deposit service charges, lending related fees, client investment fees and letters of credit fees.
|
•
|
Gains of
$5.7 million
from our strategic and other investments portfolio, comprised of gains of $3.4 million related to the partial sale of shares of one of our direct equity investments as well as gains from distributions from our strategic venture capital fund investments, and
|
•
|
Gains of
$3.6 million
from our managed funds of funds portfolio, related primarily to net unrealized valuation increases in the investments held by the funds driven by IPO, M&A and private equity-backed financing activity during the first quarter of 2017.
|
(Dollars in thousands)
|
|
Managed
Funds of
Funds
|
|
Managed
Direct
Venture
Funds
|
|
Debt
Funds
|
|
Available-
For-Sale
Securities
|
|
Strategic
and Other
Investments
|
|
Total
|
||||||||||||
Three months ended March 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Total gains (losses) on investment securities, net
|
|
$
|
10,033
|
|
|
$
|
96
|
|
|
$
|
(431
|
)
|
|
$
|
608
|
|
|
$
|
5,664
|
|
|
$
|
15,970
|
|
Less: income attributable to noncontrolling interests, including carried interest allocation
|
|
6,420
|
|
|
42
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6,462
|
|
||||||
Non-GAAP net gains (losses) on investment securities, net of noncontrolling interests
|
|
$
|
3,613
|
|
|
$
|
54
|
|
|
$
|
(431
|
)
|
|
$
|
608
|
|
|
$
|
5,664
|
|
|
$
|
9,508
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Three months ended March 31, 2016
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Total (losses) gains on investment securities, net
|
|
$
|
(6,481
|
)
|
|
$
|
(634
|
)
|
|
$
|
855
|
|
|
$
|
(817
|
)
|
|
$
|
2,393
|
|
|
$
|
(4,684
|
)
|
Less: (losses) attributable to noncontrolling interests, including carried interest allocation
|
|
(2,587
|
)
|
|
(129
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,716
|
)
|
||||||
Non-GAAP net (losses) gains on investment securities, net of noncontrolling interests
|
|
$
|
(3,894
|
)
|
|
$
|
(505
|
)
|
|
$
|
855
|
|
|
$
|
(817
|
)
|
|
$
|
2,393
|
|
|
$
|
(1,968
|
)
|
|
|
Three months ended March 31,
|
|||||||||
(Dollars in thousands)
|
|
2017
|
|
2016
|
|
% Change
|
|||||
Equity warrant assets (1)
|
|
|
|
|
|
|
|||||
Gains on exercises, net
|
|
$
|
7,956
|
|
|
$
|
6,849
|
|
|
16.2
|
%
|
Cancellations and expirations
|
|
(634
|
)
|
|
(615
|
)
|
|
3.1
|
|
||
Changes in fair value
|
|
(632
|
)
|
|
372
|
|
|
NM
|
|
||
Gains on equity warrant assets, net
|
|
$
|
6,690
|
|
|
$
|
6,606
|
|
|
1.3
|
|
|
(1)
|
At
March 31, 2017
, we held warrants in
1,762
companies, compared to
1,670
companies at
March 31, 2016
. The total value of our warrant portfolio was
$124 million
at
March 31, 2017
and $131 million at
March 31, 2016
. Warrants in 13 companies each had values greater than $1.0 million and collectively represented $29.2 million, or 23.5 percent, of the fair value of the total warrant portfolio at
March 31, 2017
.
|
◦
|
Net gains of
$8.0 million
from the exercise of equity warrant assets during the three months ended
March 31, 2017
, compared to net gains of
$6.8 million
for the comparable
2016
period, primarily reflective of increased M&A activity in the portfolio, and
|
◦
|
Net losses of
$0.6 million
from changes in warrant valuations for the
three months ended
March 31, 2017
, compared to net gains of
$0.4 million
for the comparable
2016
period, primarily driven by a decline in valuation of one company in our private warrant portfolio of $1.9 million, partially offset by warrant valuation gains in the remaining portfolio.
|
|
|
Three months ended March 31,
|
|||||||||
(Dollars in thousands)
|
|
2017
|
|
2016
|
|
% Change
|
|||||
Non-GAAP core fee income (1):
|
|
|
|
|
|
|
|||||
Foreign exchange fees
|
|
$
|
26,247
|
|
|
$
|
26,966
|
|
|
(2.7
|
)%
|
Credit card fees
|
|
17,730
|
|
|
15,507
|
|
|
14.3
|
|
||
Deposit service charges
|
|
13,975
|
|
|
12,672
|
|
|
10.3
|
|
||
Client investment fees
|
|
9,026
|
|
|
7,995
|
|
|
12.9
|
|
||
Lending related fees
|
|
8,961
|
|
|
7,813
|
|
|
14.7
|
|
||
Letters of credit and standby letters of credit fees
|
|
6,639
|
|
|
5,589
|
|
|
18.8
|
|
||
Total non-GAAP core fee income (1)
|
|
$
|
82,578
|
|
|
$
|
76,542
|
|
|
7.9
|
|
|
(1)
|
This non-GAAP measure represents noninterest income, but excludes certain line items where performance is typically subject to market or other conditions beyond our control. See "Use of Non-GAAP Measures" above.
|
|
|
Three months ended March 31,
|
|||||||||
(Dollars in millions)
|
|
2017
|
|
2016
|
|
% Change
|
|||||
Client directed investment assets (1)
|
|
$
|
5,364
|
|
|
$
|
7,318
|
|
|
(26.7
|
)%
|
Client investment assets under management (2)
|
|
23,047
|
|
|
21,731
|
|
|
6.1
|
|
||
Sweep money market funds
|
|
17,719
|
|
|
13,423
|
|
|
32.0
|
|
||
Total average client investment funds (3)
|
|
$
|
46,130
|
|
|
$
|
42,472
|
|
|
8.6
|
|
|
(1)
|
Comprised of mutual funds and Repurchase Agreement Program assets.
|
(2)
|
These funds represent investments in third party money market mutual funds and fixed-income securities managed by SVB Asset Management.
|
(3)
|
Client investment funds are maintained at third party financial institutions and are not recorded on our balance sheet.
|
(Dollars in millions)
|
|
March 31, 2017
|
|
December 31, 2016
|
|
% Change
|
|||||
Client directed investment assets (1)
|
|
$
|
5,241
|
|
|
$
|
5,510
|
|
|
(4.9
|
)%
|
Client investment assets under management (2)
|
|
23,292
|
|
|
23,115
|
|
|
0.8
|
|
||
Sweep money market funds
|
|
17,902
|
|
|
17,173
|
|
|
4.2
|
|
||
Total period-end client investment funds (3)
|
|
$
|
46,435
|
|
|
$
|
45,798
|
|
|
1.4
|
|
|
(1)
|
Comprised of mutual funds and Repurchase Agreement Program assets.
|
(2)
|
These funds represent investments in third party money market mutual funds and fixed-income securities managed by SVB Asset Management.
|
(3)
|
Client investment funds are maintained at third party financial institutions and are not recorded on our balance sheet.
|
|
|
Three months ended March 31,
|
|||||||||
(Dollars in thousands)
|
|
2017
|
|
2016
|
|
% Change
|
|||||
Fund management fees
|
|
$
|
5,169
|
|
|
$
|
4,620
|
|
|
11.9
|
%
|
Service-based fee income
|
|
1,895
|
|
|
2,092
|
|
|
(9.4
|
)
|
||
Gains on revaluation of client foreign currency instruments, net (1)
|
|
2,754
|
|
|
3,653
|
|
|
(24.6
|
)
|
||
Losses on client foreign exchange forward contracts, net (1)
|
|
(2,289
|
)
|
|
(5,654
|
)
|
|
(59.5
|
)
|
||
Gains on revaluation of internal foreign currency instruments, net (2)
|
|
4,108
|
|
|
2,491
|
|
|
64.9
|
|
||
Losses on internal foreign exchange contracts, net (2)
|
|
(3,245
|
)
|
|
(2,208
|
)
|
|
47.0
|
|
||
Other (3)
|
|
4,029
|
|
|
2,676
|
|
|
50.6
|
|
||
Total other noninterest income
|
|
$
|
12,421
|
|
|
$
|
7,670
|
|
|
61.9
|
|
|
(1)
|
Represents the net revaluation of client foreign currency denominated financial instruments. We enter into client foreign exchange forward contracts to economically reduce our foreign exchange exposure related to client foreign currency denominated financial instruments.
|
(2)
|
Represents the net revaluation of foreign currency denominated financial instruments issued and held by us, primarily loans, deposits and cash. We enter into internal foreign exchange forward contracts to economically reduce our foreign exchange exposure related to these foreign currency denominated financial instruments issued and held by us.
|
(3)
|
Includes dividends on FHLB/FRB stock, correspondent bank rebate income, incentive fees related to carried interest and other fee income.
|
•
|
Net gains of $0.5 million on client foreign exchange forward contracts and the revaluation of client foreign currency denominated cash for the three months ended
March 31, 2017
, compared to net losses of $2.0 million for the three months ended
March 31, 2016
on client foreign exchange forward contracts and the revaluation of client foreign currency denominated cash. The net losses for the three months ended
March 31, 2016
was primarily due to a reclassification of $2.8 million in unrealized gains on forward contracts to foreign exchange fee income reflecting fees earned on forward contracts executed on behalf of our clients that were previously recorded in gains on derivative instruments.
|
•
|
Fund management fees of
$5.2 million
as compared to fees of
$4.6 million
for the comparable 2016 period. The increase was due primarily to the addition of new managed funds at SVB Capital.
|
|
|
Three months ended March 31,
|
|||||||||
(Dollars in thousands)
|
|
2017
|
|
2016
|
|
% Change
|
|||||
Compensation and benefits
|
|
$
|
147,176
|
|
|
$
|
122,262
|
|
|
20.4
|
%
|
Professional services
|
|
25,419
|
|
|
19,000
|
|
|
33.8
|
|
||
Premises and equipment
|
|
15,858
|
|
|
14,984
|
|
|
5.8
|
|
||
Business development and travel
|
|
9,195
|
|
|
12,246
|
|
|
(24.9
|
)
|
||
Net occupancy
|
|
11,651
|
|
|
10,035
|
|
|
16.1
|
|
||
FDIC and state assessments
|
|
8,682
|
|
|
6,927
|
|
|
25.3
|
|
||
Correspondent bank fees
|
|
3,445
|
|
|
3,652
|
|
|
(5.7
|
)
|
||
Other
|
|
16,207
|
|
|
14,793
|
|
|
9.6
|
|
||
Total noninterest expense (1)
|
|
$
|
237,633
|
|
|
$
|
203,899
|
|
|
16.5
|
|
|
(1)
|
Our consolidated statements of income were modified from prior periods' presentation to the current period presentation, which reflects our provision for loan losses and provision for unfunded credit commitments together as our "provision for credit losses". In prior periods, our provision for unfunded credit commitments were reported separately as a component of noninterest expense.
|
|
|
Three months ended March 31,
|
|||||||||
(Dollars in thousands, except ratios)
|
|
2017
|
|
2016
|
|
% Change
|
|||||
GAAP noninterest expense
|
|
$
|
237,633
|
|
|
$
|
203,899
|
|
|
16.5
|
%
|
Less: amounts attributable to noncontrolling interests
|
|
169
|
|
|
(91
|
)
|
|
NM
|
|
||
Non-GAAP noninterest expense, net of noncontrolling interests
|
|
$
|
237,464
|
|
|
$
|
203,990
|
|
|
16.4
|
|
|
|
|
|
|
|
|
|||||
GAAP net interest income
|
|
$
|
309,993
|
|
|
$
|
281,421
|
|
|
10.2
|
|
Adjustments for taxable equivalent basis
|
|
348
|
|
|
322
|
|
|
8.1
|
|
||
Non-GAAP taxable equivalent net interest income
|
|
$
|
310,341
|
|
|
$
|
281,743
|
|
|
10.2
|
|
Less: income attributable to noncontrolling interests
|
|
7
|
|
|
3
|
|
|
133.3
|
|
||
Non-GAAP taxable equivalent net interest income, net of noncontrolling interests
|
|
$
|
310,334
|
|
|
$
|
281,740
|
|
|
10.1
|
|
|
|
|
|
|
|
|
|||||
GAAP noninterest income
|
|
$
|
117,659
|
|
|
$
|
86,134
|
|
|
36.6
|
|
Less: income attributable to noncontrolling interests
|
|
6,559
|
|
|
(2,671
|
)
|
|
NM
|
|
||
Non-GAAP noninterest income, net of noncontrolling interests
|
|
$
|
111,100
|
|
|
$
|
88,805
|
|
|
25.1
|
|
|
|
|
|
|
|
|
|||||
GAAP total revenue
|
|
$
|
427,652
|
|
|
$
|
367,555
|
|
|
16.4
|
|
Non-GAAP taxable equivalent revenue, net of noncontrolling interests
|
|
$
|
421,434
|
|
|
$
|
370,545
|
|
|
13.7
|
|
GAAP operating efficiency ratio
|
|
55.57
|
%
|
|
55.47
|
%
|
|
0.2
|
|
||
Non-GAAP operating efficiency ratio (1)
|
|
56.35
|
|
|
55.05
|
|
|
2.4
|
|
|
(1)
|
The non-GAAP operating efficiency ratio is calculated by dividing non-GAAP noninterest expense, net of noncontrolling interests, by non-GAAP taxable-equivalent revenue, net of noncontrolling interests.
|
|
|
Three months ended March 31,
|
|||||||||
(Dollars in thousands, except employees)
|
|
2017
|
|
2016
|
|
% Change
|
|||||
Compensation and benefits:
|
|
|
|
|
|
|
|||||
Salaries and wages
|
|
$
|
66,859
|
|
|
$
|
59,386
|
|
|
12.6
|
%
|
Incentive compensation & ESOP
|
|
33,819
|
|
|
26,628
|
|
|
27.0
|
|
||
Other employee incentives and benefits (1)
|
|
46,498
|
|
|
36,248
|
|
|
28.3
|
|
||
Total compensation and benefits
|
|
$
|
147,176
|
|
|
$
|
122,262
|
|
|
20.4
|
|
Period-end full-time equivalent employees
|
|
2,347
|
|
|
2,170
|
|
|
8.2
|
|
||
Average full-time equivalent employees
|
|
2,345
|
|
|
2,160
|
|
|
8.6
|
|
|
(1)
|
Other employee incentives and benefits includes employer payroll taxes, group health and life insurance, share-based compensation, 401(k), warrant and retention plans, agency fees and other employee-related expenses.
|
•
|
An increase of $7.5 million in salaries and wages, reflective primarily of an increase in the number of average full-time equivalent employees ("FTE") by 185 to 2,345 FTEs for the first quarter of 2017 compared to the first quarter of 2016, and annual pay raises. The increase in headcount was primarily to support our product development, operations, sales and advisory functions, as well as to support our commercial banking and regulatory compliance initiatives.
|
•
|
An increase of $7.2 million in expenses related to incentive compensation plans and ESOP. Our incentive compensation expense is higher in the first quarter of 2017 due to our expected full year performance for 2017 being higher than expectations for both our internal targets and as compared to selected peer banks ROE in comparison to expectations during the same period in 2016.
|
•
|
An increase of $10.3 million in total other employee incentives and benefits, related to various expenses, particularly employer payroll taxes, group health and life insurance and agency fees reflective of our increased headcount in the first quarter of 2017 compared to the first quarter of 2016. The increase in other employee incentives and benefits also includes an increase of $2.3 million in share-based compensation expense, primarily due to our current vesting expectations for our outstanding performance-based restricted stock awards as compared to our estimate for the first quarter of 2016, reflective of the increase in our stock price relative to our peers.
|
|
|
Three months ended March 31,
|
|||||||||
(Dollars in thousands)
|
|
2017
|
|
2016
|
|
% Change
|
|||||
Lending and other client related processing costs
|
|
$
|
5,539
|
|
|
$
|
4,295
|
|
|
29.0
|
%
|
Telephone
|
|
2,703
|
|
|
2,233
|
|
|
21.0
|
|
||
Data processing services
|
|
2,582
|
|
|
1,829
|
|
|
41.2
|
|
||
Dues and publications
|
|
795
|
|
|
802
|
|
|
(0.9
|
)
|
||
Postage and supplies
|
|
749
|
|
|
790
|
|
|
(5.2
|
)
|
||
Other
|
|
3,839
|
|
|
4,844
|
|
|
(20.7
|
)
|
||
Total other noninterest expense
|
|
$
|
16,207
|
|
|
$
|
14,793
|
|
|
9.6
|
|
|
|
Three months ended March 31,
|
|||||||||
(Dollars in thousands)
|
|
2017
|
|
2016
|
|
% Change
|
|||||
Net interest income (1)
|
|
$
|
(7
|
)
|
|
$
|
(3
|
)
|
|
133.3
|
%
|
Noninterest (income) loss (1)
|
|
(5,454
|
)
|
|
3,753
|
|
|
NM
|
|
||
Noninterest expense (1)
|
|
169
|
|
|
(91
|
)
|
|
NM
|
|
||
Carried interest allocation (2)
|
|
(1,105
|
)
|
|
(1,082
|
)
|
|
2.1
|
|
||
Net (income) loss attributable to noncontrolling interests
|
|
$
|
(6,397
|
)
|
|
$
|
2,577
|
|
|
NM
|
|
|
(1)
|
Represents noncontrolling interests’ share in net interest income, noninterest income and noninterest expense.
|
(2)
|
Represents the preferred allocation of income (or change in income) earned by us as the general partner of certain consolidated funds.
|
|
|
Three months ended March 31,
|
|||||||||
(Dollars in thousands)
|
|
2017
|
|
2016
|
|
% Change
|
|||||
Net interest income
|
|
$
|
275,684
|
|
|
$
|
256,178
|
|
|
7.6
|
%
|
Provision for credit losses
|
|
(28,889
|
)
|
|
(32,703
|
)
|
|
(11.7
|
)
|
||
Noninterest income
|
|
79,519
|
|
|
74,759
|
|
|
6.4
|
|
||
Noninterest expense
|
|
(172,374
|
)
|
|
(154,787
|
)
|
|
11.4
|
|
||
Income before income tax expense
|
|
$
|
153,940
|
|
|
$
|
143,447
|
|
|
7.3
|
|
Total average loans, net of unearned income
|
|
$
|
17,647,055
|
|
|
$
|
14,919,735
|
|
|
18.3
|
|
Total average assets
|
|
42,888,336
|
|
|
41,533,434
|
|
|
3.3
|
|
||
Total average deposits
|
|
38,296,563
|
|
|
37,837,645
|
|
|
1.2
|
|
|
|
Three months ended March 31,
|
|||||||||
(Dollars in thousands)
|
|
2017
|
|
2016
|
|
% Change
|
|||||
Net interest income
|
|
$
|
13,610
|
|
|
$
|
13,672
|
|
|
(0.5
|
)%
|
Provision for credit losses
|
|
(790
|
)
|
|
(638
|
)
|
|
23.8
|
|
||
Noninterest income
|
|
718
|
|
|
627
|
|
|
14.5
|
|
||
Noninterest expense
|
|
(3,919
|
)
|
|
(3,405
|
)
|
|
15.1
|
|
||
Income before income tax expense
|
|
$
|
9,619
|
|
|
$
|
10,256
|
|
|
(6.2
|
)
|
Total average loans, net of unearned income
|
|
$
|
2,245,317
|
|
|
$
|
1,871,820
|
|
|
20.0
|
|
Total average assets
|
|
2,259,018
|
|
|
1,893,413
|
|
|
19.3
|
|
||
Total average deposits
|
|
1,336,849
|
|
|
1,130,736
|
|
|
18.2
|
|
|
|
Three months ended March 31,
|
|||||||||
(Dollars in thousands)
|
|
2017
|
|
2016
|
|
% Change
|
|||||
Noninterest income
|
|
$
|
16,775
|
|
|
$
|
2,453
|
|
|
NM%
|
|
Noninterest expense
|
|
(3,472
|
)
|
|
(3,913
|
)
|
|
(11.3
|
)
|
||
Income before income tax expense
|
|
$
|
13,303
|
|
|
$
|
(1,460
|
)
|
|
NM
|
|
Total average assets
|
|
$
|
372,876
|
|
|
$
|
349,011
|
|
|
6.8
|
|
|
•
|
Net gains on investment securities of $10.9 million for the
three months ended
March 31, 2017
, compared to net losses of $1.9 million for the comparable
2016
period. The gains on investment securities of $10.9 million for the
three months ended
March 31, 2017
were related to the partial sale of shares of one of our direct equity investments as well as gains from distributions from our strategic venture capital fund investments and net unrealized valuation increases in the investments held by the funds driven by IPO, M&A and private equity-backed financing activity during the first quarter of 2017.
|
•
|
Fund management fees of $5.2 million compared to
$4.6 million
for the comparable 2016 period. The increase was due primarily to the addition of new managed funds at SVB Capital.
|
|
|
March 31, 2017
|
|||||||||||||||||||||||||||||||||
|
|
Total
|
|
One Year
or Less
|
|
After One Year to
Five Years
|
|
After Five Years to
Ten Years
|
|
After
Ten Years
|
|||||||||||||||||||||||||
(Dollars in thousands)
|
|
Carrying
Value
|
|
Weighted
Average
Yield
|
|
Carrying
Value
|
|
Weighted
Average Yield |
|
Carrying
Value
|
|
Weighted
Average Yield |
|
Carrying
Value
|
|
Weighted
Average Yield |
|
Carrying
Value
|
|
Weighted
Average Yield |
|||||||||||||||
U.S. Treasury securities
|
|
$
|
8,206,090
|
|
|
1.36
|
%
|
|
$
|
2,321,436
|
|
|
0.89
|
%
|
|
$
|
5,884,654
|
|
|
1.54
|
%
|
|
$
|
—
|
|
|
—
|
%
|
|
$
|
—
|
|
|
—
|
%
|
U.S. agency debentures
|
|
2,077,813
|
|
|
1.60
|
|
|
500,035
|
|
|
1.19
|
|
|
1,577,778
|
|
|
1.73
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Agency-issued collateralized mortgage obligations - fixed rate
|
|
1,650,329
|
|
|
2.21
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
622,312
|
|
|
2.02
|
|
|
1,028,017
|
|
|
2.32
|
|
|||||
Agency-issued collateralized mortgage obligations - variable rate
|
|
445,581
|
|
|
0.71
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
445,581
|
|
|
0.71
|
|
|||||
Total
|
|
$
|
12,379,813
|
|
|
1.49
|
|
|
$
|
2,821,471
|
|
|
0.94
|
|
|
$
|
7,462,432
|
|
|
1.58
|
|
|
$
|
622,312
|
|
|
2.02
|
|
|
$
|
1,473,598
|
|
|
1.83
|
|
|
|
March 31, 2017
|
|||||||||||||||||||||||||||||||||
|
|
Total
|
|
One Year
or Less
|
|
After One Year to
Five Years
|
|
After Five Years to
Ten Years
|
|
After
Ten Years
|
|||||||||||||||||||||||||
(Dollars in thousands)
|
|
Amortized Cost
|
|
Weighted-
Average
Yield
|
|
Amortized Cost
|
|
Weighted-
Average
Yield
|
|
Amortized Cost
|
|
Weighted-
Average
Yield
|
|
Amortized Cost
|
|
Weighted-
Average
Yield
|
|
Amortized Cost
|
|
Weighted-
Average
Yield
|
|||||||||||||||
U.S. agency debentures
|
|
$
|
641,421
|
|
|
2.63
|
%
|
|
$
|
—
|
|
|
—
|
%
|
|
$
|
75,459
|
|
|
3.01
|
%
|
|
$
|
565,962
|
|
|
2.58
|
%
|
|
$
|
—
|
|
|
—
|
%
|
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Agency-issued mortgage-backed securities
|
|
3,020,929
|
|
|
2.49
|
|
|
—
|
|
|
—
|
|
|
317,056
|
|
|
2.23
|
|
|
77,461
|
|
|
2.03
|
|
|
2,626,412
|
|
|
2.53
|
|
|||||
Agency-issued collateralized mortgage obligations - fixed rate
|
|
3,223,055
|
|
|
1.74
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
160,700
|
|
|
1.62
|
|
|
3,062,355
|
|
|
1.75
|
|
|||||
Agency-issued collateralized mortgage obligations - variable rate
|
|
299,257
|
|
|
0.74
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
299,257
|
|
|
0.74
|
|
|||||
Agency-issued commercial mortgage-backed securities
|
|
1,292,744
|
|
|
2.25
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,292,744
|
|
|
2.25
|
|
|||||
Municipal bonds and notes
|
|
138,289
|
|
|
3.82
|
|
|
6,168
|
|
|
4.94
|
|
|
55,716
|
|
|
3.81
|
|
|
59,517
|
|
|
3.73
|
|
|
16,888
|
|
|
3.78
|
|
|||||
Total
|
|
$
|
8,615,695
|
|
|
2.14
|
|
|
$
|
6,168
|
|
|
4.94
|
|
|
$
|
448,231
|
|
|
2.56
|
|
|
$
|
863,640
|
|
|
2.43
|
|
|
$
|
7,297,656
|
|
|
2.08
|
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||||||||||
(Dollars in thousands)
|
|
Carrying value (as reported)
|
|
Amount attributable to SVBFG
|
|
Carrying value (as reported)
|
|
Amount attributable to SVBFG
|
||||||||
Non-marketable securities (fair value accounting):
|
|
|
|
|
|
|
|
|
||||||||
Venture capital and private equity fund investments (1)
|
|
$
|
139,715
|
|
|
$
|
35,819
|
|
|
$
|
141,649
|
|
|
$
|
40,464
|
|
Other venture capital investments (2)
|
|
2,040
|
|
|
218
|
|
|
2,040
|
|
|
218
|
|
||||
Other securities (fair value accounting) (3)
|
|
646
|
|
|
119
|
|
|
753
|
|
|
138
|
|
||||
Non-marketable securities (equity method accounting):
|
|
|
|
|
|
|
|
|
||||||||
Venture capital and private equity fund investments
|
|
85,529
|
|
|
65,511
|
|
|
82,823
|
|
|
64,030
|
|
||||
Debt funds
|
|
16,509
|
|
|
16,509
|
|
|
17,020
|
|
|
17,020
|
|
||||
Other investments (4)
|
|
112,665
|
|
|
112,665
|
|
|
123,514
|
|
|
123,514
|
|
||||
Non-marketable securities (cost method accounting):
|
|
|
|
|
|
|
|
|
||||||||
Venture capital and private equity fund investments
|
|
117,243
|
|
|
117,243
|
|
|
114,606
|
|
|
114,606
|
|
||||
Other investments
|
|
28,437
|
|
|
28,437
|
|
|
27,700
|
|
|
27,700
|
|
||||
Investments in qualified affordable housing projects, net
|
|
132,766
|
|
|
132,766
|
|
|
112,447
|
|
|
112,447
|
|
||||
Total non-marketable and other securities
|
|
$
|
635,550
|
|
|
$
|
509,287
|
|
|
$
|
622,552
|
|
|
$
|
500,137
|
|
|
(1)
|
The following table shows the amounts of venture capital and private equity fund investments held by the following consolidated funds and amounts attributable to SVBFG for each fund at
March 31, 2017
and
December 31, 2016
:
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||||||||||
(Dollars in thousands)
|
|
Carrying value (as reported)
|
|
Amount attributable to SVBFG
|
|
Carrying value (as reported)
|
|
Amount attributable to SVBFG
|
||||||||
Strategic Investors Fund, LP
|
|
$
|
18,048
|
|
|
$
|
2,267
|
|
|
$
|
18,459
|
|
|
$
|
2,319
|
|
Capital Preferred Return Fund, LP
|
|
59,225
|
|
|
12,764
|
|
|
57,627
|
|
|
12,420
|
|
||||
Growth Partners, LP
|
|
62,442
|
|
|
20,788
|
|
|
59,718
|
|
|
19,880
|
|
||||
Other private equity fund (i)
|
|
—
|
|
|
—
|
|
|
5,845
|
|
|
5,845
|
|
||||
Total venture capital and private equity fund investments
|
|
$
|
139,715
|
|
|
$
|
35,819
|
|
|
$
|
141,649
|
|
|
$
|
40,464
|
|
|
(i)
|
On January 3, 2017, the other private equity fund was closed resulting in an immaterial impact on the Company's financial statements for the three months ended
March 31, 2017
.
|
(2)
|
The following table shows the amounts of other venture capital investments held by the following consolidated funds and amounts attributable to SVBFG for each fund at
March 31, 2017
and
December 31, 2016
:
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||||||||||
(Dollars in thousands)
|
|
Carrying value (as reported)
|
|
Amount attributable to SVBFG
|
|
Carrying value (as reported)
|
|
Amount attributable to SVBFG
|
||||||||
CP I, LP
|
|
$
|
2,040
|
|
|
$
|
218
|
|
|
$
|
2,040
|
|
|
$
|
218
|
|
Total other venture capital investments
|
|
$
|
2,040
|
|
|
$
|
218
|
|
|
$
|
2,040
|
|
|
$
|
218
|
|
(3)
|
Investments classified as other securities (fair value accounting) represent direct equity investments in public companies held by our consolidated funds.
|
(4)
|
The following table shows the amounts of our other investments (equity method accounting) at
March 31, 2017
and
December 31, 2016
:
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||||||||||
(Dollars in thousands)
|
|
Carrying value (as reported)
|
|
Amount attributable to SVBFG
|
|
Carrying value (as reported)
|
|
Amount attributable to SVBFG
|
||||||||
Other investments:
|
|
|
|
|
|
|
|
|
||||||||
SPD Silicon Valley Bank Co., Ltd.
|
|
$
|
75,316
|
|
|
$
|
75,316
|
|
|
$
|
75,296
|
|
|
$
|
75,296
|
|
Other investments
|
|
37,349
|
|
|
37,349
|
|
|
48,218
|
|
|
48,218
|
|
||||
Total other investments
|
|
$
|
112,665
|
|
|
$
|
112,665
|
|
|
$
|
123,514
|
|
|
$
|
123,514
|
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||||||||
(Dollars in thousands)
|
|
Amount
|
|
Percentage
|
|
Amount
|
|
Percentage
|
||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
||||||
Software/internet
|
|
$
|
5,505,796
|
|
|
26.8
|
%
|
|
$
|
5,668,578
|
|
|
28.3
|
%
|
Hardware
|
|
1,108,735
|
|
|
5.4
|
|
|
1,189,114
|
|
|
5.9
|
|
||
Private equity/venture capital
|
|
8,437,354
|
|
|
41.1
|
|
|
7,747,911
|
|
|
38.7
|
|
||
Life science/healthcare
|
|
1,783,037
|
|
|
8.7
|
|
|
1,866,685
|
|
|
9.3
|
|
||
Premium wine
|
|
203,834
|
|
|
1.0
|
|
|
201,634
|
|
|
1.0
|
|
||
Other
|
|
480,912
|
|
|
2.3
|
|
|
396,458
|
|
|
2.0
|
|
||
Total commercial loans
|
|
17,519,668
|
|
|
85.3
|
|
|
17,070,380
|
|
|
85.2
|
|
||
Real estate secured loans:
|
|
|
|
|
|
|
|
|
||||||
Premium wine
|
|
672,831
|
|
|
3.3
|
|
|
678,745
|
|
|
3.5
|
|
||
Consumer
|
|
2,010,464
|
|
|
9.8
|
|
|
1,925,620
|
|
|
9.6
|
|
||
Other
|
|
43,459
|
|
|
0.2
|
|
|
43,807
|
|
|
0.2
|
|
||
Total real estate secured loans
|
|
2,726,754
|
|
|
13.3
|
|
|
2,648,172
|
|
|
13.3
|
|
||
Construction loans
|
|
71,268
|
|
|
0.3
|
|
|
64,957
|
|
|
0.3
|
|
||
Consumer loans
|
|
230,961
|
|
|
1.1
|
|
|
241,153
|
|
|
1.2
|
|
||
Total gross loans
|
|
$
|
20,548,651
|
|
|
100.0
|
|
|
$
|
20,024,662
|
|
|
100.0
|
|
|
|
March 31, 2017
|
||||||||||||||||||||||
(Dollars in thousands)
|
|
Less than
Five Million
|
|
Five to Ten
Million
|
|
Ten to Twenty
Million
|
|
Twenty to Thirty Million
|
|
Thirty Million or More
|
|
Total
|
||||||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Software/internet
|
|
$
|
1,350,895
|
|
|
$
|
797,917
|
|
|
$
|
1,397,247
|
|
|
$
|
939,218
|
|
|
$
|
1,020,519
|
|
|
$
|
5,505,796
|
|
Hardware
|
|
233,704
|
|
|
188,206
|
|
|
186,639
|
|
|
348,801
|
|
|
151,385
|
|
|
1,108,735
|
|
||||||
Private equity/venture capital
|
|
665,064
|
|
|
787,139
|
|
|
1,191,618
|
|
|
1,001,610
|
|
|
4,791,923
|
|
|
8,437,354
|
|
||||||
Life science/healthcare
|
|
361,657
|
|
|
351,181
|
|
|
476,867
|
|
|
421,192
|
|
|
172,140
|
|
|
1,783,037
|
|
||||||
Premium wine
|
|
66,817
|
|
|
30,561
|
|
|
81,723
|
|
|
24,733
|
|
|
—
|
|
|
203,834
|
|
||||||
Other
|
|
189,264
|
|
|
35,669
|
|
|
42,584
|
|
|
99,102
|
|
|
114,293
|
|
|
480,912
|
|
||||||
Commercial loans
|
|
2,867,401
|
|
|
2,190,673
|
|
|
3,376,678
|
|
|
2,834,656
|
|
|
6,250,260
|
|
|
17,519,668
|
|
||||||
Real estate secured loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Premium wine
|
|
156,030
|
|
|
190,651
|
|
|
219,485
|
|
|
106,665
|
|
|
—
|
|
|
672,831
|
|
||||||
Consumer
|
|
1,731,261
|
|
|
207,285
|
|
|
71,918
|
|
|
—
|
|
|
—
|
|
|
2,010,464
|
|
||||||
Other
|
|
7,952
|
|
|
—
|
|
|
14,574
|
|
|
20,933
|
|
|
—
|
|
|
43,459
|
|
||||||
Real estate secured loans
|
|
1,895,243
|
|
|
397,936
|
|
|
305,977
|
|
|
127,598
|
|
|
—
|
|
|
2,726,754
|
|
||||||
Construction loans
|
|
12,456
|
|
|
23,205
|
|
|
14,080
|
|
|
21,527
|
|
|
—
|
|
|
71,268
|
|
||||||
Consumer loans
|
|
97,880
|
|
|
39,925
|
|
|
2,297
|
|
|
57,214
|
|
|
33,645
|
|
|
230,961
|
|
||||||
Total gross loans
|
|
$
|
4,872,980
|
|
|
$
|
2,651,739
|
|
|
$
|
3,699,032
|
|
|
$
|
3,040,995
|
|
|
$
|
6,283,905
|
|
|
$
|
20,548,651
|
|
|
|
December 31, 2016
|
||||||||||||||||||||||
(Dollars in thousands)
|
|
Less than Five Million
|
|
Five to Ten Million
|
|
Ten to Twenty Million
|
|
Twenty to Thirty Million
|
|
Thirty Million or More
|
|
Total
|
||||||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Software/internet
|
|
$
|
1,317,707
|
|
|
$
|
779,986
|
|
|
$
|
1,657,760
|
|
|
$
|
1,021,486
|
|
|
$
|
891,639
|
|
|
$
|
5,668,578
|
|
Hardware
|
|
252,339
|
|
|
160,534
|
|
|
223,781
|
|
|
244,988
|
|
|
307,472
|
|
|
1,189,114
|
|
||||||
Private equity/venture capital
|
|
635,838
|
|
|
668,998
|
|
|
1,182,427
|
|
|
888,916
|
|
|
4,371,732
|
|
|
7,747,911
|
|
||||||
Life science/healthcare
|
|
328,942
|
|
|
372,171
|
|
|
457,833
|
|
|
420,580
|
|
|
287,159
|
|
|
1,866,685
|
|
||||||
Premium wine
|
|
76,400
|
|
|
25,209
|
|
|
76,609
|
|
|
15,902
|
|
|
7,514
|
|
|
201,634
|
|
||||||
Other
|
|
124,650
|
|
|
40,950
|
|
|
61,228
|
|
|
26,320
|
|
|
143,310
|
|
|
396,458
|
|
||||||
Commercial loans
|
|
2,735,876
|
|
|
2,047,848
|
|
|
3,659,638
|
|
|
2,618,192
|
|
|
6,008,826
|
|
|
17,070,380
|
|
||||||
Real estate secured loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Premium wine
|
|
151,759
|
|
|
172,975
|
|
|
229,750
|
|
|
101,387
|
|
|
22,874
|
|
|
678,745
|
|
||||||
Consumer loans
|
|
1,664,432
|
|
|
196,345
|
|
|
64,843
|
|
|
—
|
|
|
—
|
|
|
1,925,620
|
|
||||||
Other
|
|
8,014
|
|
|
—
|
|
|
14,660
|
|
|
21,133
|
|
|
—
|
|
|
43,807
|
|
||||||
Real estate secured loans
|
|
1,824,205
|
|
|
369,320
|
|
|
309,253
|
|
|
122,520
|
|
|
22,874
|
|
|
2,648,172
|
|
||||||
Construction loans
|
|
23,976
|
|
|
6,685
|
|
|
14,016
|
|
|
20,280
|
|
|
—
|
|
|
64,957
|
|
||||||
Consumer loans
|
|
99,119
|
|
|
29,092
|
|
|
9,473
|
|
|
29,089
|
|
|
74,380
|
|
|
241,153
|
|
||||||
Total gross loans
|
|
$
|
4,683,176
|
|
|
$
|
2,452,945
|
|
|
$
|
3,992,380
|
|
|
$
|
2,790,081
|
|
|
$
|
6,106,080
|
|
|
$
|
20,024,662
|
|
(Dollars in thousands)
|
|
March 31, 2017
|
|
December 31, 2016
|
||||
Gross nonaccrual, past due, and restructured loans:
|
|
|
|
|
||||
Nonaccrual loans
|
|
$
|
138,764
|
|
|
$
|
118,979
|
|
Loans past due 90 days or more still accruing interest
|
|
60
|
|
|
33
|
|
||
Total nonperforming loans
|
|
138,824
|
|
|
119,012
|
|
||
OREO and other foreclosed assets
|
|
—
|
|
|
—
|
|
||
Total nonperforming assets
|
|
$
|
138,824
|
|
|
$
|
119,012
|
|
Performing TDRs
|
|
$
|
16,505
|
|
|
$
|
33,732
|
|
Nonperforming loans as a percentage of total gross loans
|
|
0.68
|
%
|
|
0.59
|
%
|
||
Nonperforming assets as a percentage of total assets
|
|
0.30
|
|
|
0.27
|
|
||
Allowance for loan losses
|
|
$
|
243,130
|
|
|
$
|
225,366
|
|
As a percentage of total gross loans
|
|
1.18
|
%
|
|
1.13
|
%
|
||
As a percentage of total gross nonperforming loans
|
|
175.14
|
|
|
189.36
|
|
||
Allowance for loan losses for nonaccrual loans
|
|
$
|
50,395
|
|
|
$
|
37,277
|
|
As a percentage of total gross loans
|
|
0.25
|
%
|
|
0.19
|
%
|
||
As a percentage of total gross nonperforming loans
|
|
36.30
|
|
|
31.32
|
|
||
Allowance for loan losses for total gross performing loans
|
|
$
|
192,735
|
|
|
$
|
188,089
|
|
As a percentage of total gross loans
|
|
0.94
|
%
|
|
0.94
|
%
|
||
As a percentage of total gross performing loans
|
|
0.94
|
|
|
0.94
|
|
||
Total gross loans
|
|
$
|
20,548,651
|
|
|
$
|
20,024,662
|
|
Total gross performing loans
|
|
20,409,827
|
|
|
19,905,650
|
|
||
Allowance for unfunded credit commitments (1)
|
|
46,335
|
|
|
45,265
|
|
||
As a percentage of total unfunded credit commitments
|
|
0.29
|
%
|
|
0.27
|
%
|
||
Total unfunded credit commitments (2)
|
|
$
|
16,082,331
|
|
|
$
|
16,743,196
|
|
|
(1)
|
The "allowance for unfunded credit commitments" is included as a component of other liabilities and any provision is included in the "provision for credit losses" in the statement of income. See "Provision for credit losses" for a discussion of the changes to the allowance.
|
(2)
|
Includes unfunded loan commitments and letters of credit.
|
(Dollars in thousands)
|
|
March 31, 2017
|
|
December 31, 2016
|
||||
Beginning balance
|
|
$
|
118,979
|
|
|
$
|
123,392
|
|
Additions
|
|
34,324
|
|
|
128,338
|
|
||
Paydowns
|
|
(4,327
|
)
|
|
(81,997
|
)
|
||
Charge-offs
|
|
(10,211
|
)
|
|
(49,622
|
)
|
||
Other reductions
|
|
(1
|
)
|
|
(1,132
|
)
|
||
Ending balance
|
|
$
|
138,764
|
|
|
$
|
118,979
|
|
(Dollars in thousands)
|
|
March 31, 2017
|
|
December 31, 2016
|
|
% Change
|
|||||
Derivative assets, gross (1)
|
|
$
|
190,164
|
|
|
$
|
210,070
|
|
|
(9.5
|
)%
|
Foreign exchange spot contract assets, gross
|
|
76,430
|
|
|
53,058
|
|
|
44.0
|
|
||
Accrued interest receivable
|
|
110,949
|
|
|
111,222
|
|
|
(0.2
|
)
|
||
FHLB and Federal Reserve Bank stock
|
|
57,592
|
|
|
57,592
|
|
|
—
|
|
||
Accounts receivable
|
|
59,224
|
|
|
62,569
|
|
|
(5.3
|
)
|
||
Net deferred tax assets
|
|
90,934
|
|
|
71,840
|
|
|
26.6
|
|
||
Other assets
|
|
90,490
|
|
|
106,337
|
|
|
(14.9
|
)
|
||
Total accrued interest receivable and other assets
|
|
$
|
675,783
|
|
|
$
|
672,688
|
|
|
0.5
|
|
|
(1)
|
See “Derivatives” section below.
|
(Dollars in thousands)
|
|
March 31, 2017
|
|
December 31, 2016
|
|
% Change
|
|||||
Assets:
|
|
|
|
|
|
|
|||||
Equity warrant assets
|
|
$
|
124,233
|
|
|
$
|
131,123
|
|
|
(5.3
|
)%
|
Foreign exchange forward and option contracts
|
|
54,911
|
|
|
68,027
|
|
|
(19.3
|
)
|
||
Interest rate swaps
|
|
318
|
|
|
810
|
|
|
(60.7
|
)
|
||
Client interest rate derivatives
|
|
10,702
|
|
|
10,110
|
|
|
5.9
|
|
||
Total derivative assets
|
|
$
|
190,164
|
|
|
$
|
210,070
|
|
|
(9.5
|
)
|
Liabilities:
|
|
|
|
|
|
|
|||||
Foreign exchange forward and option contracts
|
|
$
|
(45,157
|
)
|
|
$
|
(54,668
|
)
|
|
(17.4
|
)
|
Client interest rate derivatives
|
|
(10,592
|
)
|
|
(9,770
|
)
|
|
8.4
|
|
||
Total derivative liabilities
|
|
$
|
(55,749
|
)
|
|
$
|
(64,438
|
)
|
|
(13.5
|
)
|
|
|
Three months ended March 31,
|
||||||
(Dollars in thousands)
|
|
2017
|
|
2016
|
||||
Balance, beginning of period
|
|
$
|
131,123
|
|
|
$
|
137,105
|
|
New equity warrant assets
|
|
4,073
|
|
|
2,386
|
|
||
Non-cash changes in fair value, net
|
|
(632
|
)
|
|
372
|
|
||
Exercised equity warrant assets
|
|
(9,697
|
)
|
|
(8,578
|
)
|
||
Terminated equity warrant assets
|
|
(634
|
)
|
|
(615
|
)
|
||
Balance, end of period
|
|
$
|
124,233
|
|
|
$
|
130,670
|
|
(Dollars in thousands)
|
|
March 31, 2017
|
|
December 31, 2016
|
|
% Change
|
|||||
Foreign exchange spot contract liabilities, gross
|
|
$
|
122,385
|
|
|
$
|
68,018
|
|
|
79.9
|
%
|
Accrued compensation
|
|
46,189
|
|
|
135,842
|
|
|
(66.0
|
)
|
||
Allowance for unfunded credit commitments
|
|
46,335
|
|
|
45,265
|
|
|
2.4
|
|
||
Derivative liabilities, gross (1)
|
|
55,749
|
|
|
64,438
|
|
|
(13.5
|
)
|
||
Other
|
|
358,897
|
|
|
304,820
|
|
|
17.7
|
|
||
Total other liabilities
|
|
$
|
629,555
|
|
|
$
|
618,383
|
|
|
1.8
|
|
|
(1)
|
See “Derivatives” section above.
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||||||||||
(Dollars in thousands)
|
|
Total Balance
|
|
Level 3
|
|
Total Balance
|
|
Level 3
|
||||||||
Assets carried at fair value
|
|
$
|
12,716,572
|
|
|
$
|
124,239
|
|
|
$
|
12,974,923
|
|
|
$
|
130,853
|
|
As a percentage of total assets
|
|
27.4
|
%
|
|
0.3
|
%
|
|
29.0
|
%
|
|
0.3
|
%
|
||||
Liabilities carried at fair value
|
|
$
|
55,749
|
|
|
$
|
—
|
|
|
$
|
64,438
|
|
|
$
|
—
|
|
As a percentage of total liabilities
|
|
0.1
|
%
|
|
—
|
%
|
|
0.2
|
%
|
|
—
|
%
|
||||
As a percentage of assets carried at fair value
|
|
|
|
1.0
|
%
|
|
|
|
1.0
|
%
|
|
|
|
|
|
|
Minimum Ratios under Applicable Regulatory Capital Adequacy Requirements
|
||||||
|
|
March 31,
2017 |
|
December 31, 2016
|
|
"Well Capitalized”
|
|
“Adequately Capitalized”
|
||||
SVB Financial:
|
|
|
|
|
|
|
|
|
||||
CET 1 risk-based capital ratio
|
|
13.05
|
%
|
|
12.80
|
%
|
|
6.5
|
%
|
|
4.5
|
%
|
Tier 1 risk-based capital ratio
|
|
13.44
|
|
|
13.26
|
|
|
8.0
|
|
|
6.0
|
|
Total risk-based capital ratio
|
|
14.45
|
|
|
14.21
|
|
|
10.0
|
|
|
8.0
|
|
Tier 1 leverage ratio
|
|
8.51
|
|
|
8.34
|
|
|
N/A
|
|
|
4.0
|
|
Tangible common equity to tangible assets ratio (1)
|
|
8.11
|
|
|
8.15
|
|
|
N/A
|
|
|
N/A
|
|
Tangible common equity to risk-weighted assets ratio (1)
|
|
13.12
|
|
|
12.89
|
|
|
N/A
|
|
|
N/A
|
|
Bank:
|
|
|
|
|
|
|
|
|
||||
CET 1 risk-based capital ratio
|
|
12.75
|
%
|
|
12.65
|
%
|
|
6.5
|
%
|
|
4.5
|
%
|
Tier 1 risk-based capital ratio
|
|
12.75
|
|
|
12.65
|
|
|
8.0
|
|
|
6.0
|
|
Total risk-based capital ratio
|
|
13.80
|
|
|
13.66
|
|
|
10.0
|
|
|
8.0
|
|
Tier 1 leverage ratio
|
|
7.81
|
|
|
7.67
|
|
|
5.0
|
|
|
4.0
|
|
Tangible common equity to tangible assets ratio (1)
|
|
7.66
|
|
|
7.77
|
|
|
N/A
|
|
|
N/A
|
|
Tangible common equity to risk-weighted assets ratio (1)
|
|
12.82
|
|
|
12.75
|
|
|
N/A
|
|
|
N/A
|
|
|
(1)
|
See below for a reconciliation of non-GAAP tangible common equity to tangible assets and tangible common equity to risk-weighted assets.
|
|
|
SVB Financial
|
|
Bank
|
||||||||||||
Non-GAAP tangible common equity and tangible assets (Dollars in thousands, except ratios)
|
|
March 31,
2017 |
|
December 31,
2016 |
|
March 31,
2017 |
|
December 31,
2016 |
||||||||
GAAP SVBFG stockholders’ equity
|
|
$
|
3,764,331
|
|
|
$
|
3,642,554
|
|
|
$
|
3,508,871
|
|
|
$
|
3,423,427
|
|
Tangible common equity
|
|
$
|
3,764,331
|
|
|
$
|
3,642,554
|
|
|
$
|
3,508,871
|
|
|
$
|
3,423,427
|
|
GAAP Total assets
|
|
$
|
46,413,339
|
|
|
$
|
44,683,660
|
|
|
$
|
45,807,551
|
|
|
$
|
44,059,340
|
|
Tangible assets
|
|
$
|
46,413,339
|
|
|
$
|
44,683,660
|
|
|
$
|
45,807,551
|
|
|
$
|
44,059,340
|
|
Risk-weighted assets
|
|
$
|
28,691,192
|
|
|
$
|
28,248,750
|
|
|
$
|
27,368,552
|
|
|
$
|
26,856,850
|
|
Tangible common equity to tangible assets
|
|
8.11
|
%
|
|
8.15
|
%
|
|
7.66
|
%
|
|
7.77
|
%
|
||||
Tangible common equity to risk-weighted assets
|
|
13.12
|
|
|
12.89
|
|
|
12.82
|
|
|
12.75
|
|
|
|
Three months ended March 31,
|
||||||
(Dollars in thousands)
|
|
2017
|
|
2016
|
||||
Average cash and cash equivalents
|
|
$
|
2,857,614
|
|
|
$
|
2,533,391
|
|
Percentage of total average assets
|
|
6.3
|
%
|
|
5.7
|
%
|
||
Net cash provided by operating activities
|
|
$
|
96,731
|
|
|
$
|
56,061
|
|
Net cash (used for) provided by investing activities
|
|
(446,211
|
)
|
|
1,474,078
|
|
||
Net cash provided by (used for) financing activities
|
|
1,599,409
|
|
|
(1,164,884
|
)
|
||
Net increase in cash and cash equivalents
|
|
$
|
1,249,929
|
|
|
$
|
365,255
|
|
Change in interest rates (basis points)
(Dollars in thousands) |
|
Estimated
|
|
Estimated Increase/(Decrease) In EVE
|
|
Estimated
|
|
Estimated Increase/
(Decrease) In NII
|
||||||||||||||
|
EVE
|
|
Amount
|
|
Percent
|
|
NII
|
|
Amount
|
|
Percent
|
|||||||||||
March 31, 2017:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
200
|
|
$
|
7,794,970
|
|
|
$
|
2,222,586
|
|
|
39.9
|
%
|
|
$
|
1,782,573
|
|
|
$
|
425,822
|
|
|
31.4
|
%
|
100
|
|
6,757,910
|
|
|
1,185,526
|
|
|
21.3
|
|
|
1,571,462
|
|
|
214,711
|
|
|
15.8
|
|
||||
—
|
|
5,572,384
|
|
|
—
|
|
|
—
|
|
|
1,356,751
|
|
|
—
|
|
|
—
|
|
||||
-100
|
|
5,095,998
|
|
|
(476,386
|
)
|
|
(8.5
|
)
|
|
1,285,706
|
|
|
(71,045
|
)
|
|
(5.2
|
)
|
||||
-200
|
|
5,494,289
|
|
|
(78,095
|
)
|
|
(1.4
|
)
|
|
1,244,504
|
|
|
(112,247
|
)
|
|
(8.3
|
)
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
December 31, 2016:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
200
|
|
$
|
7,435,607
|
|
|
$
|
2,074,881
|
|
|
38.7
|
%
|
|
$
|
1,628,400
|
|
|
$
|
376,020
|
|
|
30.0
|
%
|
100
|
|
6,464,046
|
|
|
1,103,320
|
|
|
20.6
|
|
|
1,439,468
|
|
|
187,088
|
|
|
14.9
|
|
||||
—
|
|
5,360,726
|
|
|
—
|
|
|
—
|
|
|
1,252,380
|
|
|
—
|
|
|
—
|
|
||||
-100
|
|
5,049,829
|
|
|
(310,897
|
)
|
|
(5.8
|
)
|
|
1,191,168
|
|
|
(61,212
|
)
|
|
(4.9
|
)
|
||||
-200
|
|
5,380,594
|
|
|
19,868
|
|
|
0.4
|
|
|
1,154,914
|
|
|
(97,466
|
)
|
|
(7.8
|
)
|
|
|
SVB Financial Group
|
|
|
|
Date: May 10, 2017
|
|
/s/ MICHAEL DESCHENEAUX
|
|
|
Michael Descheneaux
|
|
|
Chief Financial Officer
|
|
|
(Principal Financial Officer)
|
|
|
|
|
|
SVB Financial Group
|
|
|
|
Date: May 10, 2017
|
|
/s/ KAMRAN HUSAIN
|
|
|
Kamran Husain
|
|
|
Chief Accounting Officer
|
|
|
(Principal Accounting Officer)
|
Exhibit
Number
|
|
Exhibit Description
|
|
Incorporated by Reference
|
|
Filed
Herewith
|
||||||
Form
|
|
File No.
|
|
Exhibit
|
|
Filing Date
|
|
|||||
31.1
|
|
Rule 13a-14(a) / 15(d)-14(a) Certification of Principal Executive Officer
|
|
|
|
|
|
|
|
|
|
X
|
31.2
|
|
Rule 13a-14(a) / 15(d)-14(a) Certification of Principal Financial Officer
|
|
|
|
|
|
|
|
|
|
X
|
32.1
|
|
Section 1350 Certifications
|
|
|
|
|
|
|
|
|
|
X
|
101.INS
|
|
XBRL Instance Document
|
|
|
|
|
|
|
|
|
|
X
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
|
|
X
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
Customer name | Ticker |
---|---|
Apartment Investment and Management Company | AIV |
Equity Residential | EQR |
No Suppliers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|